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ABSTRACT 
 
GENOMIC IMPRINTING: ESTABLISHMENT, MAINTENANCE AND STABILITY 
OF DNA METHYLATION IMPRINTS 
Lara K. Abramowitz 
Marisa S. Bartolomei 
Genomic imprinting is an epigenetic phenomenon in which genes are 
monoallelicaly expressed according to their parent-of-origin.  Imprinted expression 
entails marking parental chromosomes so that a specific parental allele is stably repressed 
or expressed. Differential DNA methylation is essential for marking and regulating 
imprinted genes and is often found at imprinting control regions (ICRs).  These DNA 
methylation imprints must be maintained throughout early development despite genome-
wide epigenetic reprogramming to allow for stable allelic expression in differentiated 
tissues.  Moreover, marking of the alleles must be erased in the germline so that 
establishment of sex-specific marks can occur during gametogenesis.  These processes 
are critical for normal imprinting, however, the precise mechanisms and factors involved 
remain largely unknown.  Of particular concern, environmental perturbations occurring 
during times of epigenetic reprogramming have been reported to disrupt imprinting.  In 
this dissertation I investigate both cis and trans mechanisms by which DNA methylation 
confers imprints and how environmental stresses can disrupt imprinted regulation.  I  
show that decreased CpG content at the endogenous paternal H19 ICR in mouse renders 
the ICR unable to silence paternal H19, indicating a cis-regulatory role for CpG density 
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in imprinted regulation of H19.  I also investigate the role that methyl-CpG-binding 
domain (MBD) proteins, involved in DNA methylation dependent repression, have in 
genomic imprinting.  Through analysis of Mbd1 and Mbd2 mutant mice, I find that 
individual MBD proteins are dispensable for normal imprinting.  In a collaborative effort 
to identify factors necessary for resetting of imprints in germ cells, we examine the 
cooperative function of Ten-eleven-translocation (TET)1 and TET2 in the erasure of 
imprints, and show that both TET1 and TET2 are required for demethylation at imprinted 
loci in the germline.  Furthermore, as a collaborative effort, we investigate possible 
deregulation of imprints upon environmental stress through analysis of spermatogonial 
stem cells (SSCs) undergoing aging and cryopreservation.  We find that stressed SSCs 
stably maintain methylation imprints and can produce sperm to be used in 
intracytoplasmic sperm injection that result in normal offspring.  These results provide 
novel insights into mechanisms involved in normal imprint establishment and 
maintenance, as well as the stability of these marks despite environmental perturbations. 
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CHAPTER ONE 
Introduction  
 
1.1 Genomic imprinting 
 
In the mammalian genome, the vast majority of genes are either biallelically 
expressed or repressed.  However, there is a small subset of genes in which expression is 
dependent on the parent-of-origin, these are known as imprinted genes (figure 1.1).  In 
the mouse there has been 150 imprinted genes verified.  Imprinted genes have high 
conservation among mammals, and play essential roles in fetal growth and development 
as well as metabolism and behavior 
(www.mousebook.org/catalog.php?catalog=imprinting).  Whereas many imprinted genes 
are ubiquitously imprinted, some exhibit tissue specific imprinted patterns, for example, 
those imprinted in the placenta (figure 1.3- 1.4) (Frost and Moore, 2010).   
 Imprinted gene expression accounts for the fact that the two parental genomes are 
not equal, as suggested by experiments conducted by the Surani and Saltor laboratories 
throughout the 1980’s.  Pronuclear transfer experiments were used to generate either a 
diploid bimaternal (gynogenetic) or diploid bipaternal (androgentic) conceptus. These 
embryos failed to develop.  The gynogenote developed mostly embryonic tissues, but 
failed to develop extra-embryonic tissues, whereas the androgenote developed extra-
embryonic tissues and failed to develop embryonic tissues.  These experiments 
demonstrated the necessity of transcripts from both parental genomes for normal  
  
  
 
Figure 1.1 Genomic Imprinting
genome which are biallelically expressed or
expression is dependent upon the parent
indicated by arrows.  Parental origin of chromosomes 
 
2 
.  Unlike the majority of genes in the mammalian 
 repressed (purple boxes), imprinted 
-of-origin (blue and red boxes). Expression is 
is indicated to the right.
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development (McGrath and Solter, 1983; McGrath and Solter, 1984; Surani and Barton, 
1983; Surani et al., 1984).   
 In order for genes to be expressed based on their parent-of-origin, the cell must be 
able to recognize the parental origin of each chromosome.  Therefore, one critical 
attribute of imprinted genes is that there is a parental-specific mark.  There are several 
key characteristics that this mark must exhibit to allow for stable parental-specific 
expression.  First, the mark must be able to influence transcription. The mark must also 
be stable and heritable so that imprinting is maintained throughout development. The 
mark is likely to be established in the germline when the maternal and paternal genomes 
do not in occupy the same nucleus.  Finally, the mark must be erasable to allow for 
resetting of the appropriate parental-specific marks to be inherited in the next generation 
(Abramowitz and Bartolomei, 2012).  DNA methylation is the only epigenetic 
modification that fulfills all these criteria.  Accordingly, allele-specific DNA methylation 
has been detected at all imprinted regions identified to date. 
1.2 DNA methylation 
 
DNA methylation in mammals occurs predominantly at the 5-position carbon on 
cytosine residues (5mC) (figure 1.7) followed by guanines (though non-CpG methylation 
has been described in embryonic stem (ES) cells, induced pluripotent stem (iPS) cells and 
oocytes (Lister et al., 2011; Tomizawa et al., 2011)).  This modification is generally 
associated with a repressed chromatin state and silencing of gene expression, as will be 
discussed in section 1.6 (Bird and Wolffe, 1999).   
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 Mammalian DNA methyltransferases fit into two categories, based on their 
preferred substrate; the de novo DNA methyltransferases, DNMT3a and DNMT3b, and 
the maintenance methyltransferase, DNMT1.  DNMT3a and DNMT3b methylate 
previously unmethylated sequences, while DNMT1 copies existing methylation marks 
onto the daughter strand during replication. An E3 ubiquitin protein ligase, UHFR1 (also 
known at NP95 in mouse), is an essential co-factor in maintenance methylation, 
recruiting DNMT1 to hemimethylated sequences (Sharif et al., 2007).  Thus, DNA 
methylation is a stable and heritable mark.  Additionally, there are two non-canonical 
family members, DNMT3L and DNMT2.  Although catalytically inactive, DNMT3L 
associates with DNMT3a and DNMT3b and stimulates their activity (Suetake et al., 
2004). DNMT2 has been shown to methylate tRNA (Goll et al., 2006) and is not likely to 
be involved in DNA methylation as targeted deletion in ES cells had no effect on global 
DNA methylation levels (Okano et al., 1998).   
 DNA methylation is essential for viability, as mice deficient in DNA 
methyltransferases die in early embryogenesis (Li et al., 1992; Okano et al., 1999).  
Importantly, when tested prior to death, these embryos exhibit loss of imprinting at many 
imprinted loci (Kaneda et al., 2004; Li et al., 1993), indicating that DNA methylation is 
not only found at imprinted loci but is critical for imprinted regulation. 
 
1.3 Mechanisms of genomic imprinting 
 
In the mammalian genome there are approximately 150 imprinted genes which 
are clustered throughout the genome.  Generally, a cluster is ~1MB in size, contains both 
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maternally and paternally expressed genes, at least one non-coding RNA, and 
differentially methylated regions (DMRs) (Bartolomei, 2009).  Genes within a cluster are 
co-regulated by a cis-acting regulatory element termed an imprinting control region 
(ICR).  These ICRs have been identified genetically, and when deleted in the mouse 
cause loss of imprinting of the entire cluster (Arney, 2003; Fitzpatrick et al., 2002; Lin et 
al., 2003; Thorvaldsen et al., 1998; Wutz et al., 1997; Yang et al., 1998).  All identified 
ICRs are also DMRs, in which allele-specific methylation is acquired in the parental 
germline (also termed primary or germline DMR).  Since establishment of DNA 
methylation at ICRs occurs at a time when the paternal and maternal genomes are in 
separate compartments (either oocyte or sperm) it allows for parental specific marking of 
imprinted genes.  These DNA methylation marks are then maintained in the offspring by 
DNMT1 (Li et al., 1993), despite genome-wide DNA demethylation in the 
preimplantation embryo (Reik et al., 2001).  Additionally, differential DNA methylation 
can also be established after fertilization in the postimplantation embryo, these regions 
are known as secondary DMRs (Bartolomei, 2009).  The vast majority of ICRs are 
maternally methylated, with methylation at promoters.  In contrast, only three paternally-
methylated ICRs (H19, Rasgrf1,IG-DMR) have been identified each with intergenic 
methylation (Ferguson-Smith, 2011).  Various models for imprinted gene regulation have 
been described, with the best defined being the insulator and long non-coding RNA 
(lncRNA) models (Bartolomei, 2009).  
1.3.1 Insulator model of imprinted regulation 
 
6 
 
The insulator model of imprinting has been best described in regulation of the 
H19/Igf2 locus, which is located on mouse chromosome 7 and human chromosome 
11p15.5.  This model of imprinted regulation is the most evolutionarily ancient (Smits et 
al., 2008). Maternally expressed H19 is a lncRNA that encodes ~2.2kb transcript 
(Bartolomei et al., 1991).  Although the precise function of H19 remains unclear, it 
harbors a microRNA (miR-675) at its first exon (Mineno et al., 2006).  Recently, miR-
675 has been described to play a role in growth suppression (Keniry et al., 2012), which 
supports the hypothesis that H19 acts as a tumor suppressor (Hao et al., 1993; Yoshimizu 
et al., 2008).  Paternally expressed Igf2 encodes a fetal growth factor, Insulin like growth 
factor 2 (DeChiara et al., 1990; DeChiara et al., 1991).  Imprinted expression at this locus 
is regulated by two cis-acting elements; (1) shared enhancers located downstream of H19 
such as those that drive expression in endodermal (Leighton et al., 1995) and mesodermal 
(Kaffer et al., 2001) tissues, and (2) an ICR located between the two genes, ~2-4kb 
upstream of the H19 transcriptional start site (Thorvaldsen et al., 1998).  This element is 
paternally methylated, with methylation established during spermatogenesis and 
maintained throughout development (figure 1.2) (Davis et al., 2000; Tremblay et al., 
1997; Tremblay et al., 1995).   
The insulator model at this locus has been worked out through a series of targeted 
mutations in the mouse and in vitro experiments.  Maternal inheritance of a mutant 
chromosome in which the ICR was deleted, resulted in biallelic Igf2 expression and a 
reduction in total H19 expression.  Conversely, when a paternal chromosome was 
inherited in which the ICR was deleted, H19 was biallelically expressed and total Igf2  
 Figure 1.2 Insulator model of imprinting at the mouse 
of maternally expressed H19
regulated by a paternally methylated ICR (grey box) harboring 4 CTCF binding sites 
(green lines).  The unmethylated maternal allele binds CTCF (green hexagon) blocking 
shared enhancers (black ovals)
(CH3) ICR, allowing interaction of 
Expression is indicated by arrows.  Parental origin of chromosomes is indicated to the 
right. 
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expression was reduced (Thorvaldsen et al., 1998; Thorvaldsen et al., 2002).  
Interestingly, when enhancers were inserted between the ICR and Igf2, Igf2 became 
biallelically expressed with no effect on H19 expression (Webber et al., 1998).  
Subsequently, it was shown that CTCF, a protein that acts as an enhancer blocker at the 
chicken β-globin locus (Bell et al., 1999), binds at the ICR in a methylation sensitive 
manner (Bell and Felsenfeld, 2000; Hark et al., 2000; Kaffer et al., 2000; Kanduri et al., 
2000; Szabo et al., 2000).  The unmethylated ICR was demonstrated to function as an 
insulator in vitro (Bell and Felsenfeld, 2000; Hark et al., 2000; Kaffer et al., 2000; 
Kanduri et al., 2000).  Thus, the following model for imprinted regulation at the H19 
locus has been proposed (Figure 1.2); CTCF binds the unmethylated maternal ICR, 
establishing an insulator, and blocking shared enhancers from accessing Igf2 promoters.  
CTCF is unable to bind to the methylated ICR, allowing the shared enhancers to interact 
with Igf2 on the paternal allele.  Furthermore, methylation at the paternal ICR leads to 
secondary methylation at the H19 promoter, silencing paternal H19 (Srivastava, 2002; 
Thorvaldsen et al., 1998; Tremblay et al., 1997).  Therefore, the insulator activity of the 
ICR regulates maternal H19 and paternal Igf2 expression. 
 Various mouse mutants have subsequently supported the role of the ICR as a 
methylation sensitive insulator regulating imprinted activity of the locus.  When CTCF 
was unable to bind the maternal ICR (either by deletion or mutations of CTCF binding 
sites), Igf2 was biallelically expressed with reduction of H19 expression (Engel et al., 
2006; Pant et al., 2004; Schoenherr et al., 2003; Szabo et al., 2004; Thorvaldsen et al., 
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1998). Furthermore, paternal inheritance of a mutant ICR that allowed binding of CTCF, 
lead to biallelic H19 expression and a reduction of Igf2 expression, (Engel et al., 2004). 
 Although the H19/Igf2 locus has been the only locus characterized to be regulated 
by the insulator model, allelic CTCF binding has been described at other imprinted loci 
(Fitzpatrick et al., 2007; Hikichi et al., 2003; Kernohan et al., 2010; Lin et al., 2011; 
Yoon et al., 2005).  At the Rasgrf1 locus there is evidence suggesting insulator activity 
(Yoon et al., 2005), however, further investigation is necessary to determine if imprinting 
at this locus is regulated in the same manner as H19/Igf2, which requires identification of 
enhancers. 
1.3.2 long non-coding RNA model of imprinted regulation 
 
The majority of imprinted loci use the lncRNA model of imprinted regulation 
(Koerner et al., 2009; Santoro and Barlow, 2011).  At these imprinted loci, a promoter for 
a lncRNA is within the ICR.  Transcription of the lncRNA is necessary for the imprinted 
regulation of the cluster in cis.  The best characterized loci that use the lncRNA 
mechanism of imprinted expression are the Igf2r and Kcnq1 imprinted clusters. 
Imprinting at the Igf2r cluster is coordinated by the paternally expressed lncRNA Airn, 
which contains a differentially methylated promoter that acts as the ICR (Wutz et al., 
1997).  Here, transcription of Airn represses Igf2r ubiquitously, and Slc22a2 and Slc22a3 
in the placenta.  Thus, Igf2r is maternally expressed in all tissues where Airn is expressed, 
and Slc22a2 and Slc22a3 are maternally expressed in the placenta.  Also at this locus are 
biallelically expressed genes Slc22a1 and Mas1, which are interspersed between the 
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imprinted genes.  In addition to the ICR, a secondary DMR is found at this cluster at the 
paternally-methylated Igf2r promoter (Stoger et al., 1993). Interestingly, inheritance of a 
paternal allele carrying a truncated Airn transcript resulted in loss of imprinting of the 
entire cluster in embryonic and placental tissues, whereas maternal truncation had no 
effect (Sleutels et al., 2002).  Thus, transcription of the full length lncRNA Airn is 
required for proper imprinting of the locus (figure 1.3).  Recently, different mechanisms 
for Airn mediated repression have been proposed for regulation of Igf2r and Slc22a3.  
Analysis of a series of Airn truncation mutant ES cells indicated that silencing of Igf2r 
required transcriptional overlap of the Igf2r promoter.  Thus, transcriptional interference, 
rather than the Airn product is critical for Igf2r silencing (Latos et al., 2012).  In contrast, 
it has been proposed that Airn interacts with the Slc22a3 promoter and recruits the 
histone methyltransferase G9a in placenta (Nagano et al., 2008).  Therefore, Airn 
mediated repression could be acting through different mechanisms to confer tissue- 
specific imprinted expression. 
 Imprinting at the Kcnq1 cluster exhibits many features similar to that at the Igf2r 
cluster.  Imprinting is dependent upon a paternally expressed lncRNA, Kcnq1ot1, whose 
promoter is an ICR exhibiting maternal-specific methylation (Smilinich et al., 1999).  
Additionally, a secondary DMR is located at the promoter for Cdkn1c (Bhogal et al., 
2004). Expression of Kcnq1ot1 is necessary for maternal specific expression of 
neighboring genes in cis (Fitzpatrick et al., 2002; Mancini-Dinardo et al., 2006).  
Interestingly, only Cdkn1c is ubiquitously imprinted, Kcnq1 only exhibits imprinted 
  
 
Figure 1.3 lncRNA model of imprinting at the mouse 
coordinated by paternal expression of the 
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 expression until ~E15.5 (Mancini-Dinardo et al., 2006; Umlauf et al., 2004).  
Additionally, several genes, such as Osbp15, Cd81, Tssc4, are imprinted exclusively in 
the placenta (figure 1.4) (Green et al., 2007; Umlauf et al., 2004).  Similar to Airn, 
paternal inheritance of a truncated Kcnq1ot1 transcript resulted in a loss of imprinting of 
the cluster (Mancini-Dinardo et al., 2006; Shin et al., 2008), except for Cdkn1c which 
maintained proper imprinted expression in a subset of embryonic tissues (Shin et al., 
2008).  Details of the mechanism by which Kcnq1ot1 acts to repress other genes in the 
cluster remains to be elucidated. 
1.4 Genomic imprinting and human disease 
 
Imprinted genes play essential roles in prenatal and postnatal growth and 
development, as well as metabolism and behavior.  Because dosage of these genes is 
tightly regulated, disease can result from chromosomal abnormalities, genetic or 
epigenetic mutations.  There are a number of human congenital diseases associated with 
imprinted clusters (Thorvaldsen and Bartolomei, 2007), including Prader-Willi Syndrome 
(PWS), Angelman Syndrome (AS), Beckwith-Wiedemann Syndrome (BWS) and Silver-
Russell Syndrome (SRS).  Additionally, loss of imprinting contributes to a variety of 
malignancies (Girardot et al., 2012). 
Failure to express genes within the SNRPN imprinted domain, located in the 
proximal arm of chromosome 15, results in PWS and AS.  Silencing of paternally 
expressed genes within this domain causes PWS, a condition characterized by infantile 
hypotonia, early childhood obesity, short stature, small hands and feet, growth hormone  
  
 
Figure 1.4 lncRNA model of imprinting at the mouse 
this locus is regulated by paternal expression of the lncRNA 
The Kcnq1ot1 promoter is contained within a maternally
box).  Expression of Kcnq1ot1
cis, (red and pink boxes) with many genes imprinted only in the placenta (pink boxes).  
Additionally, this locus harbors biallelically expressed genes (purple
Expression is indicated by arrows.  Parental origins of chromosome are indicated to the 
right and gene names are either indicated within the box or between the chromosomes.
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deficiency, hypogonadism, mental deficiency and behavioral problems (Butler, 2009).  
Loss of function of the maternally expressed gene UBE3A, which is involved in early 
brain development, causes AS.  AS is characterized by seizures, mental retardation, jerky 
arm movements, inappropriate laughter, lack of speech, among other symptoms (Butler, 
2009).  The majority of patients with BWS have abnormal methylation at 11p15, which 
harbors both the H19 and KCNQ1 clusters, resulting in the loss of maternal expression of 
the cell cycle inhibitor CDKN1C or increased expression of the paternally expressed 
growth factor IGF2 (Choufani et al., 2010).  This disease is characterized by macrosomia, 
macroglossia, prominent eyes with periorbital fullness and creased ears (Butler, 2009).  
Overexpression of CDKN1C or decreased expression of IGF2 cause SRS, characterized 
by growth retardation (Shmela and Gicquel, 2013). 
An increased risk of imprinting disorders has been described in children 
conceived by assisted reproductive technologies (ART), including in vitro fertilization 
and intracytoplasmic sperm injection (ICSI) (Owen and Segars, 2009).  These procedures 
involve endocrine stimulation of the ovary, embryo culture, and transfer of 
preimplantation embryos, which have all been shown to cause alteration of DNA 
methylation and deregulation of imprinted genes in mice (de Waal et al., 2012b; Doherty 
et al., 2000; Fauque et al., 2007; Mann et al., 2004; Rivera et al., 2008; Sato et al., 2007).  
Whereas studies suggest an increased prevalence of imprinting disorders (particularly 
BWS and AS) (Owen and Segars, 2009) in children conceived from ART, it is unclear if 
this increased risk is due to ART procedures or the underlying infertility of the parents.  
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Additionally, these syndromes are rare making it difficult to pinpoint the underlying 
contributing factors for these disorders. 
1.5 Epigenetic reprogramming in mammalian development 
 
 Although DNA methylation patterns in somatic-differentiated cells are generally 
stable and heritable, there are two waves of genome-wide DNA methylation 
reprogramming that takes place in mammalian development.  These DNA demethylation 
and remethylation events occur in the germline and the preimplantation embryo (figures 
1.5-1.6) (Reik et al., 2001).  Whereas it has been well known that the de novo DNMTs 
are involved in resetting methylation marks (Abramowitz and Bartolomei, 2012), the 
mechanisms of DNA demethylation and the enzymes involved are just beginning to be 
elucidated.  DNA demethylation can occur in two ways; (1) replication dependent 
(passive DNA demethylation) and (2) replication independent (active DNA 
demethylation).  Recently, the discovery of 5-hydroxymethylcytosine (5hmC) and the 
enzymes that coordinate the conversion of 5mC to 5hmC, Ten-eleven translocation (TET) 
1,2,3 proteins, has given us new insights into the mechanism of DNA demethylation (Ito 
et al., 2010; Kriaucionis and Heintz, 2009; Tahiliani et al., 2009) (Figure 1.7).   
It is important to note that many of the techniques used to analyze DNA 
methylation differ in the ability to distinguish between 5mC and 5hmC.  Bisulfite 
sequencing, for example, cannot distinguish between 5mC and 5hmC.  However, 
antibodies specific to the different residues have been raised and verified.  Additionally, 
there is ongoing effort to develop single base resolution techniques for distinguishing 
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between the two modifications, which include oxidative bisulfite sequencing (oxBS-seq) 
(Booth et al., 2012) and Tet-assisted bisulfite sequencing (TAB-seq) (Yu et al., 2012). 
1.5.1 Erasure of DNA methylation in primordial germ cells 
 
The resetting of methylation at imprinted loci in primordial germ cells (PGCs) is 
essential for sex-specific methylation patterns to be inherited in the next generation.  
First, somatic patterns of DNA methylation need to be fully erased so that subsequent 
establishment of sex-specific marks can occur.   
In mice PGCs are specified by external signals from the epiblast at E6.5 and arise 
from a small population of about 40 cells at E7.25 (Saitou, 2009).  At E9.5 a small 
population of about 200 cells start to migrate through the hindgut endoderm and reach the 
genital ridges at ~E10.5 (Saitou, 2009).  During this time, PGCs undergo widespread 
epigenetic changes including, loss of histone modifications, loss of DNA methylation and 
reactivation of the silent allele of imprinted genes (Hajkova et al., 2008; Hajkova et al., 
2002; Szabo and Mann, 1995).  
  A number of recent studies suggests that demethylation of PGCs occur in two 
stages in the mouse; the first corresponding to the migration phase at ~E8.5 and the 
second with the gonadal stage at ~E10.5 (Guibert et al., 2012; Hackett et al., 2013; 
Kagiwada et al., 2013; Seisenberger et al., 2012).  This first round of DNA demethylation 
is when the majority of sequences become demethylated, with ~30% of CpGs being 
methylated in E9.5 PGCs reduced from ~71% of CpGs methylated in E6.5 epiblasts 
(Seisenberger et al., 2012).  Many studies suggest that this bulk demethylation occurs in a 
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passive/replication dependent manner, that is, the DNA is replicated with a failure of 
maintenance methylation by DNMT1. Despite the presence of DNMT1 (Hajkova et al., 
2002) in PGCs, loss of methylation follows the kinetics of a replication dependent 
mechanism (Hackett et al., 2013).  In PGCs, UHFR1 is detected as being excluded from 
the nucleus and no DNMT1 is detected at replication foci (Kagiwada et al., 2013).  
Furthermore, E9.5 PGCs have a high number of hemimethylated CpG sites, suggesting a 
loss of maintenance methylation (figure 1.5) (Seisenberger et al., 2012).   
From E9.5 methylation levels drop gradually in the gonadal phase, to ~15% of 
CpGs methylated in E11.5 PGCs and again to ~14% and 7% in E13.5 male and female 
PGCs, respectively (Seisenberger et al., 2012).  This second, gonadal phase is when 
imprint erasure is completed (figure 1.5) (Hackett et al., 2013; Hajkova et al., 2008; 
Seisenberger et al., 2012).  A recent study that distinguished between 5mC and 5hmC 
reported conversion of ICR 5mC to 5hmC in PGCs.  Interestingly, the timing of this 
conversion differed for individual imprinted loci.  For example, in PGCs, ICRs at the 
Kcnq1 and Igf2r clusters were enriched for 5hmC by E10.5, while ICRs at Peg3 and 
Peg10 loci were not enriched for 5hmC until day E11.5.  This conversion corresponds 
with timing of when Tet1 andTet2 expression peaks, at ~ E10.5-11.5 PGCs (with no 
detectable Tet3) (Hackett et al., 2013).  How the 5hmC marks are removed still requires 
further investigation, though Hackett et al., 2013, found that the kinetics of 5hmC loss 
followed a replication dependent model at Peg3 and Peg10.  Additionally, various 
components of the base excision repair pathway, AID (a deaminase) and TDG (a  
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glycosylase), have been implicated in erasure of methylation in PGCs (figure 1.7) 
(Cortellino et al., 2011; Popp et al., 2010).  AID deficient E13.5 PGCs have subtle global 
increases in methylation levels (Popp et al., 2010) and E11 PGCs lacking TDG had high 
levels of methylation at the Igf2 promoter.  However, these observations could be 
explained by developmental delay in the mutant PGCs, and methods used in both studies 
could not distinguish between 5mC and 5hmC.  Therefore, further analysis is necessary 
to determine a definitive role of these BER components in reprogramming of PGCs.  
 Although the majority of the genome is demethylated in PGCs there are a few 
regions that escape erasure, for example, intracisternal-A-particles (IAPs) (figure 1.5) 
(Guibert et al., 2012; Hackett et al., 2013; Lane et al., 2003; Seisenberger et al., 2012). 
IAPs are evolutionarily the most recently acquired transposon family in the mouse 
genome, and thus potentially the most active (Qin et al., 2010).  Methylation at IAPs may 
be required to suppress this potentially active element.  Interestingly, maintenance of 
methylation at IAPs occurs even though UHFR1 is expressed only at very low levels and 
appears cytosolic, and DNMT1 is not detected at replication foci (Kagiwada et al., 2013).  
Therefore, it is unclear if methylation maintenance at IAPs in PGCs occurs using a novel 
mechanism, or if current technologies are not sensitive enough to detect these proteins 
acting in PGCs. 
1.5.2 Establishment of DNA methylation in the germline 
 
In female PGCs low levels of DNA methylation persist from E13.5 (Seisenberger 
et al., 2012), with de novo methylation occurring after birth in the growing oocyte (Bao et 
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al., 2000).  Methylation of ICRs in growing oocytes is completed by the time oocytes 
arrest in metaphase II (figure 1.5) (Lucifero, 2004). Males, in contrast, exhibit robust de 
novo methylation in E16.5 PGCs (figure 1.5) (Seisenberger et al., 2012) with methylation 
at ICRs completed postnatally by the pachytene stage of meiosis (Davis et al., 2000). 
Timing of methylation acquisition occurs in a locus-specific manner, with Snrpn, 
Igf2r and Peg3 gaining significant methylation in oocytes by 10 days postpartum (dpp), 
and Peg1 gaining methylation later, at ~25 dpp (Lucifero, 2004).  Interestingly, 
acquisition of methylation at Snrpn occurs asymmetrically, with the maternal allele 
methylated earlier than the paternal (Lucifero, 2004).  Asymmetric acquisition of 
methylation has also been observed at the H19 locus, with the paternal allele methylated 
prior to the maternal (Davis et al., 2000).  These observations suggest that an epigenetic 
marking exists at these loci carrying somatic memory.  In the case of H19, CTCF sites 
have been implicated for somatic memory by coordinating allele-specific histone 
modifications that facilitate marking of the parental origin of each allele (Lee et al., 
2010). 
As previously mentioned, de novo methylation is deposited by DNMT3a, 
DNMT3b and the co-factor DNMT3L.  Studies of conditional knockouts of Dnmt3a and 
Dnmt3b in germ cells provide evidence that DNMT3a is required for de novo methylation 
of all ICRs (both maternal and paternal) except for the paternally-methylated Rasgrf1 
ICR, which resembles repetitive DNA and requires both DNMT3a and DNMT3b 
(Kaneda et al., 2004; Kato et al., 2007).  A defect in the establishment of methylation of 
germline DMRs was also observed in mice deficient for DNMT3L (Bourc'his and Bestor, 
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2004; Bourc'his et al., 2001).  Oocytes deficient for DNMT3L lack methylation at 
maternal DMRs.  Additionally, Dnmt3L null females exhibit a maternal lethal phenotype, 
in which embryos are hypomethylated at all maternally-methylated ICRs but global 
methylation is not reduced (Bourc'his et al., 2001).  DNMT3L also plays a critical role in 
establishment of paternal methylation imprints.  Whereas reports vary on the extent that 
paternal ICRs are affected in DNMT3L deficient male germ cells, ICRs at H19/Igf2, 
Rasgrf1 and Gtl2 (IG-DMR) require DNMT3L for full methylation (Bourc'his and 
Bestor, 2004; Kaneda et al., 2004; Kato et al., 2007; Webster, 2005).  
Although the DNA methylation machinery is now well-established, it remains to 
be determined how this machinery is recruited to specific CpGs.  Interestingly, a link has 
been found between histone methylation and DNA methylation.  DNMT3L has binding 
affinity for nucleosomes containing unmethylated H3K4, which is abolished with the 
addition of methyl groups to this residue (Ooi et al., 2007).  These results suggest that 
patterns of histone methylation could dictate patterns of DNA methylation, which could 
then be stably inherited.  Furthermore, oocytes that lack lysine demethylase 1B 
(KDM1B), a H3K4 demethylase, are hypomethylated at a number of imprinted loci 
(Ciccone et al., 2009), suggesting that an unmethylated H3K4 is necessary for DNA 
methylation.  Consistently, male germ cells assayed at the onset of de novo methylation 
reveal high levels of H3K4me3 at the maternally-methylated Snrpn and Kcnq1 ICRs but 
absence of H3K4me3 at paternally-methylated H19 ICR and IG-DMR, suggesting that 
H3K4me3 prevents maternally-methylated DMRs from acquiring DNA methylation in 
the male germline (Henckel et al., 2011).  Interestingly, the association of DNA 
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methylation with an unmethylated H3K4 and the protection from DNA methylation with 
methylation of H3K4 is not limited to imprinted loci, but is also observed genome-wide 
(Meissner et al., 2008; Weber et al., 2007).  
 Even with the observation that DNA methylation requires a favorable histone 
environment, it is still unclear if there are any sequence signatures that distinguish ICRs 
from other CpG rich regions in the genome.  One such signature has been proposed to be 
the spacing of CpGs at ICRs.  Molecular modeling of the DNMT3a/DNMT3L complex 
indicates an optimal periodicity of CpGs for methylation at about 8-10 base pairs (Jia et 
al., 2007).  Interestingly, this periodicity was reported at 12 maternal ICRs (Jia et al., 
2007).  However, recent studies were unable to detect this trend at ICRs in both oocytes 
and sperm (Tomizawa et al., 2011) and were unable to detect a difference in CpG spacing 
between methylated and unmethylated CpG islands in oocytes and sperm (Smallwood et 
al., 2011).  Overall, the role of CpG spacing as a signature for ICRs remains unclear.  
 Many reports have uncovered a link between transcription and methylation 
establishment.  For example, as described above, KDM1B is critical for establishment of 
methylation of many maternal ICRs (Ciccone et al., 2009).  Interestingly, the human 
orthologue of KDM1B, LSD2, is associated with gene bodies of actively transcribed 
genes (Fang et al., 2010).  Additionally, the PWWP domain of DNMT3a binds 
H3K36me3, a mark of transcriptional elongation, which increases the methyltransferase 
activity of DNMT3a in vitro (Dhayalan et al., 2010).  These observations suggest that de 
novo methylation is targeted to sites of active transcription.     
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In accordance, multiple imprinted loci have been shown to require transcription 
for establishment of DNA methylation, the first of these being the Gnas locus (Chotalia 
et al., 2009).  This locus encodes multiple transcripts; the protein coding transcripts Gnas, 
Gnasx1 and Nesp and the non-coding transcripts Nespas and 1A.  This region contains 
two maternally methylated DMRs, one that encompasses the Gnasx1 and Nespas 
promoters, which acts as the ICR, and another that covers the 1A promoter. A targeted 
mutation in the mouse that truncated the Nesp transcript, the furthest upstream transcript, 
and caused hypomethylation (in varying degrees) at all DMRs in mutant oocytes 
(Chotalia et al., 2009), suggesting a defect in methylation establishment.  Interestingly, 
transcripts are also detected in growing oocytes at the maternally-methylated ICRs of the 
Grb10, Igf2r, Impact, Kcnq1, Zac1 and Snrpn imprinted loci (Chotalia et al., 2009; 
Mapendano et al., 2006).    
The imprinted Rasgrf1 locus, which harbors a paternally-methylated ICR, also 
requires transcription for methylation establishment (Watanabe et al., 2011).  In 
spermatogonia of mice mutant for various proteins in the piRNA pathway, including 
MILI, MIWI2 and MITOPLD, the Rasgrf1 ICR, but not other paternally-methylated 
DMRs, exhibited reduced methylation.  Further analysis revealed that a ncRNA (pit-
RNA) transcribed from the Rasgrf1 ICR was targeted by piRNAs, causing cleavage of 
this RNA.  The authors propose a model in which targeting of piRNAs to pit-RNA is an 
important step in sequence specific methylation at the Rasgrf1 locus (Watanabe et al., 
2011).  
24 
 
Although paternal-specific methylation of the H19 ICR and IG-DMR does not 
require the piRNA pathway (Watanabe et al., 2011), transcription is detected at both of 
these ICRs specifically in male PGCs at the onset of de novo methylation (Henckel et al., 
2011).  Together, these studies provide evidence suggesting the requirement of 
transcription at both maternally- and paternally-methylated ICRs. Nevertheless, 
additional experiments are necessary to prove the causality of this transcription in 
methylation establishment.  
1.5.3 Reprogramming in the preimplantation embryo 
  
Upon fertilization, two differentiated cell types with drastically different 
methylation levels, ~90% methylation in sperm and ~40% methylation in oocytes 
(Kobayashi et al., 2012), unite to form a zygote.  The epigenetic signature of these 
gametes must be erased in order to regain developmental totipotency.  However, 
throughout this reprogramming, imprints must be conserved in order to maintain the 
parental origin of each chromosome (figure 1.6).   
After fertilization the maternal and paternal genomes are in separate pronuclei 
that undergo disparate mechanisms of epigenetic reprogramming. The maternal genome 
is passively demethylated over subsequent cleavage divisions with the exclusion of 
DNMT1 from the nucleus (Howell et al., 2001; Mayer et al., 2000).  In contrast, the 
paternal pronucleus loses 5mC before the first cell division (Mayer et al., 2000; Oswald 
et al., 2000), suggesting an active mechanism of DNA demethylation (figure 1.6).  
Although a number of models for active DNA demethylation have been proposed, there  
  
 
 
Figure 1.6 Epigenetic reprogramming in the p
wide DNA demethylation after fertilization occurs with differing dynamics for the 
maternal and paternal genome.  The maternal genome is passively demethylated (red 
line) whereas the paternal genome is actively demethylated (blue line) by conversion 
5hmC.  Throughout this reprogramming, imprints and IAPs maintain DNA methylation.  
The majority of remethylation subsequently occurs shortly after implantation.
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is increasing evidence that supports the conversion of 5mC to 5hmC as a route to 
demethylation. 
Original studies indicating active DNA demethylation of the paternal genome 
used immunofluorescence with an antibody against 5mC, which detected a clear loss of 
5mC signal (Mayer et al., 2000; Oswald et al., 2000).  More recent studies reveal that 
concomitant with the loss of 5mC signal there is a strong increase in signal for 5hmC and 
the further oxidation products, 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) 
(Gu et al., 2011; Inoue et al., 2011; Inoue and Zhang, 2011; Iqbal et al., 2011; Wossidlo 
et al., 2011).  TET3 is the enzyme required for these oxidation reactions.  Tet3 is highly 
expressed in preimplantation embryos and is enriched on the paternal pronucleus (Gu et 
al., 2011; Wossidlo et al., 2011).  Analysis of 5hmC and 5mC by immunoflourecsense in 
zygotes derived from Tet3-/- oocytes revealed no 5hmC signals and retained 5mC signal 
on paternal pronuclei.  Loss of 5hmC, 5fC and 5caC from the paternal genome occurs in 
a passive manner with gradual dilution over cleavage divisions (Gu et al., 2011; Inoue et 
al., 2011; Inoue and Zhang, 2011; Wossidlo et al., 2011).  However, other pathways have 
been implicated in demethylation of the paternal pronucleus.  For example, small 
molecule inhibition of BER pathway proteins PARP1 and APE1 result in increased 
methylation of the paternal genome (Hajkova et al., 2010).  Whereas there is great 
evidence for passive loss of 5hmC, 5fC, and 5caC modifications of bulk DNA, other 
mechanisms might be employed at individual loci (figure 1.7).   
Although the paternal and maternal genomes share the ooplasm, the maternal 
genome is not converted to 5hmC, and must be protected from this oxidation.  The 
 Figure 1.7 TET mediated oxidation of 5mC and models of DNA demethylation
Oxidation of 5mC to 5hmC and further derivatives 5fC and 5caC are mediated by TETs 
1/2/3.  Demethylation can occur either in a replication dependent (passive) manner or in 
an enzymatically driven manner.  The base excision repair (BER) pathway and various 
enzymes involved (as indicated) have been implicated in DNA demethylation.  
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maternal factor STELLA (also known at DPP3a or PGC7) is critical for protection of 
both the maternal genome and paternally-methylated ICRs (as will be discussed) 
(Nakamura et al., 2007; Nakamura et al., 2012).  STELLA is recruited to these regions by 
H3K9me2 and inhibits TET3 binding, thus preventing oxidation of 5mC (Nakamura et 
al., 2012). 
 Despite genome-wide reprogramming, there are several elements that maintain 
DNA methylation in the early embryo; ICRs, IAPs, as well as some CpG island 
promoters (figure 1.6) (Smallwood et al., 2011; Smith et al., 2012).  DNA methylation is 
retained at imprinted loci by a combination of both DNMT1 and an oocyte-specific 
isoform, DNMT1o (Cirio et al., 2008; Hirasawa et al., 2008; Howell et al., 2001), and 
recruited by UHRF1 (Sharif et al., 2007). 
 Several trans-acting factors have been implicated in protecting ICRs from 
demethylation in a locus-specific manner.  As mentioned, STELLA is implicated in 
retention of methylation at maternally-methylated (Peg1, Peg3 and Peg10) as well as 
paternally-methylated ICRs (H19 and Rasgrf1) (Nakamura et al., 2007), presumably by 
protection of conversion to 5hmC (Nakamura et al., 2012).  MBD3, a member of the 
repressive nucleosomes remodeling and deacetylase (NuRD) complex, is required in the 
preimplantation embryo for maintaining methylation specifically at the H19 locus (Reese 
et al., 2007).  Furthermore, ZFP57, a KRAB zinc finger protein, is required for 
maintenance of methylation at a number of imprinted loci, including Snrpn, Peg1, Peg3, 
Peg5 and Dlk1 (Li et al., 2008), most likely through its interaction with KAP1 
(Quenneville et al., 2011). 
29 
 
 Not only does the methylated allele need to retain methylation at imprinted loci 
during embryonic reprogramming, but the unmethylated allele must maintain its 
hypomethylated status during subsequent remethylation.  At the H19 ICR maintenance of 
the hypomethylated maternal allele is accomplished by binding of CTCF.  Embryos 
containing a mutant maternal allele that cannot bind CTCF gain methylation during 
embryogenesis (Engel et al., 2006; Pant et al., 2003; Szabo et al., 2004).  In accordance 
with this model, mice with a mutant paternal allele that can bind CTCF, lose methylation 
during embryogenesis (Engel et al., 2004). 
1.6 Models for DNA methylation dependent repression 
  
 Generally, DNA methylation is a repressive epigenetic mark, though reports have 
suggested an activating role at specific loci (Wu et al., 2010; Yu et al., 2013).  Two 
models for DNA methylation dependent repression have been described. The first being a 
direct mechanism in which the presence of 5mC inhibits binding of transcription factors 
to DNA (figure 1.8).  Many transcription factors have been identified that cannot bind to 
methylated DNA, such as E2f, CREB and, as described above, CTCF (Bell and 
Felsenfeld, 2000; Campanero et al., 2000; Hark et al., 2000; Iguchi-Ariga and Schaffner, 
1989).  Thus, expression would be silenced without transcription factor binding.  The 
second model is an indirect mechanism that involves recruitment of proteins that bind 
methylated DNA and associate with chromatin modifiers (figure 1.8).  Two families of 
proteins have been identified that fit into this second model, methyl-CpG-binding domain  
  
  
 
Figure 1.8 Models of DNA methylation dependent repression
methylation can occur either directly (A) by inhibiting binding of transcription factors 
or indirectly (B) through binding of methyl
interact with transcriptional repressors and chromatin modifiers to coordinate a 
repressive chromatin environment.
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(MBD) proteins and Kaiso proteins.  These models are not mutually exclusive and can 
work in concert (Klose and Bird, 2006).   
 In addition to these mechanisms, the DNMTs have been implicated in setting up a 
repressive chromatin state upon the deposition of methylation marks.  DNMT1 has been 
shown to interact with chromatin modifiers and transcriptional repressors, for example, 
HDAC1/2, EZH2 and HP1 (Fuks et al., 2000; Robertson et al., 2000; Rountree et al., 
2000; Smallwood et al., 2007; Vire et al., 2006).  Association with these proteins would 
allow the establishment of a repressive chromatin environment throughout cell divisions.  
Furthermore, DNMT3b interacts with HDACs 1/2, HP1, Suv39h1 and the ATP 
dependent chromatin remodeler hSNF2H (Geiman et al., 2004). 
1.6.1 MBD proteins and transcriptional repression 
 
The MBD family of proteins includes 5 members; MECP2, MBD1, MBD2, 
MBD3 and MBD4.  The MBD was initially identified as the minimal domain of MECP2 
necessary for binding methylated DNA in vitro (Nan et al., 1993).  A subsequent 
homology search led to the identification of MBD1, MBD2, MBD3 and MBD4 
(Hendrich and Bird, 1998).  With the exception of MBD3, which contains amino acid 
substitutions that prevent direct binding to methylated DNA (Ohki et al., 1999), the MBD 
family of proteins binds methylated DNA and interacts with transcriptional repressors 
(figure 1.9) (Bogdanović and Veenstra, 2009). 
MECP2 was the first identified and is the most studied MBD family member.  
Mutations in human MECP2, an X-linked gene, cause the debilitating progressive  
 Figure 1.9 Methyl-CpG-
in mammals, all of which can bind methylated DNA at the methyl binding domain 
(MBD, purple box), except MBD3 which has an amino acid substitution (red star) that 
does not allow direct binding to 5mC.  MECP2, MBD1 and MBD2 
transcriptional repression domain (TRD, pink box), which interacts with co
and chromatin modifiers.  MBD1 also contains CxxC motifs (grey box) that allow 
binding to unmethylated DNA.  MBD4, with a glycosylase domain (green box), is 
involved in DNA repair. 
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neurodevelopmental disorder Rett Syndrome (Amir et al., 1999).  As with all X-linked 
disorders, Rett Syndrome more severely affects males, leading to death either prenatally 
or within the first two years of life (Schule et al., 2008). Thus, the vast majority of Rett 
patients are female.  MECP2 associates with various co-repressor complexes such as 
Sin3a, NCoR and c-Ski through interaction with the transcriptional repression domain 
(TRD) (figure 1.9) (Jones et al., 1998; Kokura et al., 2001). In vitro experiments indicate 
that targeting MECP2 to promoter DNA causes transcriptional repression (Jones et al., 
1998; Nan et al., 1998). 
Mecp2 null mice have neurological defects resembling those of Rett Syndrome, as 
well as reduced brain size and body weight (Chen et al., 2001; Guy et al., 2001).  There 
has been much effort in the field to identify targets of MECP2 as these genes could be 
causal in Rett Syndrome, however, transcriptional profiling of Mecp2 null brains indicate 
few and subtle changes (Nuber et al., 2005; Tudor et al., 2002).  Although deregulation of 
specific genes has not been identified, increased histone acetylation levels (Shahbazian et 
al., 2002) and increased transcription of transposable elements (Skene et al., 2010) have 
been detected in MECP2 deficient mouse brains.  Recently, MECP2 was shown to bind 
5hmC in the mouse brain, though the implications of this binding has yet to be 
determined (Mellen et al., 2012). 
MECP2 has been detected as bound to the imprinted loci U2af1-rs1, Ube3a, H19 
and Dlx5 in vivo (Fournier et al., 2002; Gregory et al., 2001; Horike et al., 2005; 
Kernohan et al., 2010; Samaco et al., 2005).  Moreover, deregulation of GNAS, IGF2 and 
UBE3A has been reported in Rett patient lymphocytes and postmortem brains (Ballestar 
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et al., 2005; Makedonski et al., 2005; Samaco et al., 2005). In accordance with these 
observations, in vitro analysis implicated MECP2 in the regulation of H19 (Drewell et al., 
2002).  Surprisingly, when allele-specific expression analysis was performed in Mecp2-/y 
adult mouse brain normal imprinting was detected (Samaco et al., 2005).   
 In addition to the MBD, MBD1 also contains a TRD, as well as CxxC domains 
that allow binding to unmethylated DNA (figure 1.9) (Ohki et al., 1999).  MBD1 has 
been shown to interact with repressive chromatin modifiers such as Suv39h1-HP1 (Fujita 
et al., 2003).  The functional importance of MBD1 was demonstrated in HeLa cells, 
where MBD1 was shown to interact with SETDB1 during replication.  This complex is 
recruited to chromatin by CAF1 to establish new repressive H3K9 methyl marks after 
replication, which was shown to be necessary for proper silencing of the p53BP2 
promoter (Sarraf and Stancheva, 2004). 
 Studies of patients with autism have identified mutations at MBD1 as potentially 
causative (Li et al., 2005; O'Donnell et al., 2010).  Similarly, Mbd1-/- phenotypes manifest 
most prominently in the adult brain with deficits in adult neurogenesis and hippocampal 
function, as well as autism like behaviors (Allan et al., 2008; Zhao et al., 2003).    
Analysis of Mbd1-/- adult neural stem cells has uncovered a role for MBD1 in regulation 
of a number of miRNAs, which is likely methylation independent as methylated CpGs 
are not present in proximity to the miRNAs (Liu et al., 2013; Liu et al., 2010).  MBD1 
has been described bound to U2af1-rs1 imprinted gene by ChIP analysis (Fournier et al., 
2002).  However, imprinting analysis in Mbd1 null mice has not been reported.   
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 MBD2 also binds methylated CpGs and confers transcriptional repression through 
its TRD (figure 1.9) (Boeke et al., 2000; Ng et al., 1999).  MBD2 is a component of the 
NuRD complex.  In accordance, repression established by MBD2 is sensitive to HDAC 
inhibitors (Zhang et al., 1999).   
 Mbd2 null mice are viable and develop normally but have abnormal maternal 
behaviors, decreased intestinal tumorigenesis and disordered T-cell differentiation 
(Hendrich, 2001; Hutchins et al., 2002; Sansom et al., 2003).  Analysis of the Mbd2 null 
mouse has revealed MBD2 dependent repression at specific genes.  One such study 
reported leaky expression of IL-4 in T-cells (Hutchins et al., 2002).  Additionally, 
deficiency of MBD2 on an APC (tumor suppressor) mutant background revealed elevated 
levels of known Wnt targets (Phesse et al., 2008) in the small intestine.  However, it is 
unknown if MBD2 deficiency alone would cause this upregulation.   Analysis of male 
Mbd2-/- mice revealed proper repression of the Xist gene (involved in X-chromosome 
inactivation) (Hendrich, 2001), though analysis of male Mbd2-/- fibroblasts revealed leaky 
Xist expression (Barr et al., 2007).  It is therefore unclear if this leaky expression was due 
to cell culture conditions or loss of MBD2.  Of  interest, MBD2 has been reported bound 
to the imprinted gene Peg3 in cyclophilin A knockdown P9 cells (Lu et al., 2006).  
However, early studies of the Mbd2 null mice identified normal imprinting in adult brain, 
heart and spleen (Hendrich, 2001).   
 Unlike the other MBD family members, MBD3 cannot bind methylated DNA 
(figure 1.9) (Hendrich, 2001; Ohki et al., 1999).  A recent study has indicated binding of 
MBD3 to 5hmC (Yildirim et al., 2011), however, other groups have been unable to 
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confirm this binding (Hashimoto et al., 2012).  MBD3 is an essential member of the 
NuRD complex (Saito and Ishikawa, 2002; Zhang et al., 1999), though it is likely that 
MBD2 and MBD3 form mutually exclusive NuRD complexes (Le Guezennec et al., 
2006) with distinct binding profiles (Baubec et al., 2013; Gunther et al., 2013). 
 MBD3 is essential for viability as Mbd3-null embryos die at ~E8.5 (Hendrich, 
2001).  Furthermore, Mbd3-/- ES cells have a compromised ability to differentiate (Kaji et 
al., 2006; Kaji et al., 2007).  Whereas MBD3 itself does not bind methylated DNA, it has 
been detected at H19 and U2af1-rs1 imprinted loci, which is likely indirect binding 
(Fournier et al., 2002; Reese et al., 2007).  Additionally, as described above, MBD3 has 
been implicated in maintaining DNA methylation at the H19 ICR throughout 
embryogenesis as blastocysts depleted of MBD3 lose methylation at the ICR and 
imprinted expression of H19 (Reese et al., 2007).   
 MBD4, which binds methylated DNA but lacks a TRD, is a thymine glycosylase 
(figure 1.9).  MBD4 acts as a DNA repair protein targeting sites of cytosine deamination 
(Hendrich et al., 1999).  In accordance with MBD4 as a DNA repair protein, mutations in 
MBD4 have been found in cancers with microsatellite instability (Riccio et al., 1999). 
Moreover, mice deficient for MDB4 have increased cytosine to thymine transitions and 
an increased rate of tumorigenesis (Millar et al., 2002; Wong et al., 2002).   
 
In this dissertation I have taken a two-fold approach to understanding mechanisms 
of imprinted regulation by (1) investigating the processes of how DNA methylation 
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marks and coordinates repression throughout normal mammalian development and (2) 
studying how these processes could be disrupted by environmental perturbations.  In 
chapter 2, I focus on the H19/Igf2 locus by defining a role for DNA methylation density 
in ICR mediated repression.  I find that a CpG-depleted ICR is insufficient for paternal 
H19 silencing in vivo.  Chapter 3 focuses on the role of MBD1 and MBD2 as trans-
factors mediating allele-specific repression at imprinted loci.  Here, I show that these 
MBD proteins individually are dispensable for normal imprinting at several loci. In 
chapter 4, I describe work investigating factors involved in reprogramming imprints in 
the germline.  In collaboration with the laboratory of Dr. Guo-Liang Xu at the Shanghai 
Institutes for Biological Sciences, Chinese Academy of Sciences, we identify a 
cooperative role for TET1 and TET2 in erasure of imprints in germ cells.  In Chapter 5, I 
worked in collaboration with Dr. Ralph Brinster’s laboratory at the University of 
Pennsylvania School of Veterinary Medicine, to investigate possible abnormalities in 
DNA methylation at imprinted loci in in vivo and in vitro aged spermatogonial stem cells, 
and ICSI derived offspring from spermatogonial stem cells frozen for ~14 years.  We find 
that extreme aging, cryopreservation or ICSI does not significantly disrupt methylation at 
imprinted loci, suggesting that spermatogonial stem cells are resistant to these 
environmental perturbations.  
Overall, this dissertation provides important insights into the cis and trans acting 
mechanisms involved in imprint establishment and maintenance. Understanding how 
DNA methylation regulates imprinted repression will further elucidate the etiology of 
imprinting disorders as well as other diseases caused by aberrant DNA methylation, 
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including cancer.   Moreover, as reproductive technologies advance, we are faced by new 
challenges in human reproduction. Several ART procedures have been linked to 
disruption of imprinting. This work provides evidence that methylation imprints are in 
fact stable in spermatogonial stem cells that have undergone aging and cryopreservation, 
suggesting that these techniques can be valuable sources for male infertility treatment. 
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CHAPTER TWO 
THE ROLE OF CpG CONTENT IN ICR-MEDIATED REPRESSION OF 
PATERNAL H19  
 
Imprinted expression of H19 and Igf2 in the mouse is dependent upon a 
differentially methylated ICR (as described in chapter 1.3.1) (Srivastava et al., 2000; 
Thorvaldsen et al., 1998; Tremblay et al., 1997).  Analysis of mutant mice has 
highlighted the importance of differential methylation at the ICR in both maternal H19 
expression and paternal H19 repression.  Studies clearly show that the unmethylated 
maternal ICR binds CTCF, which is required for insulation, maintenance of 
hypomethylation and activation of maternal H19 expression (Engel et al., 2006; 
Schoenherr et al., 2002; Szabo et al., 2004).  On the paternal allele, methylation at the 
ICR spreads to the H19 promoter, repressing paternal H19 expression (Srivastava et al., 
2000; Thorvaldsen et al., 1998; Tremblay et al., 1997).  Additionally, in vitro analysis 
indicated that location of CpGs within CTCF sites (but not outside of the CTCF sites) at 
the ICR was critical for repression of a reporter gene (Chen et al., 2008).  While the ICR 
has been well defined to regulate imprinted expression of H19, our understanding of how 
methylation at the ICR acts to repress paternal H19 remains incomplete.    
 Previously generated mutations at the endogenous H19 ICR have suggested the 
presence of cis-acting elements necessary for paternal H19 silencing. Aside from ICR 
deletion, which resulted in loss of imprinting upon both maternal and paternal inheritance 
(figure 2.1) (Srivastava et al., 2000; Thorvaldsen et al., 1998), there has been two mouse 
mutants described in which loss of imprinting occurred exclusively when the mutant  
 Figure 2.1 Mutant paternal ICRs and corresponding phenotypes
paternal ICR (top panel, white box) and published paternal mutant ICRs (references 
indicated) are drawn with corresponding phenotypes. Depicted are methylated CpGs 
(CH3), wild type CTCF binding sites (R1
mutant CTCF binding sites (red box), CTCF binding (green ovals), deleted sequence 
(black box).  Expression is indicated with an arrow.
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allele was paternally inherited. Upon paternal inheritance of a CpG-depleted ICR, in 
which 9 CpGs within CTCF binding sites had been mutated (H19DMD-9CG), the mutant 
paternal allele was hypomethylated and paternal H19 expression was detected (figure 
2.1). In mutant embryos, total Igf2 expression was decreased indicating the formation of 
an insulator, evidenced by a 40% decrease in size of the pups (Engel et al., 2004).  
Because CTCF was able to bind the mutant paternal ICR it remains unclear if paternal 
H19 expression was due to aberrant CTCF binding (resulting in hypomethylation and 
formation of an insulator) or because the allele had decreased CpG content.  Additionally, 
paternal inheritance of a mutant allele in which half of the ICR had been deleted 
(including two CTCF binding sites and more than half of the CpGs (H19Silk)), resulted in 
paternal H19 expression, though the mutant allele remained hypermethylated with normal 
Igf2 expression (figure 2.1) (Drewell et al., 2000).  Again, it is unclear if paternal H19 
expression was caused by deletion of CTCF sites, decreased size of the ICR or lowered 
number of CpGs.  
 Together, these studies (Drewell et al., 2000; Engel et al., 2004) implicate a cis-
acting regulatory role for the ICR in H19 repression, but it remains elusive whether 
paternal H19 expression resulted from a decrease in CpG content at the ICR or 
manipulations/deletion of CTCF sites (figure 2.1).  I addressed this question through 
analysis of a mouse mutant in which 8 CpGs within the ICR but outside of CTCF sites 
had been mutated (H19ICR-8nrCG) (figure 2.2).  Paternal inheritance of this allele resulted in 
paternal H19 expression, indicating that CpG density at the ICR is required for silencing 
H19.  The target vector and targeting scheme was designed by Dr. Nora Engel. In  
 Figure 2.2 8nrCG mutant ICR
outside of CTCF binding sites (NR regions 1
indicated in red lettering.  
Depiction of wild type ICR is drawn for comparison. CTCF binding sites (R1
also indicated (green boxes).
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addition to Dr. Engel, Dr. Marisa Bartolomei, Dr. Joanne Thorvaldsen and Christopher 
Krapp contributed to the target vector construction and isolation of targeted alleles.  I 
performed all of the breeding and analysis as well as all work for in vitro repressor 
assays.  The results were combined with analysis of a mouse mutant in which the 
sequence between CTCF sites 2 and 3 had been deleted (H19ICR-∆IVS) (Figure 2.1) and 
published in Ideraabdullah and Abramowitz et al. 2011. 
2.1 Generation of the H19ICR-8nrCG allele and experimental design 
 
To determine the role of CpG content at the ICR in H19 repression, mice carrying 
a mutant allele at the endogenous locus (H19ICR-8nrCG) were generated by homologous 
recombination in mouse ES cells.  This mutant decreased the number of CpGs at the ICR 
by 8 (~16% depletion) without changing the size of the ICR or disrupting CTCF binding 
sites (figure 2.2-2.3A).  Germline transmission of the targeted clones and Cre mediated 
excision of the neor cassette in the mouse were confirmed by southern blot (figure 2.3B).   
Mutant mice were bred onto a C57BL/6 (B6) strain and heterozygous mutants 
were crossed with wild type B6(CAST7) (C7) mice, which contained chromosome 7s 
from the Mus musculus castaneous (CAST) on a mostly B6 background (Mann, 2003).  
Tissues from F1 heterozygous mutant progeny were analyzed for imprinting defects as 
compared to wild type littermates.  Analysis was performed for both paternal and 
maternal inheritance of the mutant H19ICR-8nrCG allele (figure 2.4). 
  
 Figure 2.3 Generation of the 
scheme at the H19 locus. Positions (in kb) are relative to 
Southern probes (A, B and C) indicated by horizontal lines below locus. The 
endogenous H19 ICR (white rectangle) containing CTCF sites (white triangles), the 
H19ICR-8nrCG mutation (white box, dashed lines indicate mutated CpG sites), 
(gray boxes), neor cassette (dotted box), 
DNA (thin line) and pBluescript II KS (thick line) are shown. (
mice carrying correctly targeted alleles using external probe A 
internal probe C-SacI digest (ii).
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H19 transcription start site. 
loxP sites (black arrowheads), 129/Sv 
B) Southerns to confirm 
- EcoRV digest (i) and 
 
 
wild type 
H19 exons 
H19 
 Figure 2.4 Mating schemes to analyze effect of 
expression.  Heterozygous mice carrying the 
background were mated with 
carrying the H19ICR-8nrCGallele were analyzed for imprinting defects at the 
locus as compared to wild type
paternally (A) or maternally (B) inherite
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 littermates.  Analysis was performed on mice that either 
d the H19ICR-8nrCG allele.  
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2.2 Aberrant H19 expression from the paternal H19ICR-8nrCG allele 
 
 To determine the effects of the 8nrCG mutation on imprinting at the H19/Igf2 
locus, allele-specific expression of heterozygous mutants that paternally inherited the 
mutant allele was analyzed.  First, H19 allelic expression was assayed in neonatal tissue 
by either an RNase protection assay in liver (figure 2.5A) or RT-PCR in tongue (figure 
2.5B).  Derepression of paternal H19 was detected in both tissues.  This aberrant paternal 
H19 expression was detected as early as E6.5 in extra-embryonic tissues (figure 2.5C) 
and E13.5 in embryonic tissues (figure 2.7).   
 Biallelic H19 expression in previously described mutants had also correlated with 
a decrease in size of the mutant mouse (Engel et al., 2004; Thorvaldsen et al., 1998). 
Here, despite biallelic H19 expression, no size difference was observed between 
heterozygous mutants and wild type littermates (figure 2.6A).  Additionally, no change in 
total Igf2 was detected in neonatal livers of 8nrCG mutants compared to wild type 
littermates (figure 2.6B), suggesting that the loss of imprinting phenotype is specific to 
H19 and that Igf2 expression was not perturbed by the formation of an insulator on the 
mutant paternal allele. 
2.3 Aberrant H19 expression from the paternal H19ICR-8nrCG correlates with 
developmental and tissue-specific expression of total H19 
 Aberrant paternal expression from the H191CR-8nrCG allele was not detectable at all 
developmental time points and tissues where H19 is normally expressed, for example, 
E9.5 embryo (figure 2.5D).  Analysis was therefore performed to assess whether 
  
Figure 2.5 Aberrant H19
Allele-specific expression of 
from neonatal liver (A) or RT
conceptuses or (D) E9.5 embryos 
heterozygous mutants (+/8nrCG) and
indicated.  The percent H19
the panels.  
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 expression from the paternal H19ICR-8nrCG allele
H19 was analyzed by an RNase protection assay on RNA 
-PCR on cDNA (B-D) from (B) neonatal tongue
(E), placentas (P) and yolk sacs (Y) from F1 hybrid 
 wild type littermates (+/-). B6 and C7 controls are 
 expression derived from the paternal allele is 
 
.  (A) 
, (C) E6.5 
shown below 
  
Figure 2.6 Mutants carrying a paternal 
and Igf2 expression.  (A) Graph representing weights
(+/8nrCG) and wild type 
PCR analysis of Igf2 (blue bars) 
(+/8nrCG) or wild type littermate
Number of samples analyzed (N) is indicated above the graph.  Error bars represent 
standard deviations.   
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littermates.  Each graph represents a different litter. (B) qRT
using neonatal liver cDNA from heterozygous 
s (+/+). Igf2 expression was normalized to 
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derepression of paternal H19 in the mutants followed the temporal and spatial pattern of 
total H19 expression.  H19 is first detected in E3.5 trophectoderm and is not detectable in 
the embryo proper until E8.5 (Poirier et al., 1991).  Levels steadily increase and peak in 
neonatal liver at about 3 days after birth where levels remain high until about day 9 when 
expression decreases to very low/basal levels by day 28 after birth (Pachnis et al., 1988).   
Allele-specific H19 expression was analyzed in the same tissue, liver, throughout 
development.  Aberrant paternal H19 expression levels in the 8nrCG mutant livers were 
highest in neonatal liver (figure 2.7), when total H19 expression is at its highest (Pachnis 
et al., 1988).  Derepression of paternal H19 in the mutants was moderate in E13.5 liver 
and undetectable in liver from 4 week old mice (Figure 2.7), again corresponding with 
total H19 levels (Pachnis et al., 1988).  These data suggest that aberrant paternal 
expression detected from the H19ICR-8nrCG allele is under the same temporal regulation as 
wild type H19 expression rather than a novel regulatory mechanism created by the 
mutations. 
 In addition to analyzing derepression of H19 throughout development, allele-
specific H19 expression in embryonic versus extraembryonic tissues at the same time 
point, E13.5, was examined (Figure 2.7).  Paternal H19 expression was detected in yolk 
sac, placenta and embryo, though derepression of paternal H19 was more variable in 
extra-embryonic tissues than embryonic (Figure 2.7).  These data confirm that the 
aberrant paternal expression from the H19ICR-8nrCG allele correlates with the spatially 
restricted expression pattern of H19. 
  
Figure 2.7 Aberrant paternal
mutants.  Allele-specific RNase protection assay was performed on RNA from tissues 
and time points indicated.  RNA was collected from either F1 hybrid mutants carrying a 
paternal H19ICR-8nrCG allele (+/8nrCG
bands are indicated.  The percent paternal 
Assay for 4 week liver is shown at normal (24 hour) exposure and overexposure (96 
hours) due to low levels of expression in this 
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 H19 expression throughout development in 8nrCG 
) or wild type littermates (+/+).  Control B6 and C7 
H19 expression is shown under the panel
tissue. 
 
 
s.  
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2.4 The paternal H19ICR-8nrCG allele remains hypermethylated despite paternal H19 
expression 
   
Expression of paternal H19 is often indicative of a loss of methylation at the 
paternal allele (Engel et al., 2004; Thorvaldsen et al., 1998).  Therefore methylation at the 
mutant paternal ICR in neonatal liver, the tissue in which aberrant paternal H19 
expression was at its highest, was assessed.  Bisulfite sequencing throughout the ICR 
indicated that the mutant ICR maintained its hypermethylated status as compared to wild 
type littermates (figure 2.8A).  Hypermethylation at the 8nrCG mutant ICR in neonatal 
liver was confirmed using non-allelic high throughput pyrosequencing.  Methylation 
levels of the 8nrCG mutants were indistinguishable from their wild type littermates 
(figure 2.8B).  In order to determine if methylation was properly established at the 
H19ICR-8nrCG allele, mature sperm was analyzed.  Bisulfite sequencing analysis revealed 
that sperm from 8nrCG mutant mice properly established methylation at the mutant ICR 
(figure 2.8A).  
It is possible that while the mutant ICR remained hypermethylated, spreading of 
methylation to the H19 promoter was disrupted, thus allowing aberrant paternal H19 
expression.  I therefore assessed methylation at the paternal H19 promoter proximal 
region by bisulfite sequencing (figure 2.9A) and the promoter by methylation sensitive 
restriction digestion and southern analysis (figure 2.9B).  Interestingly, no loss of 
methylation was detected at the H19ICR-8nrCG allele as compared to wild type littermates.  
These data indicate an uncoupling of transcription and methylation, as aberrant H19 
expression is detected from the mutant H19ICR-8nrCG allele despite maintaining full  
  
Figure 2.8 Hypermethylation 
Schematic of the H19 ICR. CTCF sites (triangles, R1 
rectangle) are depicted. Illustrated below is the methylation status of the mutant paternal 
H19ICR-8nrCG and wild type
sequencing performed with neonatal liver and mature sperm. Open and closed circles 
denote unmethylated and methylated cytosines, respectively, along a single horizontal 
strand of cloned DNA. Absent circ
denote sequence mutated in the mutant allele. Shaded rectangles overlay cytosines 
assayed in CTCF sites. (B) Pyrosequencing
from neonatal liver.  Heterozygous
compared to wild type littermates (+/+
mutants (+/9CG, open triangles
et al., 2004).  Each circle or triangle represents an individual sample with the mean 
indicated by a horizontal black bar.
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Figure 2.9 Hypermethylation at the promoter region of the paternal 
allele.  (A) Schematic of the 
methylation status of the mutant 
determined by bisulfite mutagenesis and sequencing performed with neonatal liver. 
Open and closed circles denote unmethylated and methylated cytosines, respectively, 
along a single horizontal strand of cloned DNA. Absent c
sequence. Shaded rectangles overlay cytosines assayed the promoter proximal region.
(B) Schematic of the H19
and Southern blot. The position (in base pairs) relative t
depicted above. Illustrated are: the endogenous 
(rectangles); HpaII (H) restriction sites; the polymorphic 
asterisks (**); and the probe used (bold line below 
to StuI (St). Illustrated below, parental alleles were differentiated by digesting genomic 
DNA from neonatal liver with 
Genotypes of the sample and the presence (+)
above the panels. The maternal (mat) CAST allele is 3.4kb and the paternal (pat) B6 
allele is 3.2kb. 
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methylation at the remaining CpGs.  Therefore, decreasing the number of CpGs at the 
H19 ICR by 8 (~16% depletion) rendered it unable to fully repress paternal H19 
expression even though the ability to maintain methylation remained intact. 
2.5 Normal imprinting when the H19ICR-8nrCG allele was maternally inherited  
 
 The effects of the 8nrCG mutation on the maternal allele were also assessed.  
Normal monoallelic Igf2 expression was detected by RT-PCR (Figure 2.10A).  
Additionally, bisulfite sequencing analysis indicated that the maternal H19ICR-8nrCG allele 
was properly hypomethylated in neonatal liver as compared to wild type littermates 
(figure 2.10B).  These data suggest that maternal inheritance of the mutant allele does not 
disrupt imprinting at the H19/Igf2 locus and that mutant phenotypes detected were 
specific to the paternal allele. 
2.6 An in vitro repressor assay to assess contribution of methylation at the ICR on 
repression of a reporter gene 
 
 Although paternal H19 expression from the mutant H19ICR-8nrCG allele was clearly 
detected, it remains unclear if there is a specific CpG density necessary at the ICR for full 
repression of H19.  In other words, is there a certain threshold of CpGs necessary for full 
repression or is repression additive, such that the level of repression is dependent on the 
amount of methylation?  This question is difficult to assess at the endogenous locus as 
methylation at the H19 promoter could mask subtle effects of the ICR.  Additionally, 
multiple targeted mouse mutants would be costly.  I therefore set up an in vitro system to 
quantify repression from the H19 ICR.  This system would allow easy assessment of 
various mutant ICR fragments in which differing amounts of CpGs had been mutated.
 Figure 2.10 Imprinting analyses of the maternally inherited 
Allele specific Igf2 expression was analyzed by RT
from F1 hybrid mutants that inherited the 
wild type littermates (+/+).  B6 and C7 controls are indicated. (B) Schemat
ICR (above, not drawn to scale). CTCF sites (triangles, R1 
grey rectangle) are depicted. Illustrated below is the methylation status of the mutant 
maternal H19ICR-8nrCG alleles and 
mutagenesis and sequencing performed with neonatal liver
circles denote unmethylated and methylated cytosines, respectively, along a single 
horizontal strand of cloned DNA. Absent circles indicate undetermined sequ
asterisks (*) denote sequence mutated in the mutant allele. Shaded rectangles overlay 
cytosines assayed in CTCF sites. 
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To quantify repression from the H19 ICR, I set up a reporter system based on that 
used in Chen et al., 2008.  To measure methylation dependent repression by the H19 ICR, 
a reporter plasmid that has been depleted of CpGs (pCpGvitro-neo-lacZ, Invivogen) was 
used.  Using a CpG-depleted reporter plasmid ensured that any repression measured was 
due to methylation at the ICR and not from elsewhere on the plasmid.  This plasmid 
contains: a mouse CMV enhancer and human elongation factor 1α driving expression of 
LacZ, an SV40 promoter to drive expression of neor and matrix attachment regions to 
form barriers between independent expression cassettes, all of which have been mutated 
such that there are no CpGs.  Two different reporter plasmids to measure repression by 
the H19 ICR were constructed; (1) a 1.8kb ICR fragment (spanning from AatII to XhoI) 
was cloned upstream of the CMV enhancer driving LacZ expression (CpGfree1) (Figure 
2.11A) and (2) a 1.8kb ICR fragment (spanning from AatII to XhoI) replaced the CMV 
enhancer (CpGfree3) (figure 2.12A).  β-Galactosidase (β-Gal) activity could then be 
compared between methylated and unmethylated plasmids to quantify repression by 
methylation at the ICR.  CpGfree3 is almost identical to the reporter used in (Chen et al., 
2008) except they used an NcoI-BamHI ICR fragment.   
I first used the CpGfree1 reporter vector for my analysis, as this construct is most 
similar to the endogenous H19 locus where enhancers are present to drive expression.  
The wild type (CpGfree1-wt) and 8nrCG (CpGfree1-8nrCG) ICR fragments were cloned 
upstream of the CMV enhancer.  These plasmids were then either methylated or left 
unmethylated using the CpG methylase M.SssI.  These constructs were transfected into 
Hep3b or F9 cells.  Hep3b cells highly express H19 and have been used previously to  
 Figure 2.11 CpGfree1 repression assay
plasmid with either a methylated (filled lollipops) or unmethylated (open lollipops) ICR 
fragment (white box) upstream of the CMV enhancer (green box)
expression (blue arrow).  Also on the plasmid is 
selection for stable integration of the reporter plasmid.  (B
either wild type (CpGfree1
methylated (+me) or left unmethylated and
cells. β-Gal activity was measured and normalized to total protein con
Number of biological replicate
Error bars represent standard deviations.
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identify elements regulating H19 expression (Hark et al., 2000; Holmgren et al., 2001). 
F9 cells do not express H19, and thus likely express repressors required for H19 
silencing.  F9 cells were also used in Chen et al., 2008.   Cells were stably transfected and 
β-Gal activity was assessed after ~10-14 days in selection.  Significant decreases in β-Gal 
activity were detected from the methylated plasmids versus the unmethylated plasmids 
for both CpGfree1-wt and CpGfree1-8nrCG (P value < .05) in both cell lines (figure 2.11 
B-C).  However, loss of repression in LacZ expression with the methylated CpGfree-
8nrCG versus the methylated CpGfree1-wt plasmids was not detected.  This was 
surprising, as the assay did not mimic what had been seen in vivo where paternal H19 
was derepressed when the 8nrCG mutation was paternally inherited (Ideraabdullah et al., 
2011).  One possibility as to why derepression was not detected was that the strength of 
the CMV enhancer would not allow detection of subtle changes in repression. 
 Next, repression using the CpGfree3 reporter plasmids, where the wild type or 
8nrCG ICR fragments replaced the CMV enhancer, were analyzed.  The human 
elongation factor 1α remained in place and still drove high levels of LacZ expression.  
Here, analysis was limited to F9 cells.  Similar to the studies using the CpGfree1 
reporters, the CpGfree3 plasmids containing either the wild type ICR fragment 
(CpGfree3-wt) or the 8nrCG mutant ICR fragment (CpGfree3-8nrCG) was methylated or 
left unmethylated.  These reporter plasmids were stably transfected into F9 cells.  β-Gal 
activity was assessed ~10-14 days after selection.  Again, methylated CpGfree3-wt and 
CpGfree3-8nrCG reporters had decreased β-Gal activity as compared to unmethylated 
reporters (P value < .05) (figure 2.11B).  However, I did not detect derepression of the 
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methylated CpGfree3-8nrCG reporter as compared to the CpGfree3-wt (figure 2.11B).   
Because this reporter plasmid was most similar to that used in Chen et al. 2008, analysis 
of the 9CG mutant ICR fragment (CpGfree3-9CG) was included.  Using the same 
reporter system, Chen et al., 2008 reported that CpGs within CTCF sites are necessary for 
silencing the reporter gene. I therefore wanted to replicate their findings using a mutant 
ICR that mutated CpGs at CTCF sites.  Again, I was unable to detect any derepression of 
LacZ expression with the methylated CpGfree3-9CG as compared to CpGfree3-wt (figure 
2.12C).  Because I was unable to reproduce the results reported in Chen et al., 2008 and 
the methylated mutant ICR plasmids (CpGfree3-8nrCG and CpGfree3-9CG) did not 
mimic the derepression of endogenous paternal H19 as described in mutant mice (Engel 
et al., 2004; Ideraabdullah et al., 2011), I decided not to proceed forward with this assay.  
 
 
 
 
  
 Figure 2.12 CpGfree3 repression assay
plasmid with either a methylated (filled lollipops) or unmethylated (open lollipops) ICR 
fragment (white box) upstream of 
(brown arrow), which allows selection for stable integration of the reporter plasmid.  (B
C) Constructs containing either wild type (CpGfree3
9CG (CpGfree3-9CG) fragments were
stably transfected into F9 cells. 
protein concentrations. 3 biological replicates were performed for each construct
Error bars represent standard deviations.
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CHAPTER THREE 
THE ROLE OF METHYL-CPG-BINDING DOMAIN PROTEINS IN 
IMPRINTED GENE REPRESSION 
 
Although it is clear that differential DNA methylation is necessary for marking 
parental alleles and regulating imprinted expression, trans-acting factors that are involved 
in conferring allelic repression remain unknown.  Methyl-CpG-binding domain (MBD) 
proteins, which bind methylated DNA (Hendrich and Bird, 1998) and recruit repressive 
complexes (Bogdanović and Veenstra, 2009), are ideal candidates for interpreting allele-
specific DNA methylation at imprinted loci and silencing the proper allele.   
Previous studies have been unable to define a role for MBD proteins in genomic 
imprinting.  Allele-specific analysis of imprinted genes in Mbd2-/- adult mouse spleen, 
heart and brain as well as Mecp2-/y adult mouse brain showed normal imprinting 
(Hendrich, 2001; Samaco et al., 2005).  However, many imprinted genes are involved in 
fetal growth and development with undetectable or very low levels of expression in adult 
tissues (Figure 3.1) (Pachnis et al., 1988; Poirier et al., 1991).  Thus, it is possible that 
mechanisms for allele-specific repression may be different and more reliant on MBD 
proteins in tissues where imprinted genes are robustly expressed, as they are throughout 
embryogenesis. I therefore hypothesized that MBD proteins play a role in genomic 
imprinting specifically in tissues where imprinted genes are robustly expressed. 
In support of this hypothesis, MECP2, MBD1, MBD2 and MBD3 have been 
shown to bind to imprinted loci by ChIP analysis (Fournier et al., 2002; Gregory et al., 
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2001; Kernohan et al., 2010; Lu et al., 2006; Reese et al., 2007; Samaco et al., 2005). 
Additionally, depletion of NuRD complex (which contains MBD2) components, MBD3 
(Reese et al., 2007) or MTA-2 (Ma et al., 2010), in mouse blastocysts caused loss of 
imprinting of H19 (Ma et al., 2010; Reese et al., 2007) and Peg3 (Ma et al., 2010).  
Furthermore, deregulation of GNAS, IGF2 and UBE3A has been reported in Rett 
Syndrome patient lymphocytes and postmortem brains (Ballestar et al., 2005; 
Makedonski et al., 2005; Samaco et al., 2005). 
To test my hypothesis, I analyzed allele-specific expression of imprinted genes in 
Mbd1-/- or Mbd2-/- E9.5-10.5 embryos, placentas, yolk sacs, and neonatal brains.  
Functional redundancy among the MBD proteins was assessed by employing cell culture 
systems in which siRNA and shRNA constructs were used to deplete trophoblast stem 
(TS) cells or mouse embryonic fibroblasts (MEFs) of MBD proteins.  I have been unable 
to uncover a role for single MBD proteins in genomic imprinting, however, these proteins 
may be highly redundant.   
3.1 Experimental design 
 
To study the effects of loss of MBD1 or MBD2 on genomic imprinting I analyzed 
previously published mouse mutants (Hendrich, 2001; Zhao et al., 2003).  In vivo studies 
focused on MBD1 and MBD2 because these proteins are least characterized at imprinted 
loci. The mutations were bred onto two strain backgrounds; B6 and C7.  To ensure a 
CAST chromosome 7 (C7), 14 MIT markers spanning chromosome 7 were assayed.  
Heterozygous mutant mice on each strain (B6 or C7) were crossed to generate F1 hybrids 
 Figure 3.1 Expression of 
was performed on cDNA derived from adult brain (4 week), neonatal brain (day 0
E9.5-10.5 embryo and placenta to 
bars).  Expression levels were normalized to the geometric mean of 
Three individual mice were used for each tissue
deviations.  
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for analysis.  SNPs between the two strains of mice allowed assessment of allele-specific 
expression of imprinted genes along chromosome 7 (Weaver et al., 2010). 
 Because I was interested in defining a role for these proteins in genomic 
imprinting, tissues that very highly express imprinted genes; E9.5-10.5 embryos, 
placentas, and yolk sacs (figure 3.2A, 3.3A) were examined.  Additionally, analysis in 
neonatal brain was included, as many imprinted genes are expressed in this tissue and 
MBD mutant phenotypes manifest most prominently in the brain.  Although expression 
of Mbd1 and Mbd2 is highest in adult brain in wild type mice, transcripts are detectable 
in all the tissues analyzed (figure 3.2B, 3.3B).  MBD1 protein is also detectable in E9.5 
embryo and placenta (figure 3.2C).  Unfortunately, there are no available reliable 
antibodies against MBD2 to measure protein.  
3.2 Normal imprinting in Mbd1 mutant mice 
 
MBD1 has been reported to bind at imprinted genes (Fournier et al., 2002), 
however, imprinting analysis of Mbd1 mutant mice had not been reported.  B6 or C7 
female Mbd1+/- mice were mated with male Mbd1+/- mice of the opposite strain. Five 
litters of F1 hybrid E9.5-10.5 embryos, placentas and yolk sacs were collected for 
imprinting analysis.  I conducted allele-specific RT-PCR assays on paternally expressed 
Snrpn, Peg3, Kcnq1ot1, and Igf2, as well as maternally expressed Zim1, Cdkn1c, H19, 
Kcnq1 in all tissues collected at this time point.  Additionally, the maternally expressed 
gene Ascl2 was analyzed in the placenta, as this gene exhibits placenta-specific 
expression. Normally, the level of RNA detected from the repressed allele is less than 
 Figure 3.2 Experimental design and expression of 
Breeding scheme and tissues of offspring collected for analysis.  Note that the female 
parent is written first in the 
prepared from wild type adult brains (4 weeks), neonatal brains (day 0
embryos and placentas.  Expression was normalized to
and Gapdh.  Tissues from 
standard deviations.  (C) Western blot 
Protein lysates were prepared from E10.5 embryo and placenta.
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 Figure 3.3 Experimental design and expression of 
Breeding scheme and tissues of offspring collected for analysis.  Note that the female 
parent is written first in the 
prepared from wild type adult brains (4 weeks), neonatal brains (day 0
embryos and placentas.  Expression was normalized to 
and Gapdh.  Tissues from 
standard deviations.  
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 10% of total expression (though higher levels can be detected in placenta).  To control 
for this, expression levels of mutants were compared to wild type littermates.  Imprinting 
was maintained in 4 Mbd1-/- E9.5-10.5 tissues when compared to 16 Mbd1+/- and 12 wild 
type littermates (table 3.1) (P value > .05 in all cases).  Because MBD1 was reported to 
play a role in brain function, neonatal brain was also tested for loss of imprinting.  Here, 
analysis was performed on the same genes as the E9.5-10.5 litters except for Igf2 (not 
imprinted in the brain), Kcnq1 (not expressed in this tissue) and Ascl2 (not expressed in 
this tissue).  Allele-specific expression was assessed using cDNA from neonatal brains 
from 4 litters containing 5 Mbd1-/- and compared to 7 Mbd1+/- and 9 wild type littermates.  
Normal imprinting was detected in all neonatal brain samples (table 3.1) (P value > .05 in 
all cases).  I therefore conclude that MBD1 alone is not required for allele-specific 
repression at imprinted loci.   
3.3 Normal imprinting in Mbd2 mutant mice 
 
Next, analysis was extended to Mbd2 mutant mice. Mbd2 null mice exhibit 
phenotypes most similar to mice harboring a mutation for the imprinted gene Peg3 
(Hendrich, 2001; Lefebvre et al., 1998; Li et al., 1999).  Moreover, MBD2 has been 
reported bound to Peg3 in cyclophilin A knockdown P9 cells (Lu et al., 2006).  However, 
early studies of Mbd2 null mice identified normal imprinting in adult brain, heart and 
spleen (Hendrich, 2001).  Similar to the Mbd1 mutant analysis, either B6 or C7 Mbd2+/- 
females were mated with Mbd2+/- males of the opposite strain.  Again imprinting at 
paternally expressed Snrpn, Peg3, Kcnq1ot1, and Igf2, as well as maternally expressed 
 Table 3.1 Allele-specific expression analysis of imprinted genes in F1 hybrid 
Percent total expression from the normally repressed allele with standard deviations is 
indicated for each respective tissue and ge
designated in red.  Paternally expressed genes are 
Mbd1+/+ (+/+): N=12 for E9.5
Mbd1+/- (+/-): N=16 for E9.5
Mbd1-/- (-/-): N=4 for E9.5
NE not expressed in this tissue.
NI not imprinted in this tissue.
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 Zim1, Cdkn1c, H19, Kcnq1 and Ascl2 were assessed.   Allele-specific RT-PCR analysis 
performed on cDNA from E9.5-10.5 embryos, placentas and yolk sacs from 2 F1 hybrid 
litters did not detect any loss of imprinting in the 6 Mbd2-/- tissues as compared to 7 
Mbd2+/- and 2 wild type littermates (table 3.2) (P value > .05).  Similarly, normal 
imprinting was observed in neonatal brains collected from 3 litters with 4 Mbd2-/- as 
compared to 10 Mbd2+/- and 3 wild type littermates (table 3.2) (P value > .05).  Because 
previously published studies most implicated MBD2 in the regulation of Peg3 
expression, analysis of the Peg3 DMR in Mbd2 mutants was performed.  High 
throughput pyrosequencing on bisulfite mutagenized DNA from neonatal brains indicated 
that methylation levels of the Peg3 DMR in Mbd2 null mutants were indistinguishable 
from heterozygous and wild type littermates (~45% methylation) (figure 3.4).  Therefore, 
I conclude that MBD2 is dispensable for allele-specific repression at imprinted loci.   
3.4 Loss of MBD1 or MBD2 is not compensated by upregulation of transcripts from 
other MBD proteins 
 
There are multiple MBD family proteins involved in DNA methylation dependent 
repression.  Thus, it is possible that the lack of imprinting phenotypes in the Mbd1 and 
Mbd2 mutant mice were due to compensation by the other MBD proteins.  One way 
compensation can occur is through transcriptional upregulation of the other MBD 
proteins in the mutants.  To test this, I analyzed expression of Mbd2 and Mecp2 in Mbd1 
mutant embryos by qRT-PCR, but was unable to detect increased expression (figure 
3.5A).  Similarly, Mbd2 mutant embryos also did not upregulate Mecp2 or Mbd1 (figure 
3.5B).  However, these results do not rule out the possibilities that the other MBD 
 Table 3.2 Allele-specific expression analysis of imprinted genes in F1 hybrid 
Percent total expression from the normally repressed allele with standard deviations is 
indicated for each respective tissue and genotype.  Maternally expressed genes are 
designated in red.  Paternally expressed genes are 
Mbd2+/+ (+/+): N=2 for E9.5
Mbd2+/- (+/-): N=7 for E9.5
Mbd2-/- (-/-): N=6 for E9.5
NE not expressed in this tissue.
NI not imprinted in this tissue.
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Figure 3.4 Normal Methylation at the Peg3 DMR in Mbd2 mutants.  Methylation 
levels at the Peg3 DMR were determined by pyrosequencing.  Bisulfite mutagenized 
DNA from neonatal brain was analyzed from the genotypes indicated.  Each circle or 
triangle represents an individual sample with the mean indicated by a black horizontal 
bar.  
 
 
  
 
 
Figure 3.5 Expression of other MBD family members in 
embryos. (A) Expression levels of 
E9.5-10.5 embryos (purple bars).
Rplp0 and Gapdh.  (B) Expression levels of 
Mbd2-/- E9.5-10.5 embryos (blue bars).  Expression was normalized to 
Gapdh.   Number of individual samples analyzed is indicated (N)
standard deviations. 
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proteins could be upregulated at the protein level, or that they have redundant function 
with overlapping binding sites, as has been recently reported (Baubec et al., 2013). 
3.5 Assessing functional redundancy among the MBD proteins 
 
To assess compensation and redundancy between MBD proteins I used cell 
culture systems in which MBD proteins were depleted by RNAi-based knockdown.  
Experiments were performed using F1 hybrid MEFs and TS cells.  MEFs exhibit 
imprinted expression of many genes and have also been used in similar RNAi based 
experiments to identify factors involved in regulation of imprinting (Lin et al., 2011; Yao 
et al., 2010).  TS cells exhibit imprinted expression of many genes with total expression 
of these genes being greater than in MEFs (Lin, 2011).   
3.5.1 Transient siRNA depletion of MBD proteins in MEFs and TS cells 
 
I first analyzed depletion of MBD proteins by transient siRNA experiments.  
siRNAs directed against Mbd1 (siMbd1), Mbd2 (siMbd2), Mbd3 (siMbd3) and a control 
sequence that does not target any known transcripts in the mouse genome (siControl) 
were transfected into MEFs or TS cells.  48 hours after initial transfections another round 
of transfections with the siRNAs was performed.  Cells were collected ~72 hours after 
initial transfection for analysis.  I was unsuccessful at finding reliable antibodies against 
MBD2 or MBD3, and therefore could only measure levels of depletion of transcripts by 
qRT-PCR.  Depletion of MBD1 was confirmed by western blot and ~89% depletion was 
detected in these cells (figure 3.6A).  qRT-PCR indicated ~51%  decrease in transcription 
of Mbd2 (figure 3.6B), and ~63% decrease in transcription of Mbd3 (figure 3.6C). 
  
 
 
Figure 3.6 Depletion of MBD1, MBD2 and MBD3 in MEFs or TS cells
Western blot to detect MBD1 in MEF lysates from cells transfected with 
MEF lysates from cells transfected with 
levels as compared to siControl
Mbd2 (blue bars) or (C) Mbd3 
transfected and siMbd1, siMbd2
expression was normalized to 
triple transfected cells are graphed relative to
represent standard deviations.  
to detect MBD1 in TS cell lysates
TS cells transfected with 
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 Table 3.3 Allele-specific expression analysis of imprinted genes in F1 hybrid MEFS 
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Percent total expression from the normal
indicated for each siRNA experiment
red.  Paternally expressed genes are 
WT N=3 
siControl: N=3 
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  Allele-specific expression analysis performed on paternally expressed Snrpn, Peg3, 
Kcnq1ot1, and Igf2, as well as maternally expressed Zim1, Cdkn1c and H19 indicated 
normal imprinting at all loci (table 3.3).  For analysis in TS cells only the siRNA towards 
Mbd1 was tested because the MBD1 antibody was the most reliable.  Transfection 
efficiency (as determined using a fluorescent RNA) in TS cells was only ~10% (data not 
shown).  Unsurprisingly, I was unable to deplete MBD1 in these cells (figure 3.6D). 
3.5.2 Stable shRNA depletion of MBD proteins in Mbd2-/- MEFs and TS cells 
 
Because I was interested in defining transcriptional changes that resulted from a 
change in epigenetic landscape after depletion of MBD proteins (which could take longer 
than a transient assay would allow), I pursued stable depletion of these factors.  Here, 
efforts were focused on MECP2, MBD1 and MBD2 as these are the three MBD proteins 
that both bind methylated DNA and repress transcription.  Therefore, these proteins are 
most likely to exhibit redundant functions.  The siRNA sequences against Mbd1 and 
Mbd2, and a published sequence against Mecp2 (Zhou et al., 2006) were converted into 
short hairpin sequences that were cloned into the PLKO.1 lentiviral vector (Addgene).   
F1 hybrid MEFs were prepared from F1 hybrid Mbd2-/- embryos.  This allowed 
experiments to be performed in cells that had no functional MBD2, and therefore no 
MBD2 antibody was necessary.  shRNAs targeting a control sequence (shControl), Mbd1 
(shMbd1), Mecp2 (shMecp2) or Mbd1 and Mecp2 were stably expressed in Mbd2-/- 
MEFs.  Cells were collected at ~7 days and 2 passages after initial infection, for protein 
and RNA analysis.  On average, there was ~72% depletion of MECP2 (figure 3.7A,C) 
and ~84% depletion of MBD1 (figure 3.7B,C) as determined by western blot. 
 Figure 3.7 Stable depletion of MBD1 and MECP2 in 
blot to detect (A) MECP2 or (B) MBD1 in 
shControl, shMbd1, ShMecp2, or both s
was used as a loading control.
indicated. (C) Graphic representation of 
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Mbd2-/- MEFs. (A
Mbd2-/- MEF lysates from cells expressing 
hMecp2 and shMbd1 (as indicated)
  Percent protein expression as compared to shControl is 
protein levels compared to shControl.
 
 
-B)Western 
.  GAPDH 
 
 Table 3.4 Allele-specific expression 
Mbd2-/- MEFS depleted of MBD1, MECP2 or MBD1 and MECP2
 Percent total expression from the normally repressed allele with standard deviations is 
shown for MEFs expressing the indicated shRNA
designated in red.  Paternally expressed genes are 
experiments. 
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 Allele-specific expression analysis was performed on paternally expressed Snrpn, Peg3, 
Kcnq1ot1, and Igf2, as well as maternally expressed Zim1, Cdkn1c and H19.  Loss of 
imprinting was not detected in either the Mbd2-/- MEFs depleted of MBD1, Mbd2-/- MEFs 
depleted of MECP2 or Mbd2-/- MEFs depleted of both MBD1 and MECP2 (table 3.4).  
Because substantial amounts of MBD1 and MECP2 remained, no conclusions on the 
redundancy between these proteins can be made, but reduced levels of MBD family 
members did not disrupt imprinted expression. 
Stable shRNA knockdown experiments were also performed in TS cells.  Again, 
cells stably expressed an shRNA targeting a control sequence (shControl), Mbd1 
(shMbd1), Mecp2 (shMecp2) or both Mbd1 and Mecp2.   TS cells were collected at ~7 
days, and 2 passages after initial infection for analysis.  I was unable to deplete MBD1 or 
MECP2 in TS cells (figure 3.8) , which was consistent with previous studies indicating 
that shRNA knockdown has low efficiency in TS cells (Golding and Mann, 2011).  
Additionally, expression of TS cell pluripotency markers (mEomes, Fgfr2, Esrrb) and a 
marker of differentiated giant cells (Ascl2) were analyzed.  I observed high levels of 
expression of pluripotency markers (figure 3.9A), but in the samples which stably 
expressed shRNAs, transcription of Ascl2 (figure 3.9B) was detected.  Giant cells are 
tetraploid (Tanaka et al., 1998) and may exhibit different patterns of imprinted gene 
expression. Although levels of Ascl2 are low, expression indicated that a subset of cells 
were undergoing differentiation.  Biallelic expression from even a few cells could make 
analysis of imprinting difficult.  Therefore I did not continue to pursue knockdown 
experiments in TS cells. 
 Figure 3.8 Infection of shRNA constructs in TS cells
(A) MBD1 or (B) MECP2 in lysates from TS cells expressing the indicated shRNA. 
RAD21 was used as a loading control.
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Figure 3.9 Expression of pluripotency and differentiation markers in TS cells
RT-PCR to detect expression of TS cell pluripotency markers (as indicated below gel) 
in TS cells stably expressing shRNAs
expression of Ascl2, a marker of differentiated giant cells in cells stably expressing 
shRNAs (as indicated). 
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3.5.3 Overexpression of the MBD in MEFs 
 
Due to the limitations of knockdown studies, I decided to assess the issue of 
compensation using a different approach.  The prevailing model of repression by MBD 
proteins suggests that the proteins bind to methylated DNA through the MBD and other 
regions of the protein (particularly the TRD) interact with transcriptional repressors and 
chromatin modifiers.  Based on this model, overexpression of the MBD alone could 
displace binding of endogenous MBD proteins and lead to a loss of repression.  I could 
therefore overexpress the MBD in F1 hybrid MEFs and analyze allele-specific imprinted 
expression.  cDNA from wild type brain was used to amplify the MBD domain of Mecp2, 
as deletion studies have defined the boundaries of the MECP2 MBD (Nan et al., 1993).  
Primers were designed to include amino acid 76 through amino acid 160 of MECP2.   
The MBD was modified to include a C-terminal flag-tag and an N-terminal SV40 nuclear 
localization signal.  This modified MBD was then cloned into the retroviral pBABE-puro 
vector (pBABE-MBD), which expresses the puromycin resistance gene and promotes 
high levels of protein expression in mammalian cells (Morgenstern and Land, 1990).   
F1 hybrid MEFs were infected with either an empty vector (pBABE) or the 
pBABE-MBD construct.  Cells were collected ~7 days and 1 passage after initial 
infection for expression and protein analysis.  On average, a 9.25 fold increase in Mecp2 
MBD expression was detected from the cells expressing pBABE-MBD (figure 3.10A).   
  
  
 
 
Figure 3.10 Overexpression of the MBD in F1 hybrid MEFs
analyze expression Mecp2
vector (pBABE) or pBABE
Expression levels are graphed relative to
represent standard deviations.  
to detect the flag-tagged-MBD in cells that stably express pBABE
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-MBD.  Mecp2 MBD expression was normalized to 
 expression in pBABE control cells
Three biological replicates were used. (B) Western blot 
-MBD.
 
 
-PCR to 
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.  Error bars 
 
 Table 3.5 Allele-specific expression analysis of imprinted genes in F1 hybrid MEFS 
Percent total expression from the normally repressed allele with standard deviations is 
shown for MEFs expressing the indicated shRNA.  Maternally expresse
designated in red.  Paternally expressed genes are 
experiments. 
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Translation of the MBD was confirmed by western blot using an antibody against the 
flag-tag (figure 3.10B). 
Allele-specific expression analysis was performed on paternally expressed Snrpn, 
Peg3, Kcnq1ot1, and Igf2, as well as maternally expressed Zim1, Cdkn1c and H19 with 
normal imprinting detected in all samples (table 3.5).  However, the level of 
overexpression necessary to displace endogenous MBD proteins remains unknown and 
the poor quality of antibodies against the MBD proteins does not allow quantification of 
the loss of binding.  Therefore, it remains possible that levels of overexpression in this 
experiment were insufficient to displace endogenous MBD proteins from their targets.  
 
3.6 Breeding to generate Mbd1-/-Mbd2-/- mice 
 
 Of most interest would be to genetically test for redundancy between MBD1 and 
MBD2 through analysis of Mbd1-/-Mbd2-/- mice.  Previous studies have assessed 
redundancy between MECP2 and MBD2 through analysis of Mecp2-/yMbd2-/- mice.  
These double mutant mice had the same phenotypes as the Mecp2-/y mouse, suggesting 
these two proteins are not redundant (Guy et al., 2001).  However, the possibility remains 
that the strong phenotype of the Mecp2 null mouse masked slightly different phenotypes 
in the Mecp2-/yMbd2-/- mouse.  Therefore analysis of Mbd1-/-Mbd2-/- would be most ideal 
for uncovering functional redundancy, as the Mbd1 null and Mbd2 null phenotypes are 
more subtle.  Analysis of these double mutant mice could uncover imprinting defects that 
were not detected in single mutants. 
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One complicating factor in generating an Mbd1-/-Mbd2-/- mouse mutant, is that 
these two genes are located ~4 megabases apart on mouse chromosome 18. The genetic 
distance between these genes is ~5 centimorgans, meaning there is ~1/20 chance of 
recombination between the two genes during meiosis.  I have been breeding Mbd1+/-
Mbd2+/- x Mbd1-/- (breeding is set up in both directions).  Mbd2-/- mothers do not nurture 
their offspring (Hendrich, 2001), therefore, all matings were set up to get the 
recombination on a Mbd1 null background.  An Mbd1-/-Mbd2+/- recombinant mouse has 
been obtained, and breeding is currently ongoing to increase the numbers of the double 
mutant recombinants. 
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CHAPTER FOUR 
TET-MEDIATED ERASURE OF IMPRINTS IN THE MAMMALIAN 
GERMLINE 
 
 DNA methylation at imprinted loci must be erased in the germline to allow re-
setting of sex-specific marks for the next generation.  Until recently, the mechanism of 
this demethylation remained unknown. With increased sensitivity of methylation analysis 
and the discovery of 5hmC, however, these mechanisms are beginning to be elucidated.    
Recent studies have indicated two waves of demethylation in PGCs; (1) the majority of 
DNA is passively demethylated in migrating PGCs (Kagiwada et al., 2013; Seisenberger 
et al., 2012) and (2) imprints, as well as other sequences, are demethylated after the PGCs 
reach the genital ridge (Hackett et al., 2013; Hajkova et al., 2010; Seisenberger et al., 
2012). Interestingly, enrichment of 5hmC has been detected in PGCs at imprinted loci at 
the onset of demethylation (Hackett et al., 2013; Yamaguchi et al., 2013). 
 Presence of 5hmC in PGCs indicates activity of the TET proteins.  PGCs express 
both Tet1 and Tet2 (Tet1 at much higher levels), with no detectable Tet3 expression 
(Hackett et al., 2013; Hajkova et al., 2010; Kagiwada et al., 2013).  Mice deficient in 
TET1 or TET2 have been analyzed, with very subtle defects.  Some Tet1 null mice had a 
small body size at birth and Tet1 null females had compromised fertility (Dawlaty et al., 
2011; Yamaguchi et al., 2012).  Tet2 null adult mice had an increased likelihood of 
developing myeloid malignancies (Ko et al., 2011; Li et al., 2011; Moran-Crusio et al., 
2011; Quivoron et al., 2011).  Because of the subtle phenotypes of individual Tet1-/- or 
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Tet2-/- mutants, and the similar expression patterns exhibited by these proteins, we 
hypothesized that TET1 and TET2 have a cooperative role in DNA demethylation at 
imprint loci in PGCs. 
 To test this hypothesis, we analyzed germ cells of mice deficient for TET1 and 
TET2 (double knockout, DKO).  We found that PGCs lacking TET1 and TET2 retain 
DNA methylation at some imprinted loci.  Importantly, this aberrant retention of DNA 
methylation was also observed in mature male gametes and fetuses from DKO females.  
This study was done in collaboration with Dr. Guo-Liang Xu’s laboratory at the Institute 
of Biochemistry and Cell Biology, Chinese Academy of Sciences in Shanghai China.  
The mutant mice were targeted in Dr. Xu’s laboratory.  Dr. Xu’s graduate student Bang-
An Wang performed all analyses in PGCs.  I performed methylation analysis of DKO 
sperm, kidney and embryos from DKO females.  It is important to note that after 
initiation of this project, an independent study analyzing Tet1-/-Tet2-/- mice was published 
(Dawlaty et al., 2013).  A comparison of our work with that in Dawlaty et al., 2013 can 
be found in chapter 6.11. 
4.1 TET1 and TET2 deficient PGCs lack 5hmC 
 
To determine the role of TET-mediated DNA demethylation in PGCs, mutations 
targeting Tet1 or Tet2 were made in the mouse.  Double heterozygous (Tet1+/-Tet2+/-) 
male and female mice were mated to produce Tet1/Tet2 DKO mice for analysis (figure 
4.1A). The DKO mice had grossly normal prenatal and postnatal growth and 
development. 
  
Figure 4.1 Mating schemes for analysis o
erasure.  (A-B) Tet1/Tet2
DKO (red) or wild type (black) offspring. (A) DKO and 
collected at E11.5 or E13.5 and PGCs were isolated for analysis.  (B) Adult males 
from double heterozygous parents 
somatic tissues.  (C) DKO females were mated to 
heterozygous embryos were collected for analysis.
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  Because we were interested in understanding 5hmC conversion and 
demethylation at imprinted loci in PGCs, we examined DNA modifications in gonadal 
PGCs as erasure of DNA methylation at imprinted genes is known to occur after PGCs 
reach the genital ridge (Seisenberger et al., 2012).  Immunostaining of genital ridge 
sections detected presence of 5hmC in wild type PGCs at E11.5.  In contrast, 5hmC was 
barely detectable in E11.5 PGCs from DKO mice (figure 4.2).  Therefore, TET1 and 
TET2 are required for conversion of 5mC to 5hmC in PGCs.   
4.2 TET1 and TET2 deficient PGCs retained DNA methylation at imprinted loci 
 
 We next assessed whether demethylation at imprinted loci was impaired in PGCs 
that lacked TET1 and TET2, and thus could not oxidize 5mC to 5hmC.  Again, double 
heterozygous (Tet1+/-Tet2+/-) male and female mice were mated to produce Tet1/Tet2 
DKO mice for analysis (figure 4.1A).    Bisulfite mutagenesis and sequencing was 
performed on DNA from male and female PGCs at E13.5.  Normally, at this stage, 
methylation at imprinted loci has been erased (Seisenberger et al., 2012).  We analyzed a 
paternally-methylated DMR, H19, and a maternally-methylated DMR, Mest (also known 
as Peg1).  Considerable amounts of methylation were detected at both DMRs in DKO 
male and female E13.5 PGCs, whereas very little methylation was detected in wild type 
PGCs (figure 4.3).  These data indicated the requirement of 5mC to 5hmC conversion for 
imprint erasure as abnormal retention of DNA methylation at imprinted loci was 
observed in DKO E13.5 PGCs.
 Figure 4.2 Reduction of 5hmC in TET1/TET2 deficient PGCs
images of 5mC (green) and 5hmC (red) of cryosections of
wild type (WT) and DKO
outlined with dashed lines. Bar, 10 µm.
and 5hmC from (A). Each data
relative to the DAPI staining intensity of the same 
error. Figure courtesy of Dr. Guo
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 littermates. DNA is stained with DAPI (blue). PGCs are 
 (B) Quantification of the relative levels of 5mC 
 point is based on the level of the 5mC or 
cell. Error bars indicate 
-Liang Xu and Bang-An Wang. 
 
uorescence 
5hmC signal 
standard 
  
Figure 4.3 Retention of methylation at imprinted loci in TET1/TET2 deficient 
E13.5 PGCs. Bisulfite mutagenesis and sequencing was performed on DNA isolated 
from either wild type (WT) 
paternally-methylated H19
(designated in red) were analyzed.  Open and closed circles denote unmethylated and 
methylated cytosines, respectively, along
Figure courtesy of Dr. Guo
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4.3 Abnormal methylation at imprinted loci in TET1/TET2 deficient sperm 
 
It is possible that aberrant retention of DNA methylation observed in DKO E13.5 
PGCs could be erased later in gametogenesis.  We therefore analyzed methylation at 
imprinted DMRs in mature sperm.  The TET1/TET2 deficient mice used for analysis 
were conceived from mating double heterozygous males and females (Tet1+/-Tet2+/- x 
Tet1+/-Tet2+/-) (figure 4.1B).  Wild type mice used for comparisons were not necessarily 
littermates of the DKO mice, due to the difficulty of obtaining both genotypes in a single 
litter (1/16 chance of getting each genotype).   Pyrosequencing was performed on 
bisulfite mutagenized DNA from mature sperm from DKO or wild type males.  We 
analyzed the paternally-methylated H19 ICR and IG-DMR (Gtl2) and the maternally- 
methylated DMRs at Snrpn, Peg3, Mest, Kcnq1ot1 and Grb10.  Interestingly, we found 
that the levels of methylation at these DMRs were quite variable, with significant 
retention of DNA methylation detected at Mest (P value < .05), Kcnq1ot1 and Grb10 (P 
value < .01) (figure 4.4).  We therefore conclude that TET-mediated DNA demethylation 
is locus specific, with some loci more susceptible to aberrant methylation patterns in the 
absence of TET1 and TET2.  It is important to note that although conversion to 5hmC is 
blocked in DKO germ cells, UHFR1 levels are very low and DNMT1 is not detectable at 
replication foci in PGCs (Kagiwada et al., 2013). Thus, passive DNA demethylation 
could act as a back-up mechanism to demethylate imprinted loci in the absence of 5hmC 
conversion.  Passive demethylation could also explain the variability in methylation 
levels and the locus-specificity of aberrant methylation in DKO sperm. 
 Figure 4.4 Retention of methylation at imprinted loci in TET1/TET2 deficient 
mature sperm.  Percent DNA methylation
closed circles) and DKO (
Paternally-methylated DMRs are designated in blue and maternally
are designated in red. Each circle represents an indiv
genotype indicated by a horizontal black bar. *P < .05, **P < .01.
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Recent studies indicate that the majority of DNA methylation, including 
methylation at repetitive elements, is passively lost as PGCs migrate to the genital ridge 
(Kagiwada et al., 2013; Seisenberger et al., 2012).  We performed the LUminometric 
Methylation Assay (LUMA) on adult testes to assess genome-wide DNA methylation 
levels in mature germ cells.  This assay quantifies genomic cutting of a methylation 
sensitive restriction enzyme (HpaII) and methylation insensitive restriction enzyme 
(MspI) with each normalized to cutting of EcoRI.  The ratio of cuts between the two 
enzymes gives levels of global DNA methylation (Karimi et al., 2006).  LUMA analysis 
performed on DNA from DKO adult testes indicated normal levels of DNA methylation 
at ~70% of CpGs methylated (figure 4.5).  Our data supports the model that passive DNA 
demethylation is responsible for erasure of genome-wide methylation as TET1 and TET2 
were dispensable for normal genomic methylation patterns.  
 Additionally, we assessed methylation at imprinted DMRs in somatic tissues of 
mice deficient for TET1 and TET2.  Because we generated these mice from Tet1+/-Tet2+/- 
parents, the parental germline giving rise to DKOs had both TET1 and TET2 proteins.  
Additionally, TET3, the enzyme necessary for demethylation of the paternal genome 
after fertilization (Gu et al., 2011; Iqbal et al., 2011; Wossidlo et al., 2011), remained 
unperturbed.  We pyrosequenced bisulfite mutagenized DNA from DKO and wild type 
kidneys to assess DNA methylation at H19, Gtl2, Snrpn, Peg3, Kcnq1ot1 and Mest 
DMRs (figure 4.6).  We detected normal levels of methylation (~50%) at all imprinted 
DMRs, indicating that TET1 and TET2 deficiency predominantly affects germ cells. 
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Figure 4.5 Normal genomic methylation levels of adult TET1/TET2 deficient 
testes.  Methylation levels of adult (4 months of age) testis DNA were determined by 
the LUminometric Methylation Assay (LUMA) for wild type (WT, closed circle) and 
DKO (open circle) males. Each circle represents an individual sample with the mean 
methylation for each genotype indicated by a horizontal bar. 
 
 Figure 4.6 Normal methylation levels at imprinted loci in kidneys of TET1/TET2 
deficient mice.  Percent DNA
closed circles) and DKO (
Paternally-methylated DMRs are designated in blue and maternally
are designated in red.  Each circle repre
each genotype indicated by a horizontal black bar
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4.4 Aberrant methylation in fetuses from TET1/TET2 deficient females 
 
 While male reproduction was largely unaffected by TET1/TET2 deficiency, 
female DKO mice were subfertile with increased frequency of pregnancy loss.  To assess 
methylation defects in offspring from DKO females, we mated Tet1-/-Tet2-/- females with 
wild type males (figure 4.1C).  We were able to recover 2 late stage (~E16.5) embryos 
from a pregnant DKO female.  Pyrosequencing was performed on bisulfite treated DNA 
from the 2 fetuses for analysis of methylation at imprinted loci.  Interestingly, we 
detected increased levels of DNA methylation specifically at paternally-methylated 
DMRs, H19 and Gtl2, with methylation levels of ~77% and 69%, respectively (figure 
4.7).  This suggests that the DKO maternal germline was unable to properly erase 
methylation at paternally-methylated loci.  These unerased imprints were then inherited 
in offspring.  Therefore, we conclude that TET-mediated DNA demethylation is required 
for erasure of methylation at some imprinted loci in PGCs, and without TET proteins 
(TET1 and TET2) aberrant retention of methylation occurs in the germline that could be 
inherited in the next generation. 
 Figure 4.7 Retention of methylation at paternally
a TET1/TET2 deficient female
embryos from wild type  
embryos from a DKO female 
pyrosequencing.  Paternally
methylated DMRs are designate
represents an individual sample with the 
horizontal black bar.  
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CHAPTER FIVE 
STABILITY OF DNA METHYLATION IN SPERMATOGONIAL STEM 
CELLS DESPITE ENVIRONMENTAL PERTURBATIONS 
   
The reversibility of epigenetic marks makes the epigenome particularly 
susceptible to disruptions by environmental influences (McCarrey, 2012).  For example, 
manipulations associated with ART procedures occur during times of epigenetic 
reprogramming, and have been associated with aberrant DNA methylation (Eroglu and 
Layman, 2012).  Specifically, endocrine stimulation of the ovary, embryo culture, or 
transfer of preimplantation embryos, have all been shown to cause alteration of DNA 
methylation and deregulation of imprinted genes in mice (de Waal et al., 2012b; Doherty 
et al., 2000; Fauque et al., 2007; Mann et al., 2004; Rivera et al., 2008; Sato et al., 2007).  
Recent advances in understanding male germline stem cells, spermatogonial stem 
cells (SSCs), have allowed development of techniques with great potential for male 
infertility treatment.  SSCs reside within a specific microenvironment of the seminiferous 
tubule called the niche, and serve as the foundation of spermatogenesis.  SSCs can either 
undergo self-renewal or differentiate into mature sperm. These fate decisions are tightly 
regulated by growth factors and extracellular signals secreted by Sertoli cells within the 
niche (Brinster, 2007).  In 1994 Dr. Ralph Brinster described an SSC transplantation 
assay in which he displayed the ability of cultured SSCs to generate a colony of 
spermatogenesis after transplantation to the seminiferous tubules of a recipient male 
(Brinster and Avarbock, 1994).  Additionally, advances in cell culture techniques allow 
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for long-term in vitro culture of SSCs (Kanatsu-Shinohara et al., 2005).  These 
technologies allow preservation of the male germline, which has utility in species 
continuity and perpetuating valuable livestock.  Importantly, there are great medical 
applications of these technologies including preserving the germline of prepubertal boys 
undergoing radiation or chemotherapy causing infertility.   
For application of these techniques in fertility treatment, it will be necessary to 
not only cryopreserve, culture and transplant SSCs, but intracytoplasmic sperm injection 
(ICSI) will likely be used to ensure fertilization and obtain pregnancies.  The ICSI 
procedure itself involves many steps that coincide with times of epigenetic 
reprogramming, which could disrupt imprint establishment and maintenance.  First, 
gonadotropin stimulation of the ovary is used to obtain large numbers of oocytes.  
Oocytes are then cultured and injected with a single sperm.  Embryos are cultured until 
blastocyst stage and transferred into a recipient female.  All of these manipulations take 
place during periods of epigenetic reprogramming and have been reported to cause 
methylation and expression abnormalities in mice (de Waal et al., 2012b; Doherty et al., 
2000; Fauque et al., 2007; Mann et al., 2004; Rivera et al., 2008; Sato et al., 2007).  
Knowing that a wide variety of environmental influences could induce epigenetic 
perturbations, we were interested in determining the stability of DNA methylation at 
imprinted loci throughout long-term SSC culture, transplantation, cryopreservation and 
ICSI.  These studies were performed in collaboration with Dr. Ralph Brinster’s laboratory 
at the University of Pennsylvania School of Veterinary Medicine.  I worked with Dr. 
Jonathan Schmidt to assess whether in vivo and in vitro aging was detrimental to SSC 
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function.  I performed methylation analysis on SSCs and an ICSI-derived pup, with all 
cell culture work, mouse work and gene expression analysis performed by the Brinster 
Laboratory and published in (Schmidt et al., 2011).  I worked with Dr. Xin Wu and Dr. 
Shaun Goodyear to characterize offspring derived from SSCs cryopreserved for more 
than 14 years.  For these studies I performed methylation analysis, with all cell culture 
work, mouse work and genetic analysis performed by the Brinster Laboratory and 
published in (Wu et al., 2012).  Despite environmental perturbations we detected normal 
methylation at ICRs, confirming the stability of epigenetic modifications in cultured, 
frozen or serially transplanted SSCs.   
5.1 Analysis of aged SSCs 
 
 Currently, SSCs can be cultured in vitro indefinitely.  Because of the potential 
utilization of culture techniques to maintain human SSCs for fertility treatments, it is 
imperative to characterize the stability of epigenetic marks in SSCs after long-term 
culture or extreme aging.  We did this by analyzing DNA methylation profiles at 
imprinted DMRs in both in vivo aged SSCs (figure 5.1) and in vitro aged SSCs (figure 
5.2).   
5.1.1 Normal methylation detected in in vivo aged SSCs 
 
To determine the effect of in vivo aging on SSC function, SSC cultures were 
initiated when the SSCs were 8, 300 or ~1500 days of age.  SSCs were isolated from 8 
day old pups, or 10 month old adults for the 8 days (young) or 300 days (aged) SSC 
  
 
Figure 5.1 Experimental design for 
from 8 day old male pups (young) and cultured for 11 months (n=3). (B) SSCs were 
isolated from 10 month old male mice (aged) and cultured for 11 months (n=3). (C) 
SSCs were isolated from the 10
which SSCs were serially transplanted every 3 months into young testes.  SSCs were 
isolated from the final recipients at 10 months after transplantation (ST
cultured for 16 months (n=3).
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Figure 5.2 Experimental design for 
8 day old male mice (young) and cultured for 5.5, 11 or 13 months (n=3 for all).
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 Figure 5.3 Experimental design for analysis of offspring derived from aged SSCs, 
transplantation and ICSI
cultured for 7 months and subsequently transplanted into 
isolated from the recipient male 6 months after transplantation was used for ICSI.  
Analysis was performed on the ICSI
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 experimental groups, respectively (n=3 for both groups) (figure 5.1A-B).  For the third 
treatment group, SSCs were isolated from the 10th recipient of a serial transplantation 
(ST) experiment in which SSCs were serially transplanted every 3 months into young 
testes.  SSCs were isolated and cultured from the final recipients at 10 months after 
transplantation to generate the 1500 days of age (ST-aged) group (n=3) (figure 5.1C).    
To identify possible deficiencies of the aged stem cells we analyzed DNA 
methylation at multiple imprinted DMRs.   We focused on the H19 ICR and IG-DMR 
because these loci are methylated during spermatogenesis.  Using COmbined Bisulfite 
Restriction Analysis (COBRA) we were able to determine the methylation status of these 
regions.  Bisulfite mutagenesis followed by PCR amplification converts unmethylated 
cytosines to thymines, while methylated cytosines remain.  This process creates 
restriction sites that are unique to methylated sequences.  Thus, with PCR amplification 
of bisulfite treated DNA and subsequent digestion with restriction enzymes unique to the 
methylated sequence, we were able to determine the methylation status of these 
paternally-methylated DMRs.  In order to evaluate the effects of donor age on 
methylation at the H19 ICR and IG-DMR, we compared young, ST-aged, and aged SSCs 
after 11, 16 and 11 months in culture, respectively.  No differences in methylation 
patterns were observed between young, ST-aged and aged donor cultures, with ~100% 
methylation detected in all samples (figure 5.4 lanes 7-9).  Therefore, in vivo aging of 
SSCs did not disrupt methylation patterns at paternally-methylated DMRs. 
  
 Figure 5.4 Maintenance of DNA methylation 
COBRA was performed on bisulfite mutagenized DNA to analyze (A) the 
(B) IG-DMR and run out on a 1% agarose gel
undigested/unmethylated fragments are indicated to the 
representative gels displaying one sample from each experimental group.
liver; lane 2,control day 0 pup somati
donor sperm from SSCs that was cultured for 7 mo
maintained in the recipient mouse for 6 mo
(Y) donor cultured for 5.5 mo
6, young (Y) donor cultured for 13 mo
months; lane 8, ST-aged (ST
cultured for 11 months.  Modified from Schmidt et al., 2011.
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5.1.2 Normal methylation detected in in vitro aged SSCs 
 
To determine the effect of in vitro aging on SSCs, SSCs were isolated from 8 day 
old mice and cultured for 5.5, 11 or 13 months (n=3 for each group) (figure 5.2).    
COBRA was performed to assess methylation at the H19 ICR and IG-DMR in these 
samples.  No difference in methylation was observed among the in vitro aged groups, 
with ~100% methylation detected in all samples (figure 5.4 lanes 4-6).  These data 
confirmed a previous report indicating stability of epigenetic modifications over long-
term culture of SSCs (Kanatsu-Shinohara et al., 2005). 
5.1.3 Normal methylation in offspring derived from aged SSCs, transplantation and ICSI 
 
In vitro and in vivo aging did not appear to induce any methylation defects at the 
H19 ICR or IG-DMR.  However, because ICSI would likely be used in application of 
these techniques, we wanted to assess whether the combination of SSC aging followed by 
transplantation and ICSI would alter DNA methylation patterns in offspring.  SSCs were 
isolated from 10 month old mice and cultured for 7 months.  After 7 months in culture the 
SSCs were transplanted into a recipient male.  Sperm was isolated from the recipient 
male 6 months after transplantation and used for ICSI (figure 5.3).  Two offspring were 
generated from this procedure.  COBRA was performed to analyze methylation at the 
H19 ICR and IG-DMR of an ICSI derived pup (figure 5.4, lane 3) and a naturally sired 
control pup (figure 5.4, lane 2).  Methylation at the H19 ICR and IG-DMR in the ICSI 
derived pup was indistinguishable from control (figure 5.4, lanes 2-3).  We therefore 
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conclude that methylation at imprinted loci in SSCs were stable throughout aging either 
in vivo, in vitro or combined SSC aging, transplantation and ICSI.   
5.1.4 Aged SSCs have decreased stem cell function 
 
Whereas epigenetic analysis indicated normal methylation at paternally-
methylated DMRs, stem cell deficiencies were observed in the aged SSCs.  Notably, the 
ST-aged SSCs had a decreased proliferation rate in vitro, and the in vitro aged SSCs had 
compromised ability to colonize the seminiferous tubule upon transplantation (Schmidt et 
al., 2011).  Microarray analysis of in vitro aged SSCs (cultured greater than 14 months) 
identified a number of gene expression changes involved in SSC function.  Long-term 
cultured SSCs had decreased expression of genes important for SSC self-renewal, such as 
Bcl6b and Lhx1, and increased expression of genes implicated in SSC differentiation, 
Stra8 and Kit (Schmidt et al., 2011).  This suggests that as an SSC ages, the decision to 
differentiate or self-renew shifts from self-renewal in younger SSCs to differentiation in 
aged SSCs.  Therefore, SSCs will likely not be able to be cultured and maintain their 
stemness indefinitely. 
5.2 Analysis in mice derived from SSCs cryopreserved for ~14 years 
 
The findings that aged SSCs maintained expected DNA methylation levels at 
imprinted DMRs provided preliminary evidence that these techniques could be used for 
medical applications. Nevertheless, of great importance for human infertility would be 
the ability of SSCs to maintain proper epigenetic modifications despite long-term 
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cryopreservation.  Chemotherapy or radiation treatment can result in infertility.  Adult 
males can produce sperm for cryopreservation, whereas prepubertal boys cannot.  
Cryopreservation of testicular tissue from boys may allow for future transplantation of 
SSCs to re-establish fertility in adulthood (Brinster, 2007).  Therefore, we wanted to 
characterize DNA methylation profiles from mice derived from cryopreserved SSCs. 
5.2.1 Normal methylation profiles in mice derived from SSCs cryopreserved for ~14 
years 
 
Testis cells from mouse pups (aged 6-14 days) that were frozen for ~14 years, 
were thawed and transplanted into recipient testes of mice in which endogenous 
spermatogenesis had been destroyed by busulfan treatment.  Sperm from these recipient 
males were isolated and used for ICSI.  A total of 5 pups were born from the ICSI 
procedure that appeared grossly normal (Wu et al., 2012) (figure 5.5).  To assess the 
possibility that epigenetic defects occurred as a result of these procedures, we analyzed 
DNA methylation in these pups. 
LUMA was performed on genomic liver DNA (as described in chapter 4.3) to 
assess genome-wide DNA methylation.  Methylation levels of 5 control livers (sired from 
natural matings) and 4 ICSI derived livers were assessed.  Genomic methylation levels in 
the ICSI derived mice were indistinguishable from control mice at ~72% CpGs 
methylated (figure 5.6).  Therefore, repetitive elements appeared to be properly 
methylated in mice derived from ICSI using sperm from cryopreserved SSCs. 
Next, we asked if imprinted DMRs have abnormal levels of methylation.  
Previous studies have demonstrated that ICSI, as well as other environmental influences, 
 Figure 5.5 Experimental design to analyze offspring derived from SSCs 
cryopreserved ~14 years
frozen for ~14 years, were thawed and transplanted into rec
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Figure 5.6 Normal genome-wide DNA methylation detected in offspring derived 
from ICSI using sperm from cryopreserved SSCs. Methylation levels of liver DNA 
were determined by the LUminometric Methylation Assay (LUMA) for naturally sired 
mice (control, closed circles) and ICSI-derived mice using sperm from cryopreserved 
SSCs (ICSI, open circle). Each circle represents an individual sample with the mean 
methylation for each group indicated by a horizontal bar. 
 
113 
 
can induce abnormal methylation and expression of imprinted genes (de Waal et al., 
2012a).  We analyzed two paternally-methylated DMRs; H19 ICR and IG-DMR.  
Pyrosequencing of bisulfite treated liver DNA indicated normal levels of methylation at 
the H19 ICR in ICSI derived as compared to control mice (figure 5.7A).  COBRA was 
performed to analyze methylation at the IG-DMR. Using this assay, levels of methylation 
detected in the ICSI mice were indistinguishable from controls (figure 5.7B).  Therefore, 
methylation at these paternally-methylated DMRs was maintained in SSCs after long-
term cryopreservation, and properly inherited in the next generation despite the use of 
ICSI. 
Additionally, we analyzed methylation at maternally-methylated DMRs; Snrpn 
and Peg3.  Pyrosequencing analysis of bisulfite treated liver DNA did not uncover any 
significant difference between methylation levels at the Snrpn DMR in ICSI derived mice 
and control mice (figure 5.8A).  COBRA analysis of the Peg3 DMR also indicated 
normal levels of methylation in the ICSI derived mice when compared to control mice 
(figure 5.8B).  We therefore conclude that mice derived by ICSI using sperm from SSCs 
cryopreserved for ~14 years had normal levels of methylation both genome-wide and at 
imprinted loci.  These data confirms the prospect of using these procedures to restore 
fertility in males who had undergone gonadotoxic treatment as boys. 
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CHAPTER SIX 
DISCUSSION AND FUTURE DIRECTIONS 
 
Genomic imprinting is a complex epigenetic phenomenon required for normal 
mammalian development.  Imprinted expression requires marking the parental origin of 
the chromosome so that a specific parental allele is stably repressed or stably expressed.  
DNA methylation is essential for marking and silencing imprinted genes.  These DNA 
methylation imprints and allele-specific expression patterns must be maintained 
throughout early development and in differentiated somatic tissues.  Additionally, 
marking of the alleles must be reset in the germline to allow for establishment of sex-
specific marks in the mature gamete, which will be transmitted to the next generation.   
These processes are critical for normal imprinting, and can be disrupted by environmental 
stress. This dissertation focused on identifying both cis and trans mechanisms by which 
DNA methylation confers imprints and how environmental stresses can disrupt imprinted 
regulation.  We have defined a novel regulatory role for CpG content at the H19 ICR in 
silencing paternal H19.  We have also identified TET1 and TET2 as trans factors 
involved in resetting imprints in the germline and have provided evidence that individual 
MBD proteins are dispensable for normal imprinting.  Moreover, we have demonstrated 
that methylation imprints are in fact stable in spermatogonial stem cells that have 
undergone aging and cryopreservation, suggesting that these techniques can be valuable 
sources for male infertility treatment. 
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6. 1 Non-promoter methylation in gene silencing 
 
Whereas DNA methylation at the H19 ICR is established in sperm and maintained 
in the zygote, methylation at the paternal H19 promoter region is not detected until 
midgestation (Tremblay et al., 1997; Tremblay et al., 1995).   Intriguingly, mice that 
paternally inherited an allele in which the H19 ICR had been deleted did not gain 
methylation at the H19 promoter region (Srivastava et al., 2000; Thorvaldsen et al., 
2006).  It was proposed that the paternal ICR acts as a center for spreading of methylation 
to the paternal H19 promoter, indicating a cis-regulatory role for the ICR in paternal 
repression.  This had been the prevailing model for how the ICR silences paternal H19 in 
cis.  Our data indicates a novel regulatory role for DNA methylation at the H19 ICR in 
repression of H19 directly.  In mice that inherited a mutant paternal allele in which 8 
CpGs within the ICR but outside of CTCF binding sites had been deleted, H19ICR-8nrCG 
allele, significant levels of paternal H19 expression were detected despite maintaining a 
hypermethylated ICR and promoter (figures 2.5, 2.7-2.9).  Therefore, we conclude that 
while H19 promoter methylation is necessary for repression, it is clearly not sufficient.  
This is particularly the case when total H19 is expressed very highly.   In these tissues, 
the silent H19 allele is in an environment that is conducive to expression, with all the 
proper transcriptional machinery actively transcribing the normally active allele.  
Therefore, multiple levels of repression may be necessary to ensure silencing.  Our data 
highlights the importance of non-promoter methylation as a means of repression when 
promoter methylation alone is insufficient.   
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 One remaining question is how does methylation at the H19 ICR act from a 
distance to silence H19?  The repressive NuRD complex has been implicated in 
regulation of paternal H19 repression.  Depletion of NuRD components MTA-2 or 
MBD3 resulted in biallelic H19 expression in blastocysts (Ma et al., 2010; Reese et al., 
2007).  It is possible that DNA methylation at the H19 ICR recruits the NuRD complex, 
resulting in a repressive chromatin environment and H19 silencing.   With depletion of 
methylation at the ICR, there might be a decrease in NuRD recruitment resulting in a 
more permissive chromatin environment.  Of note, MBD2 also is a NuRD complex 
component, although MBD2 and MBD3 form mutually exclusive complexes (Baubec et 
al., 2013; Gunther et al., 2013; Le Guezennec et al., 2006).  Because we did not detect 
any loss of imprinting in Mbd2 null mice, it is likely that MBD3-NuRD complexes 
exclusively act at H19 in preimplantation embryos and cannot be compensated for by 
MBD2-NuRD complexes.  However, this hypothesis is difficult to confirm biochemically 
due to the low amounts of material that can be collected from preimplantation embryos. 
6.2 CpG content mediates paternal H19 repression 
 
It can be argued that the mutations made to the 8nrCG ICR disrupted a binding 
site for a repressor or generated a binding site for an activator.  We do not believe this to 
be the case for three reasons.  First, other than the presence of CTCF sites, the ICR is 
poorly conserved among species (Frevel et al., 1999; Stadnick et al., 1999).  Secondly,  
DNAse footprinting of the paternal methylated H19 ICR had not detected any footprints 
(Szabo et al., 2000).  Lastly, there have been two other mouse mutants reported to have 
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similar phenotypes to the H19ICR-8nrCG allele when paternally inherited; the H19ICR-∆IVS 
(Ideraabdullah et al., 2011) and H19SilK  (Drewell et al., 2000) alleles.  The ∆IVS mutant 
ICR has a deletion of the intervening sequence between CTCF sites 2 and 3, deleting 873 
base pairs of the ICR (figure 2.1).  The SilK mutant ICR deleted 1.2 kilobases of 
sequence, overlapping with the distal half of the ICR (figure 2.1).  When paternally 
inherited, both of these mutant ICRs maintained methylation but paternal H19 was 
detected.  The sequence deleted in the H19SilK  allele had been described as a silencer in 
Drosophila when introduced as a transgene (Lyko et al., 1997).  Later it was found that 
silencing in Drosophila was mediated by the Drosophila specific factor Su(Hw) 
(Schoenfelder and Paro, 2004).   These three disparate mutants with similar phenotypes 
contain no sequence mutations common to all mutants.  The one common feature is that 
they have lowered CpG content at the ICR.  We therefore posit that decreased CpG 
content, rather than disruption of a specific element resulted in paternal H19 expression 
from the mutant alleles.   
6.3 CpG content does not have a role in methylation maintenance 
 
Studies at the endogenous locus in mice have indicated that the ICR harbors cis- 
elements essential for maintaining paternal DNA methylation.  The H19DMD-9CG allele 
(mutated 9 CpGs within CTCF sites, figure 2.1) properly acquired methylation in sperm, 
but upon paternal inheritance, became hypomethylated during embryogenesis.  Loss of 
methylation associated with the paternal H19DMD-9CG allele could have been the result of 
either (1) CTCF aberrantly binding to CpG-depleted binding sites causing 
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hypomethylation of the entire allele, or (2) decreased CpG density rendered the ICR 
unable to be recognized for maintenance.  Because paternal inheritance of the H19ICR-
8nrCG
 allele maintained methylation we conclude that CpG content at the ICR does not 
coordinate methylation maintenance in the preimplantation embryo.  Therefore, it is 
likely that in mice with a paternal H19DMD-9CG allele, CTCF bound the mutant allele 
resulting in hypomethylation.   
6.4 Further elucidation of the mechanism for paternal repression of H19 
 
Here, we have shown significant levels of paternal H19 expression when the 
number of CpGs at the ICR was decreased by 8 (~16% depletion).  What remains 
unclear, is if there is a specific threshold of DNA methylation density necessary for 
silencing, or if repression is additive, with increased repression correlated with increased 
number of CpGs.  Unfortunately, we were unable to investigate this question using an in 
vitro repressor assay described in chapter 2.6.  Using this assay we were unable to 
reproduce derepression that was observed in mice.  One potential problem with the 
repressor assay could be that at the endogenous locus there is interaction between the ICR 
and the H19 promoter.  A different promoter may not interact with the ICR in the same 
manner.  Therefore, it would be of interest to establish an in vitro repressor assay using 
the H19 promoter.  If insertion of mutant ICRs upstream of the H19 promoter driving 
reporter expression could recapitulate derepression seen in the mouse, this assay could be 
used to better define how many CpGs are necessary at the ICR to maintain silencing. 
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Furthermore, by performing this assay in various cell-types we can determine tissue-
specificity for repression.    
There are still remaining questions regarding how ICR DNA methylation 
represses expression in cis; (1) is DNA methylation at the ICR critical for establishing 
methylation at the H19 promoter and (2) is all DNA methylation equally as effective in 
repressing?  Comparison of mice that have paternally inherited the H19ICR-8nrCG or 
H19DMD-9CG alleles indicates that CpGs within (but not outside) CTCF binding sites are 
critical to prevent full activation of paternal H19.  To address these questions one could 
make a targeted mouse mutant in which all CpGs within the ICR but outside of CTCF 
binding sites are mutated.  Allele-specific expression analysis in mice that paternally 
inherit the mutant allele would indicate whether methylation exclusively at CTCF 
binding sites (which should still inhibit CTCF binding) is sufficient to prevent full 
activation of paternal H19. Methylation analysis at the paternal H19 promoter region 
would indicate if the promoter gains methylation despite the fact that the ICR is 
hypomethylated.  These experiments would further define ICR-mediated paternal H19 
repression. 
6.5 H19ICR-8nrCG allele and implications for human disease 
 
In addition to defining mechanisms of imprinted repression, these studies 
highlight the importance of studying subtle genetic perturbations for disease etiology.  
Reports have identified epimutations at the H19/Igf2 locus in SRS patients associated 
with biallelic H19 expression (Bartholdi et al., 2009; Begemann et al., 2010; Gicquel et 
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al., 2005). The 8nrCG mutant, presented here, suggests that single base pair mutations 
play key roles in deregulation of the H19/Igf2 locus. Although disease phenotypes were 
not identified in our analysis, it is possible that the H19ICR-8nrCG allele is sensitized to 
secondary genetic/epigenetic mutations or exposure to environmental factors that could 
result in SRS-like features. Further studies that combine mutant models or include 
environmental perturbation may be necessary to generate a mouse model of SRS.   
We have shown how subtle changes in non-promoter DNA methylation could 
disrupt gene-regulation.  This finding is of particular concern for studying human 
cancers.  The cancer epigenome is characterized by global hypomethylation and local 
promoter hypermethylation (Baylin and Jones, 2011).  Research has predominantly 
focused on hypermethylation at promoters of tumor suppressor genes and has resulted in 
FDA approval of demethylating agents in the management of myelodysplasia and acute 
mylogenous leukaemia (Azad et al., 2013).  We have shown that hypomethylation in 
regions flanking genes could play an essential regulatory role in gene expression.  Non-
promoter hypomethylation could cause upregulation of oncogenes driving cancer 
progression.  It will therefore be important for future studies to focus on the global 
hypomethylation in cancers and analyze the potential off-target effects that demethylating 
agents used in treatments have on these regions.    
6.6 Individual MBD proteins are dispensable for normal imprinting in the mouse 
 
Studies have clearly indicated a role for DNA methylation in allele-specific 
marking and repression of imprinted loci (Bourc'his et al., 2001; Kaneda et al., 2004; 
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Kato et al., 2007; Li et al., 1993; Weaver et al., 2010).  However, trans-acting factors 
required for DNA methylation dependent repression remain unclear.  Here, we 
investigated the role that MBD family proteins, specifically MBD1 and MBD2, have in 
allele-specific repression at imprinted loci.  Surprisingly, we find that mouse tissues that 
highly express many imprinted genes (embryos, placentas, yolk sacs and neonatal brains) 
retained proper imprinting without any functional MBD1 or MBD2 (tables 3.1-3.2).  We 
have therefore confirmed studies performed on adult tissues indicating that MBD2 is 
dispensable for proper imprinting, and have shown for the first time that MBD1 also is 
dispensable for imprinted repression. 
There remains the possibility that the MBD proteins have redundant functions. 
Initial phenotyping of the Mbd1-/- and Mbd2-/- mutant mice revealed somewhat subtle, but 
distinct phenotypes, suggesting that these proteins regulate discrete sets of genes.    
Recent ChIP-seq analysis in which tagged-MBD proteins were expressed in mouse ES 
cells indicate that the MBD proteins that bind methylated DNA (MECP2, MBD1, MBD2 
and MBD4) have overlapping enrichment profiles with strongest interaction detected at 
methylated, CpG-dense, and inactive regulatory regions (Baubec et al., 2013).  Although 
it is unclear if MBD proteins are involved in regulation of imprinted repression, it is 
likely that multiple MBD proteins bind and are able to compensate for deficiency of a 
single protein.  
Our attempts to test redundancy using RNAi-based knockdown have been unable 
to show definitively whether these proteins have compensatory functions.  We have been 
able to severely decrease overall levels of MBD1 and MECP2 in Mbd2 null MEFs, but 
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substantial amounts of protein still remained (figure 3.7).  Thus, it is unclear if remaining 
protein was enough to confer proper allele-specific repression, or if these proteins have 
no role in imprinting.  It is therefore of utmost importance to test genetically for 
compensation.  As described in chapter 3.6 we are currently breeding to obtain Mbd1-/-
Mbd2-/- mice.  Analysis of these double mutant mice would be ideal to uncover functional 
redundancy, as the Mbd1 null and Mbd2 null phenotypes are quite subtle. Once we have 
obtained the Mbd1-/-Mbd2-/- mutant (which requires recombination as described in 
chapter 3.6) we can easily breed for triple Mbd1-/-Mbd2-/-Mecp2-/y mutants.   
6.7 MBD2 and MBD3 form functionally distinct NuRD complexes in vivo 
 
Intriguingly, the MBD protein that does not bind methylated DNA, MBD3 (Ohki 
1999), has been implicated in allele-specific repression at H19 (Reese et al., 2007).  
MBD3 and MBD2 are the most similar of the MBD proteins with 77% sequence 
conservation outside of the MBD domain (Clouaire and Stancheva, 2008) and both are 
members of the NuRD complex.  Purification and analysis of NuRD complexes indicates 
that MBD2 and MBD3 are mutually exclusive components (Le Guezennec et al., 2006). 
Recent ChIP-seq analysis reveals differential genome-wide binding for MBD3- NuRD 
and MBD2- NuRD complexes (Baubec et al., 2013; Gunther et al., 2013), which would 
suggest functional differences between the two complexes.  Whereas blastocysts depleted 
of MBD3 exhibit biallelic H19 expression and loss of methylation at the H19 ICR (Reese 
et al., 2007), Mbd2 null mice do not display imprinting defects.  Our work supports the 
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idea that MBD2 and MBD3 containing NuRD complexes have functional differences in 
regulating gene expression in vivo.  
6.8 MBD proteins: gene-specific or global regulators of repression  
 
Questions still remain as to how these proteins function in vivo and why 
phenotypes predominantly manifest in the brain even though expression is ubiquitous. 
Overall, our data are in concert with other in vivo studies that have been unable to define 
specific genes regulated by individual MBD proteins.  As opposed to early in vitro 
studies in which overexpression of MBD proteins caused repression of a methylated 
reporter gene (Boeke et al., 2000; Jones et al., 1998; Nan et al., 1997; Nan et al., 1998; 
Ng et al., 1999), studies of the null mice have produced a very small number of genes that 
are regulated by MBD proteins (Hutchins et al., 2002; Liu et al., 2013; Liu et al., 2010; 
Phesse et al., 2008).  Again, if these proteins are highly redundant, changes in expression 
would not be expected. 
There has been great interest in defining genes that are regulated by MECP2 as 
these could cause symptoms of Rett Syndrome and would be therapeutic targets.  
Numerous studies have investigated changes in gene expression in Mecp2 null mouse 
brains, however, few and subtle changes in gene expression have been identified (Guy et 
al., 2011).  Interestingly, increased transcription of repetitive elements and increased 
global levels of histone acetylation have been detected in Mecp2 null mouse brains, 
suggesting that MECP2 might be playing a more global regulatory role to subtly fine-
tune expression (Guy et al., 2011; Shahbazian et al., 2002; Skene et al., 2010). Moreover, 
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ChIP-seq analysis indicated that MBD proteins binding profiles tract with DNA 
methylation levels, supporting the idea that MBD proteins act globally rather than at 
specific loci (Baubec et al., 2013). 
It remains unknown as to why deficiencies of these proteins cause predominantly 
brain-specific phenotypes despite being ubiquitously expressed. One potential 
mechanism is that DNMT1 (rather than the MBD proteins) is the critical factor for setting 
up repressive chromatin as it deposits DNA methylation during replication.  Like the 
MBD proteins, DNMT1 has been shown to interact with chromatin modifiers and 
transcriptional repressors, for example; HDAC1/2 (Fuks et al., 2000; Robertson et al., 
2000; Rountree et al., 2000), EZH2 (Vire et al., 2006) and HP1 (Smallwood et al., 2007).  
The MBD proteins could be playing a reinforcement role to maintain chromatin state 
when cells are not replicating.  It is possible that in most tissues, where replication is 
ongoing, MBD proteins are not critical, as DNMT1 is sufficient for repression.  However, 
in the brain where neurons are post mitotic, MBD proteins have a greater role in reading 
DNA methylation marks and maintaining chromatin state in the absence of replication.  If 
this is the case, it is not surprising that the most striking phenotypes manifest in the adult 
brain and that global/subtle changes are detected rather than regulation at specific genes, 
including imprinted loci. 
6.9 TET1 and TET2 mediate DNA demethylation at imprinted loci in PGCs 
 
Recent reports suggest that DNA demethylation is mediated by 5mC oxidation to 
5hmC in the zygote and PGCs (Gu et al., 2011; Hackett et al., 2013; Inoue and Zhang, 
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2011; Iqbal et al., 2011; Wossidlo et al., 2011; Yamaguchi et al., 2013).  Our analysis in 
the germline of Tet1-/-Tet2-/- mice indicates that, indeed, demethylation at imprinted loci 
requires 5mC oxidation to 5hmC, which is mediated by TET1 and TET2.  The 
mechanism by which demethylation occurs after conversion to 5hmC and if this 
mechanism is the same for all imprinted loci remains unclear.  However, our analysis in 
Tet1/Tet2 DKO sperm indicates a locus-specific sensitivity to TET1 and TET2 
deficiency.   
Various models for how DNA demethylation can occur after conversion to 5hmC 
have been proposed (figure 1.7).  Components of the BER pathway, such as the 
glycosylase, TDG, and deaminase, AID, have been implicated in erasure of methylation 
in the germline.  AID expression, however, in E9.5-13.5 PGCs is very low (Kagiwada et 
al., 2013) and unlike TET deficiency, AID deficiency in PGCs does not lead to profound 
demethylation defects (Popp et al., 2010).  TDG, on the other hand, has relatively high 
levels of expression in PGCs (Kagiwada et al., 2013) and TDG deficient E13.5 PGCs 
retained methylation at the Igf2 promoter (Cortellino et al., 2011).  Accordingly, in TDG-
deficient ES cells, accumulation of 5fC and 5caC were detected, suggesting that TDG is 
required for active demethylation of 5hmC (Shen et al., 2013).  Another potential model 
for demethylation is that 5hmC is passively demethylated in a replication dependent 
manner, which has been reported in PGCs for the imprinted genes Peg3 and Peg10.  
Moreover, bisulfite sequencing (which cannot distinguish between 5mC and 5hmC) 
analysis revealed that H19, Nnat, Peg3, Snrpn, Kcnq1ot1 and Peg10 DMRs follow 
slower or close to expected kinetics for purely passive demethylation in PGCs (Kagiwada 
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et al., 2013).  In studying PGCs deficient in TET1 and TET2, we impeded 5mC 
conversion to 5hmC and detected retention of methylation at imprinted loci, but cannot 
conclude whether other enzymes might be necessary for normal DNA demethylation. 
6.10 Locus–specific susceptibility to TET deficiency 
 
Methylation analysis of TET1 and TET2 deficient sperm indicate that some 
maternally-methylated DMRs were fully erased in the male germline, while others were 
not (figure 4.4).  Therefore, some loci are more sensitive to loss of TET function.  In 
PGCs, timing of 5mC oxidation to 5hmC varies between DMRs.  For example, 5hmC is 
detected earlier for Kcnq1ot1 and Igf2r than it is for Peg3 and Peg10 (Hackett et al., 
2013).  Interestingly, in our studies, Kcnq1ot1 exhibited aberrant methylation in DKO 
sperm whereas Peg3 did not.  It is possible that the variability in timing of 5hmC 
conversion is indicative of different mechanisms of erasure used at these loci, some being 
more dependent on TET function.   
Many reports indicate that passive demethylation is responsible for bulk DNA 
demethylation in PGCs, supported by the fact that UHFR1 is very lowly expressed and 
DNMT1 is excluded from replication foci in these cells (Kagiwada et al., 2013; 
Seisenberger et al., 2012).  It is likely that passive DNA demethylation could occur at 
imprinted loci in the absence of 5hmC conversion.  We propose this to be the case 
because we do detect full erasure of methylation at some imprinted DMRs in DKO 
sperm.  Moreover, at loci where we do detect retention of methylation, levels are reduced 
from the expected 50% (if no erasure occurred) (figure 4.4).  Furthermore, levels of 
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aberrant methylation were quite variable between samples.  We therefore hypothesize 
that passive DNA demethylation can occur irrespective of 5mC oxidation, though at 
some loci this mechanism is not sufficient for complete erasure. 
6.11 Comparison of two independent Tet1-/-Tet2-/- mutant mice  
 
After initiation of our studies investigating the role of TET1 and TET2 in imprint 
erasure, the Jaenisch laboratory published analysis of an independent Tet1-/-Tet2-/- mutant 
(Dawlaty et al., 2013).  Whereas we find normal development of mice deficient for TET1 
and TET2 that were conceived from double heterozygous parents, Dawlaty and 
colleagues report that the Tet1-/-Tet2-/- mice were detected at a 3-fold reduced frequency.  
This perinatal lethality phenotype was only partially penetrant with some DKO mice 
developing normally (Dawlaty et al., 2013).  Seemingly, this is a major discrepancy, but 
we did not have the number of litters necessary to detect incomplete penetrance of 
lethality of DKO mice.  Because we set up double heterozygous mice for our matings, 
there was only a 1/16 chance of obtaining a Tet1-/-Tet2-/- mouse.  Mice were genotyped at 
weaning, and when a Tet1-/-Tet2-/- mouse was identified it looked grossly normal.  For 
this reason, we did not pursue potential perinatal lethality.  Dawlaty and colleagues also 
identified defects in midgestation embryos and malformations in pups deficient in TET1 
and TET2. However, these analyses were performed in litters conceived from mating 
Tet1+/-Tet2+/- females with Tet1-/-Tet2-/- males (Dawlaty et al., 2011).  Therefore, these 
abnormalities could have resulted from the combination of having a TET1/TET2 
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deficient father and a TET1/TET2 depleted mother.  Because we did not set up similar 
crosses we cannot make a comparison with our mutant mice. 
Dawlaty et al. analyzed DNA methylation in one TET1/TET2 deficient sperm 
sample, and similar to our results, reported increased methylation at Mest, normal 
methylation at H19 and Peg3, and no changes in global methylation levels (figure 4.4-
4.5).  Likewise, we both find subfertility of DKO females and increased levels of 
methylation at H19 in progeny from these females.  Dawlaty et al. additionally detected 
aberrant methylation at a number of imprinted loci in progeny of DKO males.  We have 
not done this analysis, although such studies are planned in the future.   
Overall, our studies are in agreement with those published by the Jaenisch 
laboratory.  However, direct comparison is somewhat difficult as different matings were 
typically used to obtain Tet1-/-Tet2-/- or a small sample size does not allow proper 
statistical analysis. 
6.12 Future directions for analysis of TET-mediated erasure of imprints 
 
We have clearly shown that erasure of imprints in the germline was compromised 
without functional TET1 and TET2.  Furthermore, aberrant methylation was heritable.  
Nevertheless, numerous experiments are required to fully characterize the effects that loss 
of TET1 and TET2 have on imprint erasure.  Firstly, our analysis in DKO sperm 
indicated that some DMRs properly erase methylation. These DMRs need to be analyzed 
in DKO E13.5 PGCs.  Presence of methylation at these DMRs in DKO E13.5 PGCs 
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would indicate that there was a delay in erasure, whereas absence of methylation would 
indicate that erasure of these DMRs is independent of TET proteins.   
Additionally, analysis needs to be performed for retention of methylation in 
mature oocytes.  Because we do detect increased methylation at paternally-methylated 
DMRs in offspring of DKO females, we expect that oocytes from TET1/TET2 deficient 
females would similarly retain methylation.  To this end, we also need to analyze 
methylation in progeny of DKO males.  Based on our sperm data, we expect to detect 
high levels of methylation on specific maternally-methylated loci, namely, Mest, Grb10 
and Kcnq1ot1.  Whereas our initial observations indicate that TET1/TET2 deficient males 
are fertile and offspring appear normal, it is possible that retention of methylation at 
imprinted loci is associated with tissue-specific expression changes, which may exert 
more subtle phenotypes such as growth defects or behavioral abnormalities, as observed 
with Grb10, Mest and Peg3 mutant mice (Garfield et al., 2011; Lefebvre et al., 1998; Li 
et al., 1999). 
Moreover, although aberrant methylation in DKO mice is inherited in progeny, it 
is unknown if this results in expression abnormalities.  Allele-specific expression analysis 
can be performed in progeny of Tet1-/-Tet2-/- females mated with wild type C7 males, or 
vice-versa.  This would allow us to determine if increased methylation detected in 
progeny results in biallelic expression of the corresponding genes.   
Furthermore, we would like to ensure that compromised erasure of imprints 
detected in DKO mice were intrinsic to PGCs.  That is, retention of methylation was not 
132 
 
due to overall abnormal development of PGCs or lack of TET1 and TET2 in the inner 
cell mass as these embryos developed.  In order to do this, we have been breeding for 
conditional germline-specific knockouts of Tet1 and Tet2.   
6.13 Stability of methylation imprints in spermatogonial stem cells 
 
The reversibility of epigenetic marks make them particularly susceptible to 
environmental influences that act to disrupt the epigenome (McCarrey, 2012).  
Specifically, manipulations associated with ART procedures, which occur during times of 
epigenetic reprogramming, have been associated with aberrant DNA methylation (Eroglu 
and Layman, 2012).  We therefore wanted to assess how the establishment and 
maintenance of imprints could be disrupted in a system experiencing environmental 
perturbations.  To this end, we analyzed imprints in spermatogonial stem cells (SSCs) 
subject to varying environmental insults.  Recent advances in understanding SSCs have 
lead to a variety of techniques with great potential for fertility treatment.  SSCs can be 
cultured indefinitely, transplanted into recipient mice and colonize the seminiferous 
tubule, and maintain stem cell function despite freezing and thawing (Avarbock et al., 
1996; Brinster and Avarbock, 1994; Kanatsu-Shinohara et al., 2005).  These techniques 
have great implications for treatment of male infertility, including preserving the 
germline of prepubertal boys undergoing radiation or chemotherapy causing infertility 
(Brinster, 2007).  
Our findings indicate that methylation at paternally-methylated DMRs was stable 
throughout extreme aging both in vivo and in vitro.  Additionally, cryopreservation for 
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~14 years and thawing of SSCs did not disrupt genomic methylation or methylation at 
imprinted loci.  Furthermore, aged or cryopreserved SSCs could be transplanted into a 
donor mouse and produce sperm to be used for ICSI.  Importantly, all mice born from 
ICSI had normal methylation at all imprinted loci assessed, regardless of stresses 
undergone by the SSCs.   
These results confirm the potential of using these techniques for fertility treatment 
in humans.  As treatments for pediatric cancers improve, many survivors are left infertile 
as a side-effect.  Cryopreservation of testicular tissue, prior to cancer therapies provides 
an approach to preserve the patient’s germline.  Our results here indicate that in mice, 
fertility can be acquired by transplantation of SSCs that had undergone a variety of 
environmental stresses, and emphasizes the need to study and improve these techniques 
for human SSCs. 
6.14 Decreased stem cell function in aged SSCs 
 
Little is known about how aging influences SSC function, although there is 
evidence that fertility in male mice begins to decline at about 12 to 24 months of age 
(Ryu et al., 2006).  Whereas in vivo and in vitro aged SSCs stably maintain DNA 
methylation at the paternally-methylated H19 ICR and IG-DMR (figure 5.4), stem cell 
deficiencies were observed in the aged SSCs.  Gene expression analysis indicates that the 
decision to differentiate or self-renew shifts from self-renewal in younger SSCs to 
differentiation in aged SSCs.  While methylation at imprinted loci has been identified as 
being particularly sensitive to environmental stresses, this study highlights the 
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importance of also assessing more global gene expression changes to fully understand 
cellular deficiencies.  Future research should focus on elucidating the underlying 
mechanisms directing gene expression changes, particularly at the identified candidate 
genes.  One possibility is that there is a change in chromatin compaction specifically at 
these loci.  Analysis of DNA methylation and histone modifications at these loci will give 
greater insight into the mechanism of age related SSC deficiencies.   
6.15 ICSI and disruption of imprinting 
 
The studies presented here were proof-of-principal experiments in which we 
showed that normal offspring could be born from either aged or cryopreserved SSCs.  
However, further examination is required to fully define the effects of these 
environmental influences on imprinting. Whereas we find normal imprinting in mice born 
from ICSI (figures 5.4, 5.6-5.8), numerous reports indicate disruption of imprinting 
associated with various procedures involved in ICSI (de Waal et al., 2012b; Doherty et 
al., 2000; Fauque et al., 2007; Fauque et al., 2010b; Fortier et al., 2008; Mann et al., 
2004; Rivera et al., 2008; Sato et al., 2007).  By analyzing mice that had been born, we 
might have biased our analysis towards assessing only mice that had normal imprinting.  
Previous studies indicate that many more blastocysts than post-implantation embryos 
derived from ART displayed imprinting defects (Fauque et al., 2010a).  This could 
suggest that embryos with major epigenetic abnormalities could not implant.  
Additionally, the placenta has been reported to be particularly susceptible to disruption of 
imprinting due to manipulations associated with ART (Fauque et al., 2010b; Fortier et al., 
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2008; Mann et al., 2004; Rivera et al., 2008).   Therefore, to fully assess the effects of 
long-term cryopreservation or aging of SSCs and subsequent ICSI to obtain offspring, it 
will be necessary to repeat analysis at ~E9.5, which is the time when previous studies 
have detected loss of imprinting in both embryonic and placental tissues.   
Nonetheless, loss of methylation at imprinted DMRs and behavioral abnormalities 
have been reported for adult mice born of ART procedures (de Waal et al., 2012a; Ecker 
et al., 2004; Fernandez-Gonzalez et al., 2004).   One study reported loss of imprinting at 
several genes in adult mice born of ICSI.  Loss of methylation was tissue-specific and 
detected either in muscle or brain (de Waal et al., 2012a).  Here, our analysis was limited 
to liver, and thus we could have missed aberrant methylation marks by not analyzing a 
wider range of tissues.  Therefore, future research should include methylation analysis in 
a variety of tissues in order to capture any tissue-specific loss of imprinting.  Additional 
studies should also investigate more subtle defects, such as behavioral abnormalities, 
which have also been detected in adult mice born of ART (Ecker et al., 2004; Fernandez-
Gonzalez et al., 2004). 
 Our analysis of the paternal H19ICR-8nrCG allele clearly demonstrated that biallelic 
expression can be detected even though the ICR remains hypermethylated.  Likewise, 
examples of normal or only slightly affected methylation and abnormal expression have 
been indicated in ART studies (Fauque et al., 2007; Market-Velker et al., 2010a; Market-
Velker et al., 2010b).  It is therefore of interest to examine if expression changes occur 
despite normal methylation patterns in our ICSI-derived mice. 
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6.16 Conclusion   
 
Overall, the data presented in this dissertation provides novel insights into the 
mechanisms by which DNA methylation confers imprints.  This work has identified cis-
elements and trans-factors either necessary or dispensable for maintenance of allele-
specific repression in somatic cells and resetting of imprints in the germline.  Our 
analysis of a mutant paternal H19 ICR with lowered CpG density provides a novel 
regulatory role for non-promoter CpG content in regulating expression in cis.  
Furthermore, we have shown that individually MBD1 and MBD2, proteins involved in 
DNA methylation dependent repression, are not necessary for allele-specific silencing at 
imprinted loci.  Therefore, the MBD proteins either work redundantly in coordinating 
silencing, or are not involved in imprinted repression. We have also described locus-
specific TET-mediated erasure of imprints in the germline.  Although further research is 
necessary to define the mechanism of demethylation, these data provide evidence that 
active DNA demethylation has a role in imprint demethylation in PGCs.  Lastly, our 
investigation into possible deregulation of imprints upon environmental stress has proven 
that imprints can be stably maintained in SSCs throughout extreme aging and 
cryopreservation.  Importantly, upon transplantation, these SSCs produce viable sperm 
that can be used in ICSI to derive normal offspring.  These data confirms the potential 
use of these techniques for germline preservation.  The findings presented in this 
dissertation highlight the multifaceted nature of DNA methylation dynamics and 
repression.  Continued investigation to better define mechanisms involved in normal 
imprint regulation and identification of environmental perturbations that result in 
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disruption of these processes will provide important insights into the causes and 
consequences of improper gene expression. 
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CHAPTER SEVEN 
MATERIALS AND METHODS 
 
7.1 Targeting and mouse generation of the H19ICR-8nrCG allele 
 
129/SvJ genomic DNA fragment spanning the H19 ICR [described  in (Engel et 
al., 2004)] was mutated at each of the four regions indicated below using the Quikchange 
site-directed mutagenesis kit (Stratagene) : GTACCTCGTGGACT[CG->CA]GACTC, 
TGGTGATTTG[CG->GC]CTTT[CG->GC]TAT, ACACAGCC[CG->CT]AGAT[CG-
>CT]TCAGT, CCTTCA[CG->CT]AT[CG->CT]AT[CG->CT]GTTCA (mutations 
italicized). The targeting vector was generated as described previously (Engel et al., 
2004) using this mutated ICR in place of the DMD-9CG mutation.  Mutations of CpGs 
were confirmed by sequencing. 
Targeting vectors were linearized and electroporated into E14.1 ES cells (Kuhn 
1991). G418-resistant positive clones were isolated and targeting to the H19/Igf2 locus 
was confirmed by restriction digestion followed by southern hybridization (figure 2.3). 
Correctly targeted ES cell clones were injected into C57BL/6J (B6) blastocysts and mice 
were generated by the Transgenic & Chimeric Mouse Facility at the University of 
Pennsylvania. Chimeras were obtained and mated to B6 mice. Germline transmission of 
the targeted mutant alleles was confirmed in the agouti progeny by DNA isolated from 
tails and analyzed by Southern blot (figure 2.3). 
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The neor cassette (flanked by loxP sites) was excised in the mouse by mating 
heterozygous mutant mice to mice expressing Cre recombinase under the control of the 
human cytomegalovirus promoter on a B6 genetic background (obtained from Dr. 
Edward Morissey, University of Pennsylvania). neor excision was confirmed in the 
progeny by Southern blot (figure 2.3). 
7.2 Mice 
 
All mouse studies adhered to procedures approved by the Institutional Animal 
Care and Use Committee at the University of Pennsylvania.  
8nrCG heterozygous mutant mice were maintained by mating to C57BL/6 (B6) 
(The Jackson Laboratory).  For imprinting analysis 8nrCG heterozygous mutant mice 
were crossed with C57BL/6(CAST7) (C7).  C7 mice contain a Mus musculus castaneus 
(CAST; The Jackson Laboratory) chromosome 7s on a B6 background.  Matings were 
carried out in both directions to obtain F1 hybrids for analysis. 
Mice carrying a null Mbd1 mutation (Mbd1+/-; from the mutant mouse regional 
resource centers) were mated either to B6 or C7 for maintenance.  To generate Mbd1 null 
mice, Mbd1+/- are mated with Mbd1+/- of the same background (B6 or C7).  For 
imprinting analysis Mbd1+/- (B6) were mated with Mbd1+/- (C7).  Matings were carried 
out in both directions to obtain F1 hybrids for analysis.   
Mice carrying a null Mbd2 mutation (Mbd2+/-; from Dr. Steven Reiner, University 
of Pennsylvania) were mated either to B6 or C7 for maintenance.  To generate Mbd2 null 
mice, Mbd2+/- are mated with Mbd2+/- of the same background (B6 or C7).  For 
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imprinting analysis Mbd1+/- (B6) were mated with Mbd1+/- (C7).  Matings were carried 
out in both directions to obtain F1 hybrids for analysis.  
To obtain Mbd1-/-Mbd2-/- double mutant mice, we cross Mbd1+/-Mbd2+/- mice with 
Mbd1-/- mice of the same background (either B6 or C7). 
7.3 Genotyping 
 
Genotyping is performed on DNA isolated from an ear clip.  DNA is prepped by 
incubating an ear clip in 100µL of solution A (25mM NaOH, .2mM EDTA) at 95°C for 
one hour followed by addition of 100µL solution B (40mM Tris).  2µL of DNA is used 
for each genotyping PCR.   
For each PCR reaction DNA was added to 1X GoTaq (Promega) and .25-.5µM 
primer master mix.  All PCR cycling conditions were as follows: 2 min at 95°C; 36 
cycles of 15 sec at 95°C, 15 sec at annealing temperature (listed in table 7.1), 20 sec at 
72°C.   
Breeding to obtain null Mbd1 or Mbd2 mutant alleles on a C7 background, the 
following MIT markers were used; 7.305, 7.57, 7.112, 7.52 7.27, 7.211, 7.163, 7.148, 7.5 
7.222, 7.285, 7.207, 7.140, 7.362.   
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Table 7.1 Genotyping PCRs 
Mutant/region Primer sequence (5’-3’) Expected 
size (bp) 
Annealing 
Temperature 
(°C) 
notes 
CAST 7 MIT markers NA 55  
8nrCG NR3F:GGGTCACCCAAATAGGGATT 
NR3R:TGACCCATGAGTTTGCCATA  
221 58 AvaI 
will cut 
mutant; 
BglII 
will cut 
WT 
8nrCG H19-2.3F: 
CAATGTTCATAAGGGTCATGGGGTG 
H19-2.0R: 
CGTAAGGTGTCACAAATGCCTGATCCC 
Mut:250 
WT:200 
58  
Mbd1 XYZ59: 
TCTTCTCAGACTGAGAAGGGTGA 
XYZ60: 
CACTGAACATTGCCCAGAGCACA 
XYZ:61 
AAACGGCGGATTGACCGTAATGG 
Mut:500  
Wt: 300  
55 1µL of 
10 µM 
primer 
used for 
each 
Mbd2 P61: ACG CTG GCC TAG TGC CGT GC 
P62: TTG TGG TTG TGC TCA GTT C 
ENP1: TCC GCA AAC TTC TAT TTC TG 
Mut:200 
WT:600 
55 1 µL of 
10 µM 
primer 
used for 
each 
  
7.4 DNA isolation 
 
Tissues were incubated overnight at 55°C in 500µL of lysis buffer (50mM Tris-
HCl (pH8), 100mM EDTA, .5% SDS, .5mg/ml proteinase K).  DNA was then isolated by 
performing two phenol/chloroform extractions.  DNA was dissolved in 50µL of dH2O. 
Sperm were taken from the cauda epididymis and incubated overnight at 55°C in 
500µl sperm lysis buffer (10mM Tris-HCl (pH 7.5-8), 10mM EDTA, 2%SDS) with 5µL 
β-mercaptoethanol and 12µL proteinase K.  DNA was then isolated by performing two 
phenol/chloroform extractions.  DNA was dissolved in 50µL of dH2O. 
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7.5 Methylation sensitive southern at H19 
 
10µg genomic DNA was digested with PvuII and StuI in combination with HapII 
or MspI to analyze the methylation at the H19 promoter and structural gene.  A 2.5-kb 
EcoRI-StuI fragment was used as a probe (figure 2.9). 
7.6 Bisulfite mutagenesis 
 
For SSC aging studies, bisulfite mutagenesis of DNA was carried out in agarose 
beads (Olek et al., 1996).   
For 8nrCG mutant studies, bisulfite mutagenesis was performed using MOD50 
Imprint DNA Modification Kit (Sigma-Aldrich) according to manufacturer’s protocol. 
For all other studies, bisulfite mutagenesis was performed using EpiTect Bisulfite 
Kit (Qiagen) following manufacturer’s protocols. 
7.7 PCR amplification of bisulfite DNA for sequencing or COBRA 
 
 Nested PCR was performed on bisulfite treated DNA.  50ng of DNA was used for 
the first round of PCR and 1µL of amplified DNA was used for second round PCR.  For 
PCR reaction PuReTaq Ready-to-go PCR beads (GE Healthcare) were used with .3µM 
primers in a final volume of 25µL.  All primers and PCR conditions are listed in bisulfite 
assays section.  For COBRA, 5-10µL of second round PCR product was cut with the 
appropriate enzyme as listed in section 7.8. 
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 For sequencing, second round PCR products were separated by gel 
electrophoresis on a 1% agarose gel.  The band was excised and purified using the 
QiaQuick Gel Extraction kit (Qiagen) according to manufacturer’s protocol and eluted in 
30µL dH2O.  Purified PCR product was cloned using the TOPO-TA kit (Invitrogen) 
follow manufacturer’s protocol.  A minimum of 10 clones from each sample were 
sequenced by the University of Pennsylvania Sequencing Facility.  Sequencing results 
were analyzed using MacVector.   
7.8 Bisulfite assays 
 
Region: H19 ICR Repeat1-2 
Accession: U19619 
Reference: (Tremblay et al., 1997) 
First round: 
  Primer 1: BMsp2t1 
  Sequence (5’-3’): GAG TAT TTA GGA GGT ATA AGA ATT 
Primer 2: BHha1t3 
  Sequence (5’-3’): ATC AAA AAC TAA CAT AAA CCC CT 
Second round: 
  Primer 1: Bmsp2t2c 
  Sequence (5’-3’): GTA AGG AGA TTA TGT TTA TTT TTG G  
  Primer 2: BHha1t4ct 
  Sequence (5’-3’): CTA ACC TCA TAA AAC CCA TAA CTA T 
Product size:  423 bp 
For COBRA: HinfI will cut a methylated sequence to produce 200 and 210bp 
fragments. 
PCR Conditions: denature 94 °C 2min; 35 cycles of denature 94°C for 10 sec, 
anneal 55°C 30 sec, extend 72°C 1 min 
NOTE- decrease ramping speed to annealing temp to .5°C/sec 
 
Region: H19 ICR Repeat 3 
Accession: U19619 
Reference: (Davis et al., 2000) 
First Round: 
  Primer 1: BHha5t2 
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  Sequence (5’-3’): TTG TGA GTG GAA AGA TTA ATT GTT TGG 
  Primer 2: BHha5t3 
  Sequence (5’-3’): ATA CAC ACA TCT TAG CAC CCC TAT AAA TCC  
C 
Second Round: 
  Primer 1: BHha5t 
  Sequence (5’-3’): TAG AGA TAG TTA AAG TTA AGG TTT GTT TAT 
G 
   Primer 2: BHha5t3 
  Sequence (5’-3’): ATA CAC ACA TCT TAG CAC CCC TAT AAA TCC 
C 
 Product size: 333 bp 
PCR Conditions: denature 94 °C 2min; 35 cycles of denature 94°C for 10 sec, 
anneal 55°C 30 sec, extend 72°C 1 min 
NOTE- decrease ramping speed to annealing temp to .5°C/sec 
 
Region: H19 ICR Repeat 4 
Accession: U19619 
Reference: (Thorvaldsen et al., 2002) 
First Round: 
  Primer 1: BTV3-1 
  Sequence (5’-3’): GGT AAA TTT ATG GGT TAT TTA AGG 
  Primer 2: BTV3-4 
  Sequence (5’-3’): CCC AAC CTC TAC TTT TAT AAC   
Second Round: 
  Primer 1: BTV3-2 
  Sequence (5’-3’): AAT GTT TAT AAG GGT TAT GGG GTG G  
  Primer 2: BTV3-3 
  Sequence (5’-3’): CCT AAA TTC AAT AAA ACA TTA CAA 
 Product size: 425 bp 
PCR Conditions: denature 94 °C 2min; 35 cycles of denature 94°C for 10 sec, 
anneal 55°C 30 sec, extend 72°C 1 min 
NOTE- decrease ramping speed to annealing temp to .5°C/sec 
 
Region: H19 Promoter Proximal 
Accession: U19619 
Reference: (Thorvaldsen et al., 2006) 
First Round: 
  Primer 1: B12 (BH19-0.9f) 
  Sequence (5’-3’): GTT GAG GAT TTG TTA AGG TGT TAT TGT 
  Primer 2: B14 (BH19-0.5r) 
  Sequence: AAT AAT AAC TAA TTT AAA CAC TCC TCA CC 
Second Round: 
  Primer 1: B13 (BH19-0.8f) 
  Sequence (5’-3’): GAG TGG TTA TGA TTG GTT AGT TTT TGA G 
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  Primer 2: B14 (BH19-0.5r) 
  Sequence: AAT AAT AAC TAA TTT AAA CAC TCC TCA CC 
 Product size: 380 bp 
PCR Conditions: denature 94 °C 2min; 35 cycles of denature 94°C for 10 sec, 
anneal 55°C 30 sec, extend 72°C 1 min 
NOTE- decrease ramping speed to annealing temp to .5°C/sec 
 
Region: Snrpn DMR 
Accession: AF081460 
Reference: (Lucifero et al., 2002) 
First round: 
Primer 1: SnrpnA 
  Sequence: TAT GTA ATA TGA TAT AGT TTA GAA ATT AG 
  Primer 2: SnrpnD 
  Sequence (5’-3’): AAT AAA CCC AAA TCT AAA ATA TTT TAA TC 
Second round: 
  Primer 1: SnrpnB 
  Sequence (5’-3’): AAT TTG TGT GAT GTT TGT AAT TAT TTG G 
  Primer 2: SnrpnC 
  Sequence (5’-3’): ATA AAA TAC ACT TTC ACT ACT AAA ATC C 
Product Size: 451 
For COBRA: HinfI will cut only methylated sequence at positions 262 and 316. 
PCR Conditions: 2 cycles; 94°C for 4 min, 55°C for 2 min, 72°C for 2 min. 35 
cycles; 94°C for 1 min, 55°C for 2 min, 72°C for 2 min 
 
Region: IG-DMR 
Accession: AJ320506.1 
Reference: (Takada et al., 2002) 
First round: 
Primer 1: IGDMRF1 
Sequence (5’-3’): TTA AGG TAT TTT TTA TTG ATA AAA TAA TGT 
AGT TT 
  Primer 2: IGDMRR1 
  Sequence (5’-3’): CCT ACT CTA TAA TAC CCT ATA TAA TTA TAC 
CAT AA 
Second round: 
Primer 1: IGDMR2FG 
Sequence (5’-3’): TTA GGA GTT AAG GAA AAG AAA GAA ATA 
GTA TAG T 
  Primer 2: IGDMR2RG 
  Sequence (5’-3’): TAT ACA CAA AAA TAT ATC TAT ATA ACA CCA 
TAC AA 
Product Size:  483  
For COBRA: HinfI will cut methylated fragment at positions 62 and 231. 
146 
 
PCR Conditions: 5 cycles of denature 94°C for 1 min, 50°C for 2 min, 72°C for 3 
min; 30 cycles of denature 94°C for 30 sec, 50°C for 2 min, 72°C for 1.5 min 
 
Region: Peg3 DMR 
 Accession: AF105262.1 
Reference: (Ma et al., 2010) 
 First Round: 
  Primer 1: Peg3A-BL 
  Sequence (5’-3’): TTT TGA TAA GGA GGT GTT T 
  Primer 2: Peg3D-BL 
  Sequence (5’-3’): ACT CTA ATA TCC ACT ATA ATA A 
 Second Round: 
  Primer 1: Peg3B-BL 
  Sequence (5’-3’): AGT GTG GGT GTA TTA GAT T 
  Primer 2: Peg3C-BL 
  Sequence (5’-3’): TAA CAA AAC TTC TAC ATC ATC 
 Product size: 446 
 For COBRA: EcoRV will cut methylated sequence to produce 114bp and 332bp 
fragments 
PCR Conditions: denature 94 °C 2min; 35 cycles of denature 94°C for 10 sec, 
anneal 55°C 30 sec, extend 72°C 1 min 
NOTE- decrease ramping speed to annealing temp to .5°C/sec 
 
7.9 LUminometric Methylation Assay 
 
500 ng of DNA was digested with 5 units of MspI and 5 units of EcoRI or 5 units 
of HpaII and 5 units of EcoRI in 20µL reactions. After a 4-hour incubation 15µL of 
Pyrosequencing annealing buffer (Qiagen) was added to each sample. 30µL of each 
sample was loaded into the Pyrosequencer and analyzed using the PyroMark MD 
(Qiagen) program with a nucleotide dispensation order of GTGTCACATGTGTG. The 
ratio of the MspI/EcoRI peaks (corresponding to nucleotides 9/10) was compared to the 
ratio the HpaII/EcoRI peaks (nucleotides 9/10) to determine genome-wide methylation 
levels. 
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7.10 Pyrosequencing of bisulfite treated DNA 
 
50-100 ng of bisulfite treated DNA was used for PCR. The PyroMark PCR kit 
(Qiagen) was used following the manufacturers protocol in a 25µL reaction. PCR 
conditions were: 95°C for 15 min followed by 45 cycles of 95°C for 15 sec, 55°C for 30 
sec and 72°C for 15 sec. For Grb10 annealing temperature was 54°C. 5µL of the 
biotinylated PCR product was used for each sequencing assay with the appropriate 
sequencing primer (see chart).  Pyrosequencing was performed using PyroMark Q96MD 
(Qiagen) system following the manufacturer’s protocol and the PyroMark Gold 96 
reagents kit (Qiagen). Methylation was analyzed using Qiagen’s Pyro Q- CpG software.  
See table 7.2 for primer sequences and number of CpGs analyzed. 
Table 7.2 Pyrosequencing assays 
DMR 
analyzed 
Forward PCR 
Primer (5’-3’) 
Reverse Biotinylated PCR 
Primer (5’-3’) 
Sequencing 
Primer (5’-3’) 
Number 
of CpGs 
Analyzed 
H19 GGGTAGGATATA
TGTATTTTTTAGG
TTG 
CTCATAAAACCCATAA
CTATAAAATCAT 
TGTAAAGATT
AGGGTTGT 
6 
IG-DMR GTGGTTTGTTATG
GGTAAGTTT 
CCCTTCCCTCACTCCAA
AAATTAA 
GTTATGGATTG
GTGTTAAG 
5 
Snrpn GGTAGTTGTTTTT
TGGTAGGATAT 
ACTAAAATCCACAAAC
CCAACTAACCT 
AAAAATGTGA
GTATGTGTAGT
TA 
7 
Peg3 GGTTTTTAAGGGT
AATTGATAAGG 
CCCTATCACCTAAATAA
CATCCC 
AATTGATAAG
GTTGTAGATT 
6 
Kcnq1ot1 TTTTGTGTGATTT
TATTTGGAGAGT 
CCTCAAAACCACCCCT
ACT 
GTAAGTATTTA
AGGTTAGAAG
TAGA 
7 
Mest GGAGGTTTTATAT
AAGTATTTGTTTT
T 
ACCACCCAACTAACAC
TAAA 
GGTTTTATATA
AGTATTTGTTT
TTT 
5 
Grb10 GTTGTTTATTATT
TGGTTGAGAG 
CTACAATAATCCAAAT
AATAAACAACTCC 
GTTGTTTATTA
TTTGGTTGAGA
G 
4 
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7.11 RNA extraction 
 
RNA was isolated using Trizol Reagent (Invitrogen) following manufacturer’s 
protocol.  RNA was dissolved in 50µL RNase free dH2O.  RNA was isolated from E6.5 
conceptuses using the Absolutely RNA Microprep Kit (Agilent Technologies) according 
to manufacturer’s protocol and eluted in 30µL Elution.  All RNA samples were stored at 
-80°C. 
7.12 Reverse transcription 
 
800ng of RNA was DNAse treated using RQ1 DNase (Promega) following 
manufacturer’s protocol.  Half of the DNAse treated RNA was used for reverse 
transcription with SSIII RT (Invitrogen) following the manufacturer’s protocol.  The 
remaining half of the DNAse treated RNA was used a negative control and underwent the 
same conditions except water was added instead of SSIII RT.  cDNA was diluted to 
~2ng/µL concentration. 
7.13 H19 allele-specific RNase protection assay 
 
For H19 RNase protection assay 5µg of RNA was used with the RPAIII RNase 
protection assay kit (Ambion) following manufacturer’s protocol. The probe was 
prepared from a 754 bp BamHI-StuI genomic DNA fragment.  RNase protection gels 
were exposed to storage phosphor screens that were scanned on a Typhoon Trio variable 
mode imager.   Band intensities were quantified using ImageJ.  
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7.14 Allele-Specific expression by RT-PCR and restriction digest 
 
~2ng of cDNA was used for an RT-PCR reaction.  For each reaction a master mix 
was prepared with a final concentration of 1x GoTaq (promega), .3µM primers (listed in 
table 7.3) in a final volume of 15µL.  PCR conditions were as follows 2 min at 95°C; 30-
35 cycles of 15 sec at 95°C, 15 sec at annealing temperature (listen in table 7.3), 20 sec at 
72°C.  Linear range for individual samples was determined and was usually between 30-
35 cycles.  10µL of amplification product was cut with appropriate restriction enzyme 
(listed in table 7.3).  Restriction Digests were resolved on a 12% acrylamide gel and band 
intensities were quantified using ImageJ. 
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Table 7.3 Allele-specific RT-PCR assays for imprinted genes on mouse chromosome 
7 
Gene Primers (5’-3’) Annealing 
Temp (°C) 
Product 
Size 
(BP) 
Restriction 
Enzyme 
Digested 
B allele 
band 
size (BP) 
Digested 
C allele 
band 
size (BP) 
Ascl2 Mas1:TGAGCATCCCACC
CCCCTA 
Mas2:CCAAACATCAGCG
TCAGTATAG 
58 474 SfcI 474 266, 207 
Cdkn1c P57-L: 
GCCAATGCGAACGGTG
CG 
P57-4: 
TACACCTTGGGACCAG
CGTACTCC 
60 364 TaqaI 306, 58 257, 58, 
49 
H19 HE2:TGATGGAGAGGAC
AGAAGGG 
HE4:TTGATTCAGAACG
AGACGGAC 
55 235 Cac8I 173, 62 2235 
Igf2 Igf2-18: 
ATCTGTGACCTCTTGAG
CAGG 
Igf2-20: 
GGGTTGTTTAGAGCCA
ATCAA 
58 200 MlucI 180, 20 165, 20, 
15 
Kcnq1 Lqt1:CATCGGTGCCCGT
CTGAACACG 
Lqt3:TTGCTGGGTAGGA
AGAGCTCAG 
60 189 BsmFI 189 113, 76 
 
Kcnq1ot1 Lit1F:AATTGGGAACTTG
GGGTGGAGGC 
Lit1R:GGCACACGGTAT
GAGAAAAGATTG 
60 814 StuI 814 601, 213 
Peg3 Pg4:ATGCCCACTCCGTC
AGCG 
Pg7:GCTCATCCTTGTGA
ACTTTG 
60 487 MnlI 110, 377 487 
Zim1 Zm1:CTTCAAGCAGAGC
ACAAAGC 
Zm3:GTGGCACACGAAA
GGTTTCTC 
59 490 FauI 490 236, 254 
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7.15 Allele-Specific Lightcycler assay 
 
Allele-specific analysis of Snrpn expression was performed using the LightCycler 
Real-Time PCR system (Roche).  ~2ng of cDNA was used for each sample.  Each 
reaction had primers (Sn1: 5’-CTCCACCAGGAATTAGAGGC-3’; Sn3: 5’-
GCAGTAAGAGGGGTCAAAAGC-3’) at .6µM concentration, probes at a .3µM 
concentration (SnMut: 5’-GAAGCATTGTAGGGGAAGAGAA-FL-3’; SnAnc: 5’-
RED40-GGCTGAGATTTATCAACTGTATCTTAGGGTC-P-3’), MgCl2 at 3.875mM 
concentration, PuReTaq Ready-to-go PCR bead (GE Healthcare) in a 20µL reaction.  The 
PCR conditions were as follows: denature 95°C 2 min; amplification 45 cycles of 95°C 1 
sec, 50°C 15 sec, 72°C 6 sec ; melt 95°C 1 min, 35°C 3 min, 40°C 1 min, 45°C 1 min, 
85°C 0 sec (.5°C/sec ramp); Cool 40°C 30 sec.  Analysis was performed using 
Lightcycler3 program. 
7.16 Relative quantification of expression 
 
Relative quantification of RNA levels was performed using the LightCycler Real 
Time PCR System (Roche).  ~2ng of cDNA was added to a PuReTaq Ready-to-go PCR 
bead (GE Healthcare), .3µM primers (listed in table 7.4), .38µL TaqStart Antibody 
(Clontech), 1x EvaGreen (Biotum, Inc.) and MgCl2 (listed in table 7.4).  All expression 
was normalized to the geometric mean of Rplp0 (acidic ribosomal phosphoprotein p0) 
and Gapdh (glyceraldehydes-3-phosphate dehydrogenase).   
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Table 7.4 Real time PCR assays 
Gene Primer (5’-3’) Final Mg2+ 
Conc. (mM) 
Annealing 
Temp (°C) 
H19 HE2:TGATGGAGAGGACAGAAGGG 
HE4:TTGATTCAGAACGAGACGGAC 
3 55 
Igf2 Igf2F:CGCTTCGTTTGTCTGTTCG 
Igf2R:GCAGCACTCTTCCACGATG 
3 58 
Mecp2 qMecp2F: 
CAGGCAAAGCAGAAACATCA 
qMecp2R: 
GCAAGGTGGGGTCATCATAC 
3 60 
Mbd1 qMBD1F: 
GAGCACAGAGAATCGCCTTC 
qMBD1R: 
CACACCCCACAGTCCTCTTT 
3 60 
Mbd2 Mbd269L: 
AACTGGAGGAGGCACTGATG 
Mbd269R: 
GGGGAAGGTCAGTCGAAAGT 
3 60 
Gapdh GapdhF1: 
ATCACTGCCACCCAGAACAC 
GapdhR1: 
ATCCACGACGGACACATTGG 
3 60 
Rplp0 Arbp0#72L: 
TCCCACTTACTGAAAAGGTCAAG 
Arpb0#72R: 
TCCGACTCTTCCTTTGCTTC 
4.5 58 
 
7.17 Cloning CpGfree1 and CpGfree3 
 
For cloning of CpGfree1, AatII (GACGTC) and XhoI (GAGCTC) restriction sites 
were inserted upstream of the CMV enhancer in pCpGvitro-neo-lacZ (Invivogen) using 
the QuikChange II XL Site-Directed Muatgenesis Kit (Stratagene) and the following 
primer sequences: for cloning of AatII- sense: 5’-
GTGAGCAAACAGCAGATTAAAAGGAAGACGTCTAGGTACCTTCCTGCAGGAG
TC-3’; antisense: 5’-
GACTCCTGCAGGAAGGTACCTAGACGTCTTCCTTTTATACTGCTGTTTGCTCA
C-3’. For cloning of XhoI- sense: 5’-
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GTGAGCAAACAGCAGATTAAAAGGAAGACGTCTACTCGAGTTCCTGCAGGAG
TC-3’; antisense: 5’-
GACTCCTGCAGGAACTCGAGTAGACGTCTTCCTTTTAATCTGCTGTTTGCTCA
C-3’. For cloning of CpGfree3, an XhoI (GAGCTC) restriction site was cloned at the 3’ 
end of the CMV enhancer in the CpGfree1 vector using the QuikChange II XL Site-
Directed Muatgenesis Kit (Stratagene) using the primer sequences; sense: 5’-
TAAGGTCAATAGGGGTGCTCGAGACTAGTGGAGAAGAGCA-3’; antisense: 5’-
TGCTCTTCTCCACTAGTCTCGAGCACCCCTATTGACCTTA-3’. 
Targeting vectors for the 8nrCG and 9CG mutant ICRs were digested with 
HindIII to obtain a 2.2kb ICR fragment.  A HindIII digest was also used to isolate the 
wild type H19 ICR from 129/SvJ lambda library.  These 2.2kb ICR fragments were 
cloned in pBluescriptII KS vector.  The pBluescriptII KS vectors containing ICR 
fragments were digested with AatII and XhoI.  The 1.8kb fragments were cloned into the 
CpGfree1 and CpGfree3 vectors. 
CpGfree1 and CpGfree3 were then either left unmethylated or were methylated 
using the CpG Methylase M.SssI (Zymoresearch) following manufacturer’s protocol.  
Methylation was confirmed by restriction digests with the methylation sensitive enzymes 
HpaII and HhaI. 
7.18 In vitro repressor assay in Hep3b cells 
 
Hep3b cells were cultured in 10% FBS (Gemini), DMEM+Glutamine (Gibco).  
On day 0, 1x106 Hep3b cells were seeded on a 10cm plate and incubated at 37°C 
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overnight.  On day 1 these cells were transfected with 1µg of either methylated or 
unmethylated CpGfree plasmids (linearized by digestion with Nhe1) using Lipofectamine 
2000 (Invitrogen) following manufacturer’s protocol.   On day 2, each transfected 6cm 
plate was passaged 1:2 onto 10cm plates.  Selection with 400µg/mL G418 was initiated 
on day 3 and selected for ~10-14 days.  After selection, protein lysates were collected and 
β-gal activity was measured using the High Sensitivity β-Galactosidase Kit (Agilent 
Technologies) following manufacturer’s protocol.  Total protein concentration was 
measured using the Coomassie Plus Protein Assay Reagent (Thermo Scientific) following 
manufacturer’s protocol. 
7.19 In vitro repressor assay in F9 cells 
 
F9 cells (obtained from Dr. Hua-Ying Fan, University of Pennsylvania) were 
cultures in 10% FBS (Gemini), DMEM+Glutamax (Gibco) on 1% gelatinized plates.  On 
day 0, .3x106 F9 cells were seeded on a 10cm plate and incubated at 37°C overnight.  On 
day 1 these cells were transfected with 1µg of either methylated or unmethylated 
CpGfree plasmids (linearized by digestion with Nhe1) using Lipofectamine 2000 
(Invitrogen) following manufacturer’s protocol.   On day 2, each transfected 6cm plate 
was passaged 1:6 onto 10cm plates.  Selection with 350µg/mL G418 was initiated on day 
3 and selected for ~10-14 days.  After selection, protein lysates were collected and β-gal 
activity was measured using the High Sensitivity β-Galactosidase Kit (Agilent 
Technologies) following manufacturer’s protocol.  Total protein concentration was 
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measured using the Coomassie Plus Protein Assay Reagent (Thermo Scientific) following 
manufacturer’s protocol. 
7.20 Isolation of F1 hybrid mouse embryonic fibroblasts 
 
F1 hybrid MEFs were isolated from individual E12.5-14.5 embryos generated 
from crosses between wild type B6 females and C7 males or Mbd2+/- (B6) females and 
Mbd2+/- (C7) males.   The liver was removed from embryos for genotyping. The 
remaining embryo was placed in a 6cm plate containing PBS (Gibco).  Under the tissue 
culture hood the embryo was places in 2.5 ml 0.1% Trypsin-EDTA (Gibco) and minced. 
After incubation at 37 °C for 30-45 min with occasionally agitation, the digested cells 
and tissues were transferred into a T75 flask with 12 ml MEF medium (10% FBS 
(Gemini), DMEM +Glutamax (Gibco)). When the cells became confluent, MEFs were 
split or frozen at Passage 2 (P2). For knockdown experiments, P4-P6 MEFs were used. 
7.21 siRNA knockdown in MEFs 
 
3 siRNA sequences targeting Mbd1, Mbd2 or Mbd3 (sequences listed in table 7.5) 
were generated from Invitrogen (Invitrogen Stealth siRNA) and diluted in 1mL RNase-
free water according to manufacturer’s protocol.  All sequences were tested using the 
following protocol and the sequences producing the best depletion (siMbd1#39, 
siMbd2#42 and siMbd3#38) were used for analysis.  
 1.4x104 MEFs/well were plated onto a 12-well plate in 5% FBS (Gemini), 
DMEM+Glutamax (Gibco).  These cells were transfected while in suspension using 
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lipofectamine 2000 (Invitrogen) and 2µL of individual siMbds, all 3 siMbds or a negative 
control siRNA which does not target any known sequence (Invitrogen), following 
manufacturer’s protocol.  Medium was changed after 4 hours and cells were cultured in 
10%FBS (Gemini) in DMEM+Glutamax (Gibco).  48 hours after initial transfection, a 
second transfection was performed with each well passaged into a well on a 6-well plate. 
The cells were transfected while in suspension using Lipofectamine 2000 (Invitrogen) 
and 5µl of the appropriate siRNA.  48 hours after second transfection, 85% of the cells 
were lysed for protein analysis with the remaining cells spun down for expression 
analysis.   
Table 7.5 siRNA sequences 
Name Sequence  
siMbd1#39 sense:GCACCUUAUGCCAUCCCAUUCCCAA 
antisense:UUGGGAAUGGGAUGGCAUAAGGUGC 
siMbd1#38 sense:GAUUGCGUCCAUAUCAGACCCAUCA 
antisense:UGAUGGGUCUGAUAUGGACGCAAUC 
siMbd1#37 sense:UGGAAACGCCGAGAGUCCUUUCGAA 
antisense:UUCGAAAGGACUCUCGGCGUUUUCCA 
siMbd2#42 sense:GGAAAUGCUGUUGACCUUAGCAGUU 
antisense:AACUGCUAAGGUCAACAGCAUUUCC 
siMbd2#41 sense:GCGAGUCCAACAAGUACGCAAGAAA 
antisense:UUUCUUGCGUACUUGUUGGACUCGC 
siMbd2#40 sense:CCCUGCUGUUUGGCUUAACACAUCU 
antisense:AGAUGUGUUAAGCCAAACAGCAGGG 
siMbd3#59 sense:GAGUGGGCCCUGGCUGUACAGAUGA 
antisense:UCAUCUGUACAGCCAGGGCCCACUC 
siMbd3#58 sense:CCUUUGACAUUGCAGAAGAACUGGU 
antisense:ACCAGUUCUUCUGCAAUGUCAAAGG 
siMbd3#38 sense:UCCGCACCGGAAAGAUGUUGAUGAA 
antisense:UUCAUCAACAUCUUUCCGGUGCGGA 
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7.22 Culturing trophoblast stem cells 
 
TS cells (obtained from Dr. Michael Golding, Texas A&M University) were 
cultured as described previously (Himeno et al., 2008).  Briefly, TS cells were cultured 
on mitomycin-C treated MEFs in TS medium (RPMI 1640 (Gibco) supplemented with 
20%FBS (HyClone), 2-mM L-glutamine (Gibco), 1mM sodium pyruvate (Gibco), 
100mM 2-mercaptoethanol, 50U/mL penicillin, 50µg/mL streptomycin) with 1X FGF4 
and Heparin (F4H) (Sigma) added fresh.  TS cells can also be cultured in 70% MEF-
conditioned medium (CM) 30% TS medium 1.5X F4H.  To make the CM, mitomycin-C 
treated MEFs were plated at a high density and cultured in TS medium without F4H for 
at least 72 hours. The CM was harvested and centrifuged at 1000 rpm for 20 min to 
remove cellular debris.  The supernatant was collected and passed through a 0.2 µm filter 
and frozen at -20°C. 
 For culturing TS cells, medium was changed every 48 hours, and fresh F4H was 
added each time. To passage TS cells, cells were treated with 0.05% Trypsin-EDTA at 37 
°C for 3 min and were split 1:5 to 1:20. To collect TS cells without MEF contaminants, 
cells were trypsinized and replated in 70% CM + F4H for 45 min. The supernatant was 
transferred to a new plate for another 45 min. This supernatant contained predominantly 
TS cells. 
To ensure TS cells did not differentiated we analyzed expression of the 
pluripotency genes Esrrb, mEomes, Fgfr2 (table 7.6) and a marker of differentiation, 
Ascl2 (as described previously in table 7.3).  ~2ng of cDNA was used for each RT-PCR 
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reaction containing 1X GoTaq (promega) and .3µM of the appropriate primer. The PCR 
conditions for pluripotency markers were: 2 min at 95°C; 35 cycles of 15 sec at 95°C for 
10 sec, 15 sec at 55°C, 20 sec at 72°C 
Table 7.6 RT-PCR assays for pluripotency markers 
Gene Primer Sequence (5’-3’) 
Essrb Esrrb-c286f: ACTCTGCATCCCGGACCCCC Esrrb-c473r: GCGTGGGTGCTCAGGGCAAT 
mEomes mEomes-F: GTGACAGAGGACGGTGTGGAGG 
mEomes-R: AGAGGAGGCCGTTGGTCTGTGG 
Fgfr2 Fgfr2-F: GACAAGCCCACCAACTGCACC Fgfr2-R: CGTCCCCTGAAGAACAAGAGC 
 
 7.23 siRNA knockdown in TS cells 
 
9.1x104 TS cells/well were plated into each well of a 12-well plate in 
70%CM+1.5XF4H.  These cells were transfected while in suspension using 
lipofectamine 2000 (Invitrogen) and 2µL of siMbd1 #39, a negative control siRNA 
(Invitrogen), or a fluorescent RNA (Invitrogen) following manufacturer’s protocol.  
Medium was changed after 4 hours and cells were cultured in 70%CM+1.5XF4H.  48 
hours after initial transfection, a second transfection was performed with each well 
passaged into a well on a 6-well plate. Cells were transfected while in suspension using 
Lipofectamine 2000 (Invitrogen) and 5µL of the appropriate RNA.  24 hours after second 
transfection, fluorescence was detected to determine transfection efficiencies.  48 hours 
after second transfection 85% of the cells were lysed for protein analysis with the 
remaining cells spun down for expression analysis.   
7.24 Cloning shRNA into a lentiviral vector 
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 shRNAs against Mbd1 and Mecp2 were cloned into the PLKO.1(Addgene) 
lentivirus vector.  siMbd1#39 sequence was used to target Mbd1 and the sequence used to 
target Mecp2 was that used in (Zhou et al., 2006).  For converting sequences into an 
shRNA and cloning into PLKO.1, oligos were ordered following the scheme: forward 
oligo: 5’CCGG-sense sequence-CTCGAG-antisense sequence-TTTTTG3’ reverse oligo: 
5’AATTCAAAAA- sense sequence- CTCGAG-antisense sequence.  Therefore, the 
following oligos were ordered to target Mbd1: Mbd1-39F:5’-
CCGGGCACCTTATGCCATCCCATTCCCAACGAATTGGGAATGGGATGGCATA
AGGTGCTTTTTG-3’; Mbd1-39R: 5’-
AATTCAAAAAGCACCTTATGCCATCCCATTCCCAACGAATTGGGAATGGGAT
GGCATAAGGTGC-3’.  To target Mecp2 the following oligos were ordered: Mecp2F:5’-
CCGGGTCAGAAGACCAGGATCTCCGAAGAGATCCTGGTCTTCTGACTTTTTG-
3’; Mecp2R:5’-
AATTCAAAAAGTCAGAAGACCAGGATCTCCGAAGAGATCCTGGTCTTCTGAC-
3’. 
Oligos were resuspended in dH2O to a concentration of 20µM and annealed by 
mixing 5µL forward oligo, 5µL reverse oligo, 5µL 10x NEB buffer 2 and 35µL dH2O.  
The reaction was incubated at 95°C for 4 min.  The heat block (containing the reaction) 
was then placed at room temperature and allowed to cool over 4 hours.  The reaction was 
purified using Qiagen’s QIAquik PCR purification kit.  The annealed oligos were 
phosphorylated using T4 PNK (New England Biolabs) following manufacturer’s 
protocol. 
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For cloning annealed oligos into the pLKO.1 vector, the vector and annealed 
oligos were digested with AgeI and EcoRI.  The digested fragment and vector were 
ligated together and transformed using DH5α chemically competent cells (Invitrogen) 
following manufacturer’s protocol.   
DNA from individual clones was digested with EcoRI and NcoI to ensure 
insertion of the shRNA sequence into the vector.  Positive clones produce ~2kb and ~5kb 
fragments, whereas an empty vector will produce ~2kb and ~7kb fragments.  Positive 
clones were sequenced with the PLKO.1 sequencing primer (5’-
CAAGGCTGTTAGAGAGATAATTGG-3’).   
To produce viral particles, ~70% confluent 15cm plate of 293T cells (cultured in 
10%FBS (Gemini), DMEM+Glutamax (Gibco)) was transfected with 15µg pLKO.1 
shRNA plasmid, 11.25µg psPAX2 packaging plasmid (Addgene) and 3.75µg pMD2.G 
envelope plasmid (Addgene) using Lipofectamine 200 (Invitrogen) following 
manufacturer’s protocol.  After overnight incubation at 37°C the medium was replaced 
with 25mL fresh DMEM+Glutamax (Gibco) +10%FBS (Gemini) +1/100 
penicillin/streptomycin (University of Pennsylvania Cell Center) +1/100 non-essential 
amino acids+ 1/100 sodium pyruvate (Gibco). Supernatant was harvested 76 hours later.  
For concentration of Lentivirus, supernatant was filtered through a .45µm filter 
and spun for 1.5 hours at 28000 x g at 4°C.  The pellet was resuspended in 500µL of PBS 
(Gibco) and left overnight at 4°C.  The virus was aliquoted the following day and stored 
at -80°C. 
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To titrate the lentiviruses, 293T cells were infected with varying dilutions of virus 
and treated with 1.5µg/mL puromycin. Numbers of viable cells after 4-6 days of drug 
selection were counted and the virus titer were calculated. 
7.25 shRNA knockdown in MEFs 
   
3.5x105 Mbd2-/- MEFs were plated into each well of a 6 well plate and incubated 
at 37°C overnight.  Cells were infected with 30 MOI of viruses containing shMecp2, 
shMbd1, both or shControl in 8µg/mL polybrene (American Bioanalytical).  24 hours 
after infection cells were passaged onto a 6 cm plate and puromycin treatment (at a 
concentration of 1.2µg/mL) was initiated.  24 hours into selection, cells were re-infected 
with 30 MOI shMecp2 (only shMecp2 required 2 rounds of infection).  48 hours into 
selection cells were passaged onto a 10cm plate.  ~7 days after selection cells were 
collected with ~75% of cells lysed for protein analysis and 25% of cells pelleted for RNA 
analysis. 
7.26 shRNA knockdown in TS cells 
 
5.5x105 TS cells were plated into each well of a 6 well plate (cultured in 
70%CM+1.5F4H) and incubated at 37°C overnight.  Cells were infected with 30 MOI of 
viruses containing shMbd1or shControl in 8µg/mL polybrene (American Bioanalytical).  
24 hours after infection cells were passaged onto a 6 cm plate and puromycin treatment 
(at a concentration of 1.75µg/mL) was initiated.  48 hours into selection cells were 
162 
 
passaged onto a 10cm plate.  ~7 days after selection cells were collected with 75% of 
cells lysed for protein analysis and 25% of cells pelleted for RNA analysis. 
7.27 Western blot analysis 
 
Cell pellets were lysed with TNE (100 mM Tris, pH 7.4; 1% NP-40; 10 mM 
EDTA) buffer with 1:100 Proteinase inhibitor cocktail (Sigma) and 1 mM DTT.  
Embryos and placentas were lysed in 5X RIPA buffer and vortexed for 5 min.  Total 
protein concentration was measured using the Coomassie Plus Protein Assay Reagent 
(Thermo Scientific) following manufacturer’s protocol.  Lysates were mixed with 5X 
loading buffer, denatured by heating at 95°C for 10 min.  20µg of total protein was 
fractionated on an 8% SDS-PAGE gel. The protein was transferred to a nitrocellulose 
membrane (BioRad), blocked in 5% milk in TBST (0.05% Tween-20 in 1X TBS) and 
probed with primary antibodies (as listen in table 7.7) overnight and secondary antibodies 
for one hour (HRP-conjugated anti-rabbit (1:2500 dilution), GE Healthcare). The blot 
was visualized using chemiluminescence (ECL Plus; GE). Quantification was performed 
using ImageJ. 
Table 7.7 Antibodies used for western blot 
Antibody raised 
against 
Company Lot# Dilution Secondary 
MBD1 Santa Cruz C161 1:200 Rabbit 
MECP2 Dr. Zhaolan Zhou , 
University of 
Pennsylvania 
 1:2000 Rabbit 
RAD21 Bethyl A300-080A-3 1:500 Rabbit 
GAPDH Cell Signaling 8 1:1000 Rabbit 
Flag-tag Sigma M2 1:1000 Mouse 
 
163 
 
7.28 Cloning of MBD overexpression vector 
 
Primers were designed to include amino acid 76 through amino acid 160 of 
MECP2, which deletion studies defined as the MBD (Nan et al., 1993).  Primers also 
included sequences in order modify the MBD to contain a C-terminal flag-tag and an N-
terminal SV40 nuclear localization signal.  Oligos also included a BamHI restriction site 
(GGATCC) to be included 5’ of the flag sequence and a SalI restriction site (GTCGAC) 
to be included 3’ of the NLS sequence.   Primer sequences were as follows:  
MBDBAMAA76F:5’- 
AAAAGGATCCATGGATTACAAGGATGACGACGATAAGCCTCGGCTTCCCCCA
AACAGCGG-3’; MBDAA163R: 5’- 
AAAAGTCGACTCAAACCTTCCGTTTCTTTTTCGGGGGCTCCCTCTCCCAGTTA
CCGTGA-3’.  2ng of cDNA derived from a wild type adult mouse was added to a 
reaction mix with 1X GoTaQ (promega), .3µM of the primers listed above in a 20µl final 
reaction.  PCR conditions were as follows 2 min at 95°C; 35 cycles of 15 sec at 95°C, 15 
sec at 55°C, 20 sec at 72°C.   
 Amplified fragments were run out on a 1% agarose gel and the band was excised 
and purified using the QiaQuick Gel Extraction kit (Qiagen) according to manufacturer’s 
protocol and eluted in 30µL dH2O.  Purified PCR product was cloned using the TOPO-
TA kit (Invitrogen) follow manufacturer’s protocol.   
 The Topo vector containing the MBD fragment and the retroviral pBabe-puro 
expression vector (Morgenstern and Land, 1990) (obtained from Dr. Xiaolu Yang, 
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University of Pennsylvania) were digested with BamHI and SalI.  The pbabe-puro vector 
and MBD insert fragments were ligated and transformed in chemically competent Top 
10F cells (Invitrogen) following manufacturer’s protocol.  Positive clones were identified 
by presence of the ~350bp fragment after digestion with BamHI and SalI.  One positive 
clone was sequenced by the University of Pennsylvania Sequencing Facility using 
primers overlapping the MBD: (qMBDF: 5’-CCGGGGACCTATGTATGATG-3’; 
qMBDR:  5’-AGGAGGTGTCTCCCACCTTT-3’). 
7.29 MBD overexpression in F1 hybrid MEFS 
 
 To produce viral particles, 5µg of DNA (either pBabe-MBD or pBabe) was 
transfected using CaCl2 into Pheonix-E cells (obtained from Dr. Xiaolu Yang, University 
of Pennsylvania) and cultured in 10%FBS (Gemini), DMEM+Glutamax (Gibco).  The 
transfected cells were incubated overnight at 37°C and medium was replaced with 2 mLs 
of fresh medium.  The following day, the viral containing medium was harvested and 
spun down at 1,000 RPM for 5 minutes to collect any cellular debris.  2mLs of fresh 
medium was added to the transfected Pheonix-E cells.   5.5x105 MEFS were resuspended 
in the 2mLs of viral supernatant with 8µg/mL of polybrene (American Bioanalytical) and 
500µL of fresh medium in a 6 well plate.  The next day, the MEFS were passaged onto a 
6cm plate and resuspended in new viral medium from the Pheonix-E cells.  24 hours after 
the second round of infection, cells were treated with puromycin at a concentration of 
1.2µg/mL.   Puromycin concentration was increased daily until it reached 2µg/mL.  Cells 
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were collected for analysis after ~7 days in selection with ~25% of cells used for RNA 
analysis and ~75% used for protein analysis. 
 Overexpression of the Mecp2 MBD was quantified using the the LightCycler 
Real-Time PCR system (Roche). ~2ng of cDNA was added to a PuReTaq Ready-to-go 
PCR bead (GE Healthcare), .3µM primers qMBDF, qMBDR (listed section 7.28), .38µL 
TaqStart Antibody (Clontech), 1x EvaGreen (Biotum, Inc.) and 3µM MgCl2.  PCR 
conditions followed those outlined in section 7.16 with and annealing temperature of 
58°C. All expression was normalized to the geometric mean of Rplp0 (acidic ribosomal 
phosphoprotein p0) 
7.30 Statistical analysis 
 
 To calculate P-value for gene expression changes and β-gal activity changes, a 
two-tailed paired T-test was used.  For analysis of DNA methylation a P-value was 
calculated using a chi-squared test comparing the proportion of mutant and wild type 
samples showing abnormal methylation (sperm: methylation levels > 15% for maternally 
methylated DMRs and < 85% for paternally methylated DMRs; somatic tissues: 
methylation levels < 40% or > 60%).  A P-value was considered significant if <.05. 
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